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Polymer Microarrays - 
Development and Applications 
Guilhem Tourniaire 
The global aims of this PhD were to investigate and develop high throughput methods for 
screening libraries of biocompatible polymers. 
Initial studies involved the development of a novel polymer microarray platform which would 
provide unsurpassed miniaturisation for polymer screening. This required substantial 
development and optimisation of several parameters and the best results were achieved by 
printing polymers dissolved in 1 -methyl-2-pyrrolidinone and patterned using a contact 
microarrayer with solid pins. In order to obtain minimal background interference while 
studying the adsorption of proteins and the adhesion of living cells on the polymers, 
microarray platforms were developed that used different substrates. The first one used a gold-
coated substrate that quenched non-specifically bound fluorescently-labelled proteins, 
whereas the second utilised a hydrogel coating that prevented non-specific cellular adhesion. 
Additionally, it was shown that the platform using the gold coated substrate was ideally suited 
to the high throughput study of the physico-chemical properties of the arrayed polymer 
libraries, via scanning electron microscopy, FT-IR and TOF-SIMS. These polymer 
microarray platforms provided high throughput while minimising the amount of both 
polymers and expensive reagents used. 
To demonstrate the range of properties displayed by the polymer libraries and their versatility 
the polymer microarrays were used with both adherent and non-adherent immortalised cell 
lines. In both cases, it was demonstrated that polymers could be selected that provided 
selective cellular immobilisation. Such methodologies were subsequently utilised to identify 
novel materials that allowed gentle immobilisation of human primary renal tubular epithelial 
cells and mouse bone marrow dendritic cells. 
This platform was applied to the identification of polymers with potential applications in the 
field of stem cell biology. In one project, polymers were screened for the selective 
immobilisation of multipotent mesenchymal stromal cell populations from human bone 
marrow. Initial results showed that several poly(urethanes) with large soft segments provided 
unexpectedly high selective adhesion of the stromal population. The second project 
investigated the use of novel substrates that maintained mouse embryonic stem cell cultures in 
their undifferentiated phenotypic state. 
Finally, the polymer microarray platform was optimised for the study of protein adhesion. 
Initial experiments showed that this platform could be applied to a range of plasma and glyco-
proteins. It was demonstrated that different proteins showed very different patterns of 
adsorption over the printed polymers. As a result, it was hypothesised that such platforms 
may have the potential to be used as diagnostic tool for the identification of proteins in 
biological samples and serum profiling applications. 
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Chapter 1: Introduction 
1.1 Microarray 
1.1.1 Introduction 
The Encarta dictionary defines an array as: "a group of things arranged in an impressive 
or structured way" hence literally, a microarray is a microscopic group of things 
arranged in an impressive or structured way. In molecular biology, a microarray can be 
described as a collection of distinct capture molecules attached or deposited onto a 
substrate at defined locations. 
One of the first application of microarrays was described over ten years ago by Mark 
Schena el al.', who developed an array of cDNA probes to monitor the expression of 45 
Arabidopsis genes in parallel. Since then, many different types of capture molecules 
(including antibodies, proteins, carbohydrates, small molecules and biomaterials) have 
been immobilised, allowing the study of a wide range of biological, chemical and 
medicinal systems. In all cases the key facet of microarrays is that they allow multiple 
tests to be performed in a single experiment. Over the past ten years, developments in 
the field of microarrays have required contributions from many areas of basic science, 
engineering and computing. Today, microarrays continue to evolve and provide essential 
tools in many areas of research. Their applications generally fall into one of the three 
following categories 2 : 
• Survey arrays are used to identify patterns within a very large number of 
samples. 
• Scan arrays have been developed for diagnostics. They contain fewer probes 
that have been carefully selected resulting in more robust and easily interpreted 
results. 
• Efficient arrays refer to techniques that do not require assays to be run in 
parallel but take advantage of the high multiplexing capability of arrays resulting 
in reduced time, cost and material. 
The quality of the data generated depends upon the physical quality of the arrays and 
control of the variables used for manufacturing such arrays. When developing new 
applications, researchers are faced with an ever increasing choice of parameters such as 
the type of surfaces and capture molecules used, the methods of immobilisation, 
detection and analysis employed. 
1.1.2 Surfaces and immobilisation 
The surfaces used to create an array must be optimised for the immobilisation of the 
biomolecule of interest, as well as preventing the non-specific binding of the target 
molecules. The choice of a given surface will have major influences on the method of 
immobilisation, the concentration and retained bioactivity of the probes immobilised, 
and finally, the ease of interaction/binding between probes and targets. When developing 
an array containing multiple probes, homogeneity in concentration and activity of the 
different probes is critical to the success of any assay. 
1.1.2.1 Type of immobilisation 
The immobilisation of a given biomolecule will be affected by a combination of the 
nature of the surface, the properties of the biomolecule and the liquid medium in which 
it is delivered. The mechanism of immobilisation of biomolecules on a surface can be 
divided into two main categories 3 : 
Adsorption, which relies on non-covalent interactions between the biomolecules 
and the surface. These interactions can be classified according to their relative 
strength: Electrostatic interactions (10-20 Kcal/mol) arise from the presence of 
charge on the substrate and biomolecule. Hydrogen bond interactions (3-7 
Kcal/mol) originate from the interaction of an electronegative atom and a 
hydrogen atom, which is bonded to another electronegative atom. Van der Waals 
(1-2 Kcal/mol) forces arise from the polarisation of molecules into dipoles, and 
hydrophobic forces (1-2 Kcal/mol) are generated from nonpolar molecules that 
tend to self-associate in the presence of aqueous solution. 
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• Covalent immobilisation, which relies on the formation of an irreversible 
chemical bond between the biomolecules and the functionalised surface. The 
formation of such bonds is generally achieved through the reaction of functional 
groups such as an amine or a thiol on the biomolecule and aldehyde or epoxide 
of active ester on the substrate 4 . Recently, versatile strategies based on the 
reactions of photoactivated carbene 5 have allowed the covalent immobilisation of 
a variety of proteins  and small molecules 7 . This approach benefits from the high 
reactivity of the carbene which readily undertakes an insertion reaction with a 
variety of chemical bonds: C-H, 0-H, C-Cl, N-H, Si-H and C=C. 
1.1.2.2 Type of surface 
Depending on the intended application, the surface may need specific properties such as 
thermal and chemical stability, flatness and homogeneity. Additionally the substrate 
must be compatible with the detection method used in order to achieve high sensitivity. 
For example, if fluorescence is used as a detection method then the surface should have 
a low fluorescent background. 
In the light of the commercialisation of microarrayers and detection systems, surface 
formats have been standardised, with a compact microscope slide format, with a printing 
area of up to 75 mm x 25 mm allowing over 20,000 thousands spots (50 tm diameter) to 
be printed on a single slide. Currently, this format has become a standard, however, it 
should be noted that many other formats are still being used, such as the bottom of 
multiwell plates, which allowing smaller arrays to be interrogated with different analytes 
in each well 8 . 
Regarding the chemical nature of the surfaces, there is a huge range on offer depending 
on the desired application and the biomolecules to immobilise. The most widely used 
substrates are based on glass slides. Glass substrates are reasonably flat, transparent, 
resistant to high temperature and easy to handle, but more importantly, there is a wide 
range of well established protocols for the modification of their surface properties 4 . 
Silicon substrates are also suitable for functionalisation 9 . Gold substrates have been 
employed for several applications as they can easily be functionalised by self-assembled 
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monolayers (SAMs) of alkane thiolates lo . SAMs consists of a single layer of molecules 
on a substrate. These SAMs allow patterning via photolithographic techniques". SAMs 
of alkyl thiolates on gold are photosensitive; as a result, they can be selectively patterned 
by exposure to ultraviolet light (UV) through a Photomask (Figure 1.5). Finally, gels 
and membranes have also been used as substrates since they provide a three dimensional 
architecture with greater capacities of immobilisation and thus enhanced detection 
sensitivities 12 . 
The choice of substrate and surface chemistry has a major impact on the performance of 
any type of microarray assay and should be carefully selected for any given application. 
1.1.3 Printing technologies 
One of the cornerstones of microarray technologies is the ability to deliver nano- and 
picoliter volumes of materials onto a substrate in a defined pattern with speed, 
reproducibility and at high density. This capability has been aided by the emergence of 
several new companies that have focussed on developing robotic instrumentation to 
achieve these goals. Currently, there are a huge range of different technologies available, 
however, none is perfect and they should be carefully selected depending on the 
intended application. In order to give an overview of the subject, these printing systems 
will be divided into two main technologies: contact-printing (sometimes referred to as 
pin-printing) and reagent jetting (also called ink-jet based deposition) technologies. 
1.1.3.1 Contact printing" 
The term "contact printing" found its definition in the fact that at a given point in the 
process there is continuity between the transfer device (pin), the solution delivered and 
the substrate onto which the solution is deposited. This technology is based around a 
high precision X-Y-Z robot that holds one or more pins that are dipped into the solution 
contained in the source plate (usually a 384 well plate), and then deposited by contact 
onto the substrate. The main factors affecting this printing are a combination of the 
physical and chemical properties of the pin(s), the solution(s), the substrate and the 
printing parameters of the robot (speed and number of deposition). Among the most 
important properties are the viscosity and surface tension of the liquids, the wetting 
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characteristics of both the substrate and pins and finally parameters controlling the robot 
such as speed of deposition. Additionally, external factors like humidity and temperature 
can affect the quality of the printing. 
Initial experiments were carried out with a simple solid pin but over recent years many 
different pin designs have been developed allowing a wide range of feature sizes, each 
of which have some advantages and some drawbacks (Figure 1.1). 
A 	 B 
 II::!. jjJ 	JJJ 
Figure 1.1 Contact printing pins, (A) & (B) solid pin and spilt pins, respectively, with a 
magnj/Ication of their head, (C) ring and pin .system with an illustration of its motion 
through the film of liquid within the ring. 
Solid pins: 
Solid pins are plain needles that must be washed and re-loaded after every deposition. 
As a result only a single spot is created by inking. The size of the feature created (which 
is related to the amount of liquid transferred) can be modified by changing the diameter 
of the pin used. The main advantages of these devices are their low sample wastage, 
excellent spot-size reproducibility and robustness. 
Split and Stealth 14  pins: 
Split and Stealth pins were inspired by the design of traditional ink pens, in which a slit 
is used to draw up ink. The Stealth pins are amongst the most widely used pins. Their 
main advantage is that they allow the deposition of hundreds of spots without having to 
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reload. On the down side, these pins can easily become damaged resulting in non-
uniform depositions. They also waste a lot of sample (>70%),as they require a pre-
blotting step in order to obtain uniform spot size, and are sensitive to sample 
evaporation' . 
Ring am/pin' 6: 
This system captures a film of liquid within a ring by dipping it into the sample solution. 
The deposition is performed by a solid pin travelling through the liquid film, which 
subsequently transfers a drop of solution onto the substrate without disrupting the liquid 
film in the ring. In this design the ring acts as a reservoir allowing multiple printing of 
the same solution. The main drawbacks of this technique are the large dead volume used 
to generate the ring, and the stability of the film, which can be affected by factors such 
as humidity and temperature. 
Many other pin based technologies (including Hitachi X-cut pin 17, capillary pins, dip-
pen nano lithography' 8) have been recently developed, but it is too early to evaluate the 
impact that these devices will have in the field of array production. 
1.1.3.2 Non-contact printing 19 
Inkjet systems are the more advanced of the printing systems, and rely on technology 
commonly used in desktop printers, where extremely small volumes of solution are 
deposited without contact between the dispensing tip and substrate. The main 
advantages of this system compared with the contact printing are gentle deposition, 
enabling printing on fragile substrates, and better control of the quantities of liquid 
delivered, allowing a wider range of spot sizes to be printed. These systems can be 
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Figure 1.2 Inkjet printing systems, cross sectional view of inkjet nozzles illustrating the 
generation of droplets, (A) thermal jet, (B) piezo jet, (C) solenoid jet. 
Thermal jet: 
The thermal jet, also called a bubble jet, is based on the rapid heating of the solution 
(using resistance), which generates a vapour bubble that forces the liquid out of the 
nozzle. One of the main limitations of these printers arises from the fact that they were 
optimised for specific ink composition, printing densities and substrates. These 
limitations probably explain why no microarrayer manufacturer has actually 
commercialised such a design. Nevertheless, due to very affordable costs, several 
researchers have published work that used modified desktop printers for the delivery and 
patterning of biomolecules20 . 
Piezo jet: 
The piezo jet is probably the most popular non-contact system; it uses a pressure wave 
generated by a rapid dimensional change of a piezoelectric material to eject a droplet 
from the nozzle. Commercial desktop printers use dozens to hundreds of such nozzles, 
however, most piezo-based microarrayers use a single channel. In this system, the liquid 
delivery is controlled by the duration and amplitude of the voltage applied to the piezo 
material allowing up to several hundred spots to be delivered per second. The size of the 
spot generated is usually closely related to the diameter of the nozzle, however, it can 
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easily be increased by delivering several spots in the same position. Microdrop GmbH 
uses piezo technology in combination with a heated nozzle 21  allowing the printing of 
highly viscous liquids such as waxes. 
Solenoid jet: 
The solenoid jets use electrically controlled high speed valves that prevent the 
pressurised reagent from leaking out of the nozzle. These allow unsurpassed control of 
delivered solutions varying from a few nanoliters to several microliters 22. Unlike the 
previous systems, the volume dispensed is directly proportional to the pulse width which 
controls the valve opening. The main limitation of this system comes from the lower 
limit of volume delivery (-1 nI), which is too large to produce high density microarrays. 
1.1.4 Detection methods 
The adaptation of diverse assays to microarray formats has led researchers to investigate 
the use of various detection methods, some of which were previously used in other 
assays, and some that were specially designed for microarray applications. The most 
important parameters dictating the quality of a detection technique are described 
below23 : 
. The sensitivity is related to the lowest detectable amount of a given analyte (also 
referred to as the limit of detection). 
. The resolution is the smallest change in quantity that can be detected. In a 
multiplex assay, it can also be used to describe the ease by which two different 
analytes can be analysed. 
. Signal-to-noise ratio (S/N) is the ratio of the measured value (signal) to the 
background value (noise). In a microarray, S/N is often given by the intensity of 
the analyte over the intensity level given by the non-specific binding on the 
substrate or the intrinsic background value of the substrate. 
. The specificity of a binder is the ability of its binding site to distinguish between 
the ligand to which the binder is specific, and other compounds. It is particularly 
important when using multiplexed detection, such as mixture of antibodies where 
cross-reactivity can reduce both the sensitivity and S/N of an assay. 
-8- 
The dynamic range represents the range of concentrations (usually expressed as 
a log value) over which a given detection system is able to measure an analyte. 
In fluorescence, this range is between the lowest detectable amount (taking into 
account the background), and the amount giving rise to signal saturation. 
When assessing a detection method many others factors will also come into play 
including cost, reproducibility, ease of development and safety. An ideal detection 
method would have high sensitivity, resolution, signal-to-noise ratio, specificity and 
reproducibility, a large dynamic range and a low cost. None of the detection methods 
currently available are perfect, and it is the duty of the assay developer to assess which 
parameters should dictate the selection of any specific method. 
The detection methods used in the field of microarrays can be divided into two main 
categories: 
. Label-based detection using a chemical that can be readily visualised (such as a 
dye) attached to the molecule to be detected. 
. Label-free detection, which "directly" detects the molecule of interest. 
1.1.4.1 Label-based detection 
A wide range of labels have been adapted for use in a microarray format, which are 
classified by the different physico-chemical properties they encompass. The most 
popular labels are based on fluorescence, chemi luminescence, and radioactivity. Label-
based detection can be divided into two sub-categories. Firstly, when the label is directly 
attached to the molecule of interest (direct labelling) or, secondly, when the label is 
bound to another molecule that specifically recognises the molecule of interest (indirect 
labelling) to provide a mean of detection (for example, using a fluorescently labelled 
antibody to detect an immobilised antigen). Direct labelling is usually less labour-
intensive, however, the presence of a label can alter the conformation and reactivity of 
the molecule to which it is attached. The use of an indirect method allows signal 
amplification, which can significantly increase the sensitivity and resolution of an assay. 
Fluorescence: 
Fluorescence detection is based on the use of dyes that absorb photons when illuminated 
at a specific wavelength, and which are subsequently re-emitted at a lower frequency 
(higher wavelength). Fluorescence dyes are easy to manipulate, are widely available, 
and they provide high sensitivity, quantitative measurements over large dynamic ranges 
and also allow multiplexing 24 . As a result, the majority of the research published in the 
area of microarrays uses fluorescent-based detection. 
Several approaches have been developed to further enhance the stability and sensitivity 
of fluorescent assays, such as the use of fluorescent dendrimers to amplify the detection 
of oligonucleotides 25, or the use of semiconductor nanocrystals (1-1 Onm), commonly 
referred to as Quantum-dots 26 '27 . These are usually brighter and more stable than organic 
fluorophores, and their fluorescent properties can easily be tuned by modifying their size 
and composition, furthermore, they display very narrow bandwidth emissions allowing 
for highly multiplexed applications. The main limitations in fluorescence detection come 
from detector sensitivity and the auto-fluorescence of the background. 
Detectors used in fluorescence assays are based on charge coupled devices (CCD's) that 
convert light into electrical current to allow quantification of the light emitted. The light 
sources used to illuminate the fluorophores are based on two different technologies; 
firstly, laser-based systems that provide high excitation intensity and narrow bandwidth 
but are relatively expensive. Secondly, white light source systems that use large 
excitation bandwidth gas discharge lamps (e.g. mercury vapour lamps) in conjunction 
with sets of optical filters to select specific excitation and emission wavelengths. The 
main advantages of these platforms are their reduced cost (vs. the laser-based scanner) 
and versatility, since filters are commercially available and can be easily changed. 
Chemiluminescence: 
Chemi luminescence is the production of photons by a chemical or electrochemical 
reaction. Chemiluminescence has been extensively used as a means of detection and 
quantification in traditional immunoassays 28  and has been used on a number of 
microarray platforms. An example of such a reaction involves the catalytic oxidation of 
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luminol by hydrogen peroxide in the presence of horseradish peroxidase attached to an 
antibody29. The detection and quantification is subsequently carried out using a simple 
CCD camera., the main advantages being the high sensitivity and low cost. 
Radioisotopes: 
Radioisotopes (33P, 125J)  have been used extensively in the area of biochemistry and 
genetics to label molecules and follow their fate in various physiological processes. The 
use of radioisotopes as labels in microarray formats has been successfully 
30,3 and these labels provide high sensitivity, however, their use is likely to 
stay limited as radioactivity raises safety concerns regarding its manipulation and 
disposal and competing technologies such as fluorescence offer much greater advantages 
such as multiplexing. 
1.1.4.2 Label-free detection 
Label-free detection methods have the advantage that they do not rely on the use of a 
label that can modify the physico-chemical properties of the analyte. Many different 
label-free detection systems have been investigated, however, their use remains quite 
limited as they rely on expensive instruments with fairly limited throughputs. 
Surface Plasmon Resonance (SPR): 
Surface plasmon resonance spectroscopy measures the changes in the index of refraction 
following the deposition of organic or biomolecular thin film onto noble metal surfaces 
(Au, Ag, Cu). This technology is widely used in the study of many types of interactions 
such as protein-protein, antibody-antigen and receptor-ligand. Most microarray 
applications use an immobilised capture agent (e.g. an antibody) on a gold surface, 
followed by the addition of analyte (e.g. antigen). As the analyte interacts with the 
capture agent, the system records in real-time the changes in the reflection angle of light, 
which is proportional to the amount of immobilised analyte. The main advantage of such 
a system is its versatility, since it can follow the kinetics of immobilisation of many 
analytes, however, due to fairly low sensitivity this system requires a relatively large 
amount of analyte, and its throughput remains quite limited32. 
Mass spectrometry: 
Mass spectrometry (MS) is based upon the analysis of matter according to atomic mass. 
With the advances in the field of proteomics, several platforms have been adapted to the 
parallel analysis of large numbers of sample. Matrix assisted laser desorption/ionisation 
time-of-flight (MALDI-TOF) mass spectrometry has been used extensively in the field 
of proteomics for the identification of novel biomarkers 334. Recently, the development 
of surface-enhanced laser desorption/ionisation (SELDI) has allowed partial on-chip 
separation of protein mixtures (before analysis) using a combination of spots showing 
different physico-chemical protein affinities 35 ' 36 . 
Time-of-flight secondary ion mass spectroscopy (TOF-SIMS) has also been used in the 
detection of unlabelled DNA fragments hybridised to complementary PNA strands on a 
microarray37 . Mass spectrometry applied to microarray platforms is a powerful detection 
method, however, limitations arise from limited throughput and difficult quantification. 
1.1.4.3 Conclusions 
As for any other platform, none of the available detection methods are perfect. Today, 
most research in the field of microarrays uses fluorescent based detection since it is 
affordable, sensitive and allows a certain degree of multiplexing. Direct fluorescent-
based detection usually requires either specific labelling of the analyte(s) of interest, or 
unspecific labelling of several analytes in a mixture; these are subsequently identified by 
their coupling partner on the array (e.g. a DNA microarray). Indirect fluorescent-based 
detection involving specific labelling requires the operator to know which analyte they 
wants to measure. However, certain areas of research would greatly benefit from a 
platform that allows the multiplexed analysis of an unknown mixture of samples. This 
can be partially implemented by detection systems that rely on mass spectrometry, 
however, these platforms are usually expensive and their throughput is limited to the 
analysis of one sample at a time. Tomorrow's detection system is likely to combine a 
quick detection method such as fluorescence to identify and quantify the microarray 
spot(s) of interest, together with rapid mass spectrometry for the characterisation of 
unknown bound analytes. 
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1. 1.5 Applications 
1.1.5.1 DNA microarrays 
The mapping and sequencing of the human genome highlighted the need for novel 
methods allowing the rapid deciphering of genetic information. DNA microarrays 
appeared in the middle of the nineties" 38  and soon became an essential tool for the 
characterisation and identification of genes of interest. DNA microarrays rely on the 
ability of a given DNA molecule to bind specifically to, or hybridise with its 
complementary DNA (cDNA) sequence. These microarrays are prepared by 
immobilisation of thousands of oligonucleotides, or eDNA fragments. Following 
hybridisation with a complex mixture of genetic materials, it is possible to decipher the 
composition and relative amounts of each of the fragments present in the mixture. Gene 
expression is a highly complex and tightly regulated process that allows a cell to respond 
dynamically both to environmental stimuli and to its own changing needs. This 
regulatory mechanism acts as both an "on/off' switch to control which genes are 
expressed in a cell as well as a "volume control" that increases or decreases the level of 
expression of particular proteins as necessary. As a result of extensive developments, 
DNA microarrays are now the tool behind many genomic discoveries; they are used to 
profile the expression levels of genes 39,40,  to study genomic gain and IOSS41,  to identify 
mutation or polymorphism in gene sequences 42  and to re-sequence portions of the 
genome43 . 
The main application of DNA arrays has been in the study of gene expression levels. 
This approach allows the comparison of the level of gene expression of a control sample 
with that of a sample subjected to specific conditions such as disease' 45 , cell cycle46 or 
a drug treatment47 by monitoring the nature and quantities of messenger RNA (mRNA) 
present in the nuclei. Such comparisons can be carried out on a single array by mixing 
the control and sample probes (prepared by reverse transcription of mRNA into cDNA) 
labelled with two different fluorophores (e.g. Cy3 and Cy5) (Figure 1.3). Following 
hybridisation, washing and scanning, the identity and relative amounts of each 
immobilised probe can be obtained directly from the integrated fluorescent intensities 
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arising from each spot. This approach allows rapid identification of the specific gene 
sets that are modified under given conditions, and therefore holds great potential for the 
development of focussed diagnostic arrays 48 for the screening of disease49 or drug-
induced effects 5° 
Control 	 Cancer 
Cell lyses & 	4, RNA isolation 
in RNA 
RT I PCR & labelling 4ui 	Fluorescent Tags 
cDNA  
Combine equal amounts 
Hybridisation  
Immobilised 
Washing & 	 oligonucleotides 
visualisation 	 (before hybridisation) 
cancer cells 
Figure 1.3 illustration of a DNA microarray for gene expression studies. General 
protocol to monitor changes in gene regulation in a cancer patient (cancer vs. control) 
using a dual-channel microarray. 
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Another area in which DNA microarrays hold great potential is in the study of gene gain 
and loss. It is believed that DNA repair genes are one of the body's frontline defences 
against mutations. Mutations within these genes often manifest themselves as lost or 
broken chromosomes. It has been hypothesised that certain chromosomal gains and 
losses are related to cancer progression s ' and that the patterns of these changes are 
relevant to clinical prognosis. In one approach, large pieces of DNA from known 
chromosomal locations are immobilised on a microarray surface and hybridised with a 
mixture of fluorescently labelled genomic DNA harvested from both normal (control) 
and diseased (sample) tissue. This technique is sometime referred to as array-based 
"Comparative Genomic Hybridization" (or array-CGH), it allows for highly multiplexed 
study of genomic gains and losses and the monitoring of changes in the number of 
copies of particular genes which may be involved in a disease state, hence providing an 
insight into the progression of given diseases 52 . 
DNA microarrays can also be used to study mutations or single nucleotide 
polymorphisms (SNP). These microarrays can be used to identify sets of mutations 
common in specific populations (family, cancer, disease 53).  Subsequently, the identified 
SNP can be used to determine whether a patient is at risk of developing a given 
disease54. Unlike previous applications, these arrays are used with genomic DNA from a 
single sample. 
Finally, DNA microarrays allow the rapid sequencing of whole genome or specific gene 
sets. Indeed DNA microarrays have been used to sequence the genome of closely related 
species such as pathogens and allowed the discrimination of different species and sub-
species55 . The results of such studies and the selection of specific probes allow the 
development of DNA microarrays that can detect the presence of many different 
pathogens which is of particular interest in environmental and biodefense applications 56 . 
In the light of the development of new methodologies, DNA microarrays have provided 
many answers in the field of genomics. However, every method has its limitations and 
DNA microarrays are no exception. Indeed, the expression of messenger RNA does not 
always correlate with the quantity of the corresponding protein due to variable 
translation rates and protein lifetimes. Additionally, mRNA transcripts do not account 
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for post-translational modifications such as proteolysis, phosphorylation, glycosylation 
and acetylation 57 . As a result there is a need for both DNA arrays and a highly paralleled 
and miniaturised approach for the large scale analysis of proteins. 
1.1.5.2 Protein and antibody microarrays 
Traditional methods for the analysis of proteins made use of gel electrophoresis coupled 
with mass spectrometry (MS). However, such methods have several limitations, such as 
the difficulties in detection of low abundance proteins, low reproducibility, time-
consuming protocols and difficulties in the separation of hydrophobic membrane 
proteins and basic or high molecular weight proteins. These methods are also difficult to 
automate; however, recent developments in multiplexed capillary electrophoresis 
coupled to MS have allowed the rapid separation and analysis of complex protein 
mixtures58 . 
In an attempt to overcome some of these limitations, so-called protein microarrays have 
been developed. These are based on the selective binding of proteins with a large variety 
of capture molecules such as antibodies, proteins, carbohydrates, peptides and small 
molecules. These arrays have been used to perform two main types of analysis: 
• the determination of the abundance of proteins of interest in complex protein 
samples with highly specific and carefully selected capture agents (usually via 
antibody-antigen interactions). 
• the elucidation of the function and reactivity of given proteins, for example by 
the study of protein-protein interactions, receptor-ligand interactions and 
enzymatic activities. 
Oligonucleotide/cDNA microarrays are prepared from capture agents and analytes that 
are relatively stable, and have highly characterised structures and reactivites. On the 
other hand, proteins present much more complex structures and require a carefully 
designed environment in order to prevent denaturation. Such difficulties significantly 
increase the complexity of the array designs, since it becomes essential to have highly 
engineered surfaces and capture agents. Huge amounts of research have gone into these 
areas and they are the subject of extensive reviews 59 ' 60 .However, only a few examples 
MW 
of some of the most important applications of such protein microarrays will be presented 
here. 
Antigen/antibody microarrays: 
The high affinity and specificity of the antibody/antigen interactions has allowed the 
development of several platforms that permit the analysis of changes in the 
abundance/existence of proteins over a large dynamic range (factors of 106_ 10 '0) in 
biological samples such as biopsies, body fluids and cell lysates. Such platforms have 
already demonstrated great potential in the area of serum-protein profiling, allowing the 
identification of new biomarkers 61 . These discoveries will facilitate the development of 
diagnostic tools for the rapid identification of disease states 62 and cancers. These arrays 
can also be used for studying the physiological responses to certain treatments 63 . The 
immobilisation of large libraries of antibodies and/or antigens can provide a high 
throughput means of examining the levels of specificity and cross-reactivity of 
antigen/antibody interactions under specific conditions, using various buffers and 
surfaces, which can subsequently help in the development and validation of efficient and 
sensitive assays. 
Protein-protein microarrays: 
The study of protein-protein interactions usually involves the immobilisation of proteins 
onto a surface. Immobilisation using fused-proteins is currently one of the most popular 
methods of protein patterning, as it allows site-specific/non-covalent immobilisation of 
proteins while maintaining their conformation and activity 64 '65 . Following 
immobilisation, one or more protein(s) of interest is incubated on the array and protein-
protein interactions are studied. Such arrays hold great potential in a number of 
applications such as the identification of enzymatic substrates (see 1.1.5.3 Microarrays 
for enzymatic assays) and the profiling of signalling pathways 66 '67 . 
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Small molecule and peptide microarrays: 
Small molecule microarrays consist of peptides, drug-like molecules or natural products 
immobilised onto a surface and probed for interactions with a protein of interest 68 . They 
are very stable and can be easily prepared through a variety of immobilisation reactions. 
They hold promise in the development of drugs as they have the potential to accelerate 
target-protein identification and also offer a new insight into the study of specific 
signalling pathways. 
Carbohydrate microarrays: 
Carbohydrates (glycoproteins, glycolipids, proteoglycans) play major roles in biological 
pathways, such as cell adhesion, migration and signalling. Several examples of arrays 
have been developed that allow the detection of carbohydrate-protein interactions. Such 
arrays present several advantages in that they are highly stable, sensitive and 
reproducible. A wide range of applications have been developed in such formats 69 . 
Wang et aL 7° probed microbial polysaccharides against human sera, in order to identify 
human serum antibodies with anti-carbohydrate binding activities against a wide range 
of microbial infections. Carbohydrate arrays allow the analysis and discovery of known 
and/or new carbohydrate-mediated molecular recognition in a highly multiplexed 
manner. 
Many other capture molecules have been successfully developed and used to study 
proteins. Bock et aL 7 ' reported photoaptamer arrays applied to multiplexed proteomic 
analysis, where proteins bound specifically to aptamers were photo cross-linked for 
improved signal to noise ratio. Shi et al.72 used molecularly imprinted polymers to 
generate poly(saccharide)-like cavities that exhibited highly selective recognition for 
several proteins. 
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1.1.5.3 Microarrays for enzymatic assays 
An enzyme is a protein or RNA produced by living organisms that is able to catalyse or 
facilitate a specific chemical reaction involving other substances without itself being 
destroyed or changed. Each enzyme has a specific structure (native conformation), 
function, distribution of electrical charges, surface geometry, and specificity which 
depends on its tertiary structure (three-dimensional (313) shape). Enzymes are 
responsible for the control of reactions and responsible for the control of cellular 
metabolism. As a result, they represent an essential class of targets for the development 
of new therapeutic agents. The early phase of the drug discovery process comprises the 
identification and validation of biological targets, the development of assays to identify 
compounds with activity against the target function (hits), and finally the optimisation of 
these hits. With advances in the field of combinatorial chemistry, researchers are now 
able to generate large numbers of peptides in a highly multiplexed manner; these 
peptides are subsequently used to decipher the substrate specificities of a variety of 
enzymes. However, the rate limiting step in such approaches remains the development 
of efficient high throughput assays for hit identification and activity assessment. Three 
main approaches have been investigated in order to interface enzyme research with 
microarray technologies. 
In the first approach, the enzyme's substrates (peptides or proteins 73 ) are arrayed onto 
the surfaces either through covalent attachment 74 or entrapped within a 3D matrix 
75. 
Following the array fabrication, enzymes are applied on top of the arrayed molecules, 
and modifications of the arrayed molecules can be recorded using a variety of 
methodologies including fluorescence 74 , radioisotope 76  and MS77 . The main limitation of 
this approach arises from the close vicinity of the arrayed molecules to the surface, 
which can reduce the access and subsequent specificity of the enzymes. This limitation 
is partially overcome by the use of 3D matrices (hydrogel or glycerol) which allows 
better accessibility of the substrate while maintaining them in a semi-wet environment. 
The second approach involves arraying libraries of enzymes 78 . As in the case of the first 
approach, this can be undertaken through covalent linkage to the surface 66 or by 
deposition into 3D matrixes 78, followed by reaction with substrates. The main challenge 
faced during covalent attachment to a surface is the maintenance of the tertiary structure 
of the enzyme, which is essential for its specificity and activity. 
The last approach consists of arraying the products of enzymatic reactions. In order to 
achieve the patterning of the enzymatic products, the substrates need to be encoded 
using a tag that allows controlled immobilisation onto a surface. This can be addressed 
by generating peptides with unique code tags that are complementary to tags on the 
surface. This was successfully carried out by Diaz-Mochon et al. 79, who generated a 
library of 10,000 peptides, each encoded with a specific PNA tag (using solid-phase split 
and mix methodology 80). Following enzymatic reaction in solution in the presence of the 
whole peptide library, each enzymatic product (containing a specific PNA tag) can be 
addressed and studied on a tailor made array of complementary DNA. Unlike the 
previous methodologies, in this approach the enzymatic reactions do not take place in 
the vicinity of a surface but in solution which overcomes the limitations of accessibility 
and specificity. 
1.1.6 Conclusions 
Over the last 10 years, microarray technology has seen an incredible growth and has 
now established itself as an industry in its own right. The number of publications in the 
field of microarray has seen a truly remarkable increase that even other promising fields 
of science such as nanotechnology and microfluidics are far from matching (Figure 1.4). 
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Figure 1.4 Annual trend in number of publications since 1995, obtained from a search 
using IN Web of Science with the term microarray (blue), microfluidic (orange) or 
nanotechnology (Red). 
The emergence of such an outstanding field would not have been feasible without the 
collaboration of scientists from many different disciplines. Indeed the microarray area is 
probably one of the best examples of multidisciplinary approaches with the integration 
of knowledge from engineers, chemists, biologists, physicists, medical and computer 
scientists. Traditionally developed to study the expression of genes, the use of 
microarray platforms that allow faster discovery is now spreading over a range of 
biological sciences, including the study of proteins (referred to as proteomics), 
carbohydrates (referred to as glycomics) and enzymes. Tomorrow's challenge is likely 
to be the integration of huge amounts of data generated using these different platforms 81 
in order to further our understanding of oncology, biological pathways and their 
complex interactions 82 '83 . As improvements in robustness and quality of the data are 
produced, microarray applications are now also emerging in diagnostics 84 , where many 
researchers predict that they will play an essential role in the years to come with the 
development of pharmacogenomics 85, which correlates drug efficiency and toxicity with 
the genetic information of a given patient to provide personalised medicine. 
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1.2 Whole cell microarrays 
1.2.1 Introduction 
Cell-based assays represent a major part of the screening activities in the 
biopharmaceutical industry, where they serve as early biological filters in various stages 
of the drug discovery process 86 . Following the mapping of the human genome, they 
provide an essential tool for the validation of gene targets. 
Like other screening platforms, cell-based assays have been driven toward 
miniaturisation and automation from traditional Petri dishes to the use of 96 and 384 
well plates. Even though higher density plates (1536 and 3456 well plates) are now 
available, only a few cell-based assays have been successfully adapted to such formats, 
as their design prevents homogeneous cell distribution due to surface tension. In a search 
for a smaller format allowing higher parallelisation, reduced cost and lower cell 
consumption, several researchers have investigated the use of cell-based microarray 
technology. Like other microarray platforms, the success of cell-based microarrays relies 
on the development of stable and reproducible assays, which require careful selection 
and optimisation of various parameters such as the choice of surfaces, immobilisation 
methods and the means of detection and analysis. However, it should not be forgotten 
that unlike most biomolecules, cells represent a very complex and is yet not fully 
characterised biological system, which is extremely sensitive to many environmental 
factors such as pH, temperature, nutrients and contaminants. 
1.2.2 Principles of cellular immobilisation 
The surface of the cell is composed of many different molecules including a lipid 
bilayer, membrane proteins, glycoproteins and small molecules. As a result, the 
principles underlying the immobilisation of cells onto a surface are far more complex 
than the immobilisation of single biomolecules. Such complexity suggests that the 
interactions of the different components of the cell membrane with a given surface 
should not be considered as independent events, but rather as the result of cooperative 
and dynamic non-covalent interactions. 
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The immobilisation of cells onto surfaces has been the subject of extensive research for 
nearly a century87 . Several different approaches have been developed, from electrostatic 
interactions to the use of cell specific antibodies or specific receptors. 
One of the most popular means of cellular immobilisation uses the principle of 
electrostatic interactions, where a highly positively charged surface such as immobilised 
poly-L-lysine promotes non-specific immobilisation of cells. However, one of the major 
drawbacks of this approach is the risk that cell health and cycles may be modified by 
such strong interactions 88 '89 . A gentler and more selective cellular immobilisation 
method is based on biomolecular recognition. This immobilisation route is based on 
interactions of proteins present on the outer surface of the cells with complementary 
biomolecules on the substrate. This type of interaction is the cornerstone of several cell-
based microarray formats with highly cell-specific interactions, which may be for 
example between, antibody and antigen 90,  or integrins and adsorbed extracellular matrix 
proteins 91,92 
Two main types of approach have been used for the design of surfaces in cell-based 
microarray assays. The simplest uses surfaces that promote cell adhesion, whereby a 
monolayer of cells is grown on both the substrate and the arrayed biomolecules. This 
approach has been very popular in the development of reverse transfection arrays where 
cell modification (transfection) occurs only on the deposited feature, while the 
monolayer of cells surrounding the spot is unchanged 93 . The other approach uses 
surfaces that are designed to prevent the binding of cells outside the deposited spots, 
resulting in a patterned array of cells. This can be achieved by a variety of methods, such 
as coating with hydrophilic gels (polyacrylamide 92 or agarose94) or with proteins that 
block cellular adsorption such as albumin 9 . The main advantage of the latter design is 
that it facilitates detection and subsequent analysis, since cells are only present on the 
spotted features, whereas in the monolayer approach, the analysis can be biased by the 
subjective positioning and size of the analysed spots. 
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1.2.3 Array fabrication and printing technologies 
Unlike DNA arrays where very high density arrays of microscopic spots (usually 5-50 
p.m in diameter) is desirable, cell microarrays are limited by the minimum size of the 
arrayed features. Indeed it as been demonstrated that the use of very small features can 
have an immediate impact on cell fate, as it can mediate cell apoptosis (programmed cell 
death) 96 . Additionally, even though the use of a single cell screen can, in theory, be 
achieved, it is usually desirable to study a minimum number of cells (50 to 100) in order 
to provide statistically relevant and meaningful results. As a result, cell-based 
microarrays generally use features ranging from 200 p.m up to a few millimetres in 
diameter. 
Cell microarrays can be divided into two main categories, depending on whether cells 
are bound to an array of biomolecules (substrate-based cell microarray), or the cells 
themselves are microarrayed (genuine cell microarray). The latter approach, which can 
be used to generate arrays of different cell types, is technically more demanding 
especially when the arrayed cells need to remain viable. 
1.2.3.1 Substrate-based cell microarrays 
A wide range of methods and equipment has been used to generate arrays of 
biomolecules or cells. The simplest consist of directly printing the molecules or cells of 
interest onto the surface using contact or inkjet printing robots. In another approach, 
several researchers have used self-assembled monolayers (SAM's) followed by mask 
and photolithographic methods 95 ' 97 , in order to pattern different functionalities on a 
surface (Figure 1.5). These functionalities are subsequently used to immobilise 
biomolecules that promote or inhibit cellular adhesion. In the case of functionalised 
SAM arrays, several groups used manual pipetting of the biomolecules or cells of 
interest to generate the array 97 ' 98 . 
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Figure 1.5 Substrate patterning using SAM and photolithography. 
1.2.3.2 Genuine cell microarrays 
The deposition and immobilisation of cells on an array can be particularly challenging if 
the cells are to remain viable throughout the process. As a result, initial examples of 
genuine cell microarrays have been developed using frozen" or fixed' °°" ° ' cells that 
were immobilised manually99101 . However, a few examples of live cell printing have 
been published ' °2 ' °4 , and interestingly, all of these experiments were carried out using 
modified commercial ink-jet printers. Due to their design, the printing of viable cells 
using these modified systems was limited, and only a few cell lineages were patterned. 
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1.2.4 Detection methods, imaging and analysis 
Most of the detection and imaging systems used in the field of cell-based microarrays 
rely on fluorescence detection systems. With the drive towards increasing throughput, 
these systems have required automation for both detection and image analysis. Two 
main technologies are used for the imaging of such arrays, depending on the level of 
resolution necessary. 
Low resolution systems (2-10 gm), where individual cells do not need to be observed, 
are based on standard DNA microarray scanners. These systems are compatible with a 
range of fluorophores and generate single images of a whole microarray. Subsequent 
analysis is generally carried out with commercial software allowing quantification of 
fluorescence for each spot' 05 . 
In contrast, high resolution systems (down to 0.2 gm) are based on conventional 
microscopes fitted with a motorised component allowing the automatic capture of single 
high resolution image for each spot. The use of these systems, initially developed for 
microplate assays, is essential when each cell needs to be visualised or subcellular 
localisation is necessary. The main inconvenience of these systems comes from the 
handling and analysis of the very large amount of data generated. However, with the 
development in the field of high content screening, several software packages' 06-108  have 
been developed to carry out automated image analysis. These software packages allow 
rapid analysis of multiple parameters (including cell number, shape and size and, 
fluorescent intensities) from hundreds of images in order to provide accurate and 
meaningful interpretation of various assays. 
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1.2.5 Main Applications 
The field of cell-based microarrays is still in its infancy with most of the research 
published over the last five years. Nevertheless, cell-based microarray technologies are 
now emerging for a variety of applications: transfection microarrays are used in gene 
function studies, microarrays of antibodies, glycans, proteins and peptides are used to 
study the nature and function of cell membrane components, and microarrays of 
biomaterials and small molecules, respectively, are used for tissue engineering and 
cytotoxicity studies. 
1.2.5.1 Transfection microarrays 
One of the first demonstrations of cell-based microarrays was carried out by Ziauddin 
and Sabatini 93 where cells were transfected with expression vectors. Transfection 
microarrays allow a large number of different genes to be screened in parallel for 
induction or repression of a given function in the cells. In this approach, expression 
vectors are mixed with a matrix such as gelatine and printed onto a glass microscope 
slide. Transfection reagents can be added to the matrix or directly added on top of the 
slide surface. A layer of cells is then grown onto the array and after an incubation of 40 
hours, the cells growing on top of the expression vector become transfected giving rise 
to clusters of 30-80 cells expressing the encoded protein which in turn results in a 
change in cellular physiology or phenotype. This methodology was successfully used to 
identify proteins with specific functional characteristics, to localise proteins at the 
subcellular level and to study the effect of protein on cellular phenotype. Another 
application was developed by How and co-workers' 09  where a similar methodology was 
used to screen the transfection efficiency of libraries of synthetically prepared 
polyplexes and lipoplexes. All these modifications can be detected by methods that are 
used in traditional multiwell plate approaches. Specific proteins can be identified and 
localised by immunostaining or by co-transfection of a reporter gene such as green 
fluorescent protein (GFP). 
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Initial experiments were carried out with expression constructs of cDNAs, but more 
recently several groups have reported the use of short interfering RNA (siRNA) and 
110 short hairpin RNA (shRNA) to knockdown the expression of selected genes 
A wide range of transfection reagents have already been successfully used in 
microarrays, from liposomes and dendrimers' °9 to cationic polymers" and viral 
carriers' ' 2 Transfection microarrays have several advantages, they are compact, easy to 
handle, they use small quantities of reagents and cell, and provide a highly multiplexed 
assay. Moreover, as the proteins are translated within the environment of living 
mammalian cells, they fold correctly. 
The transfection arrays have shown great promise, however, a number of issues still 
have to be addressed for this technology to be widely accepted or recognised. The main 
limitation comes from the fact that the method is only applicable to cells that transfect 
easily such as HEK293. Over recent years, several strategies have been investigated to 
overcome such limitations. Yamauchi et al." reported the use of an electroporation type 
transfection microarray, suitable for use with certain primary cells whereas Bailey et al. 
12  made use of a viral vector to improve the scope of the method. Another limitation of 
transfection microarrays is that they are only suitable for cells that adhere to the spot 
containing the expression vector. In order to solve this problem Kato et aL" 3 have 
developed a methodology allowing the immobilisation of a non-adherent cell line by use 
of a biocompatible anchor for membrane (BAM). This system consists of an oleyl group 
that inserts into the lipid bilayer of cell membrane resulting in immobilisation of the 
non-adherent cells. In a later study, Kato et al. demonstrated that these immobilised non-
adherent cells could be transfected for expression of GFP or knockdown of genes by 
RNAi" 4 
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1.2.5.2 Cell-based microarrays for study of cell membrane composition and 
properties 
Another area in which cell-based microarrays have flourished is in the identification and 
profiling of cell membrane composition and properties. 
Antibody Arrays: 
Antibody arrays provide a means of high throughput profiling of blood cell populations 
and are now being developed as diagnostic tools for applications ranging from blood 
typing to the identification of Ieukaemias and drug-induced changes in cell surface 
antigens. The first application of antibody arrays was first developed over two decades 
ago by Chang who immobilised antibodies for the identification of allotypes of human 
leukocyte antigens' 5 Several groups have reported the development of antibody arrays 
to screen antibody-protein interactions 60. This approach was used by Liu 90  who spotted 
antibody onto a polystyrene surface to identify clusters of differentiation (CD) antigens 
present on the surface of whole prostate cancer cells. These CD antigens are used to 
classify the different leukocyte subpopulations. Another application of antibody arrays is 
to identify cell surface markers that can be subsequently used for the isolation of given 
cell populations". These arrays can also provide a means of studying cellular processes 
induced by antibody recognition, such as increased intracellular calcium following CD3 
immunocomplex formation on the surface of human Jurkat T-cell lymphoma cells" 6 
More recently, Campbell et aL" 7 have developed an antibody array for blood typing 
applications. These arrays comprise of antibodies immobilised on a gold surface and 
allow the identification of red blood cell surface antigens using whole blood in a label-
free detection mode. 
One of the main challenges of such applications is to maintain the antibodies' antigen-
binding activity. Indeed, activity can be greatly affected by denaturation or steric 
hindrance following spotting onto surfaces. Significant research into improving such 
limitations has been undertaken, and this has been extensively documented in a series of 
reviews59 ' 60 . 
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Glycan: 
Glycans are polysaccharides that are present both within the cells (where they play an 
important role in intrinsic signalling), and on the outer surface of the cell membrane. 
Surface glycans can be recognised by specific binding proteins (lectins) which play an 
important role in cellular adhesion, glycoprotein synthesis, and protein regulation, but 
also in immune function where they recognise carbohydrates present on pathogen 
surfaces. The interaction between glycans and lectins was shown to be of low 
monovalent affinity and high polyvalent affinity, which indicates multi-site binding 118  
As a result, arrays that study the interactions of isolated lectins with immobilised 
glycans represent only partially the in vivo situation. However, it was recently 
demonstrated that glycan microarrays could be utilised with whole cells to identify and 
quantify carbohydrate-mediated cellular adhesion. Indeed, Nimrichter et al. 
demonstrated 1 14  selective adhesion of CD4+ T-cells to an array of 45 different glycan 
that were covalently attached to a glass surface. 
Peptide-MHC: 
The major histocompatibility complex (MHC) is a set of molecules present on cell 
surfaces that are responsible for lymphocytes recognition and antigen presentation. 
Following the presentation of an antigen on the surface of a macrophage, a specific 
immune response is triggered by the proliferation of T-cells. It has been shown by Soen 
et al."9 that immobilisation of a series of peptide-MHC complexes allows the detection 
of specific T-cells that recognise disease-related antigens in a mixed cell population. 
Peptide-MI-IC complex microarrays should allow the identification and characterisation 
of multiple epitope-specific T-cell populations. As a result, this approach holds great 
potential as a diagnostic tool for the presence of viral and bacterial infections, cancer, 
autoimmunity, and successful vaccination. 
Double-layer lipid membrane: 
Synthetic membranes composed of phospholipid bilayers are designed to mimic the 
behaviour of plasma membranes present on the surface of cells. Biologically active 
molecules of interest can be embedded within these membranes to allow the study of 
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biological processes ranging from simple ligand/receptor interactions to complex cell-
cell signalling. The major advantage of this model compared to traditional 
immobilisation of molecules of interest directly onto a substrate (as presented above in 
the case of antibodies, glycans and peptide-MHC) is the lateral fluidity of such synthetic 
membranes. Indeed, the ability of bioactive molecules to freely move and distribute 
within such an environment allows the study of complex interactions in which 
dimerisation or oligomerisation of the analytes of interest is necessary for a given 
biological signalling event. Given the growing interest of such technology, several 
groups have investigated the multiplexing of lipid bilayer-supported assays by creating 
patterned arrays of lipid bilayer membranes. Yamazaki et al.' 20 have, for example, 
developed arrays of membrane on fused silica through a lithographic procedure, and 
successfully utilised these membrane arrays for the study of mammalian membrane 
proteins responsible for adhesion, antigen presentation and subsequent activation of 
intact T-cells. 
1.2.5.3 Cell-based microarrays for tissue engineering 
Another area in which cell based microarray technology is flourishing is in the discovery 
of new materials for cell biology and tissue engineering. Indeed one of the major 
challenges in these fields is to develop methods for the restoration, maintenance and 
enhancement of tissue and organ function. In order to accomplish these goals it is 
essential to control the fate of the engineered tissues. One of the major obstacles to this 
is the limited availability of materials that can support the growth, proliferation and/or 
differentiation of specific cells. Due to the immense diversity of cells present in our 
bodies, there is no universal material for this purpose. As a result, a large amount of 
research is invested in the discovery of new synthetic or naturally derived materials that 
can support specific tissues. 
The use of high throughput approaches for the generation and analysis of new cell 
supports offers an important tool in finding correlations between the design and 
performance of materials suited to this purpose. Consequently, Anderson et al. 
developed a microarray platform that allowed the synthesis and screening of a library of 
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poly(acrylates)' 21 . Following the generation of the polymer library, embryonic stem cells 
(ESC) were incubated and were shown to differentiate on certain polymer spots. Cell 
compatibility was then measured in terms of the cellular coverage of each polymer spot. 
These polymer microarrays allow the rapid identification of several polymers of interest. 
Moreover, the high multiplexing ability of such screens should permit the study of 
structure-activity relationships, which will ultimately bring a better understanding of the 
factors affecting cellular adhesion and proliferation. 
Another approach used to mediate cellular adhesion and differentiation is to coat a 
substrate directly with extracellular matrix proteins. This methodology was applied in a 
study of the adhesion of three common cell lines (HEK, PC12 and NIH 3T3) to 14 
different extracellular matrix (ECM) proteins 91 . Additionally, the adhesion of primary 
and immortalised chondrocytes to certain ECM proteins was investigated, and it was 
shown that these closely related cells had different adhesion profiles. Flaim and co-
workers 92  printed 5 different ECM proteins, but this time in 32 different combinations, 
to study which of these protein mixtures could maintain the function of primary rat 
hepathocytes, and also drive the differentiation of mouse ESC toward an early hepatic 
fate. These studies demonstrated that microarray technology could be interfaced with the 
study of cell-ECM protein interactions, which could provide important insights into how 
to direct the in vitro differentiation of stem cells. Traditionally, ESC differentiation is 
carried out by supplementing the culture media with cytokines (small secreted proteins 
which mediate and regulate a number of cellular systems), or by the use of co-culture 
which involves the growing of ESC on a layer of feeder cells. Yamazoe and Iwata 98 used 
the latter approach and developed a model microarray experiment based on an array of 3 
different feeder cells used as a support to direct the differentiation of ESC towards a 
neuronal fate. After 8 days of ESC culture onto the 3 different feeder cells, 
differentiation towards the neuronal cell type was assessed by immunocytochemical 
staining, and reverse transcription polymerase chain reaction analysis. Both methods 
showed that only the ESC's grew onto stromal PA6 cells presenting neural markers. 
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1.2.5.4 Cell-based microarrays for drug discovery 
The generation of new chemical entities has increased dramatically over recent years 
with advances in combinatorial chemistry, genomics and proteomics. Cell-based 
screening represents about 50 % of all screening activities within the biopharmaceutical 
industries, thus there is huge pressure for the development of highly paralleled, 
miniaturised and reliable assays to evaluate the efficiency and toxicity of new drug 
candidates. However, the number of approved new drugs has not followed the 
development of new compounds, in part due to a large proportion of these new entities 
failing at various stages of their toxicity evaluations. In view of these problems, Bailey 
and co-workers developed a microarray format using small molecules embedded within 
a biodegradable polymer This microarray was successfully utilised to screen 
the cytotoxicity of the immobilised compounds on different cell lines. Additionally, they 
demonstrated how this type of small molecule microarray could be used in conjunction 
with genetically engineered cells to find correlations between the down-regulation of 
some genes and the subsequent cell fate induced by a specific compound. 
When a chemical enters the human body, a variety of enzymes are involved in its break 
down (metabolism) and clearance. These brackdown mechanisms involve the formation 
of metabolites which are sometimes biologically active. Indeed, this process forms the 
basis of the so-called "prodrugs", where the breakdown products of the administered 
substance are effectively the active compounds. However, in some cases, the generated 
metabolites of exogenous chemicals can lead to unwanted effects and harmful biological 
responses. As a result, metabolite screens are particularly useful in the early phases of 
any drug development. Lee et al. have developed a cell based microarray platform for 
metabolising enzyme toxicology assays (MetaChip) 123 . In this approach, different 
isoforms of the cytochrome P450 were encapsulated in sol-gel spots and then printed a 
gradient of concentrations of 3 anti-cancer prodrugs onto these spots. The slide 
containing the P450 sol-gels and prodrug solutions was subsequently stamped onto a 
monolayer of human breast cancer cells (MCF7). After 6 hours of incubations, the 
cytotoxicity of the metabolites was evaluated by measuring the percentage of dead cells 
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in contact with each spot and calculating the LD 50. Finally, the cytotoxicity results were 
confirmed by traditional solution phase reactions. 
1.2.5.5 Conclusion and Perspectives 
The field of cell-based microarrays is still very much in its genesis and many technical 
issues still have to be addressed in order to produce reproducible and meaningful results 
using these methodologies. However, the economic pressure to generate higher 
throughput methods, while minimising expensive reagents and the consumption of rare 
cell lines, has promoted development of many original solutions. The majority of 
advances in the field of cell-based microarrays have occurred with multidisciplinary 
approaches that integrate the latest advances from the fields of chemical and cellular 
biology, surface sciences, robotics and bioinformatics. 
Until recently, most successful cell microarray platforms were based on the 
immobilisation of cells through interactions with biomolecules arrayed on the substrate 
(substrate-based cell microarray). Advances in microfluidics' 2426 and electrode-based 
cellular manipulation 127-129  are likely to bring unsurpassed control of cellular patterning 
of both adherent and non-adherent viable cells. These advances will allow a wider range 
of applications, and should facilitate the transfer of cell microarray technologies from 
academic-based laboratories toward more widespread use within industrial research 
laboratories. 
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1.3 Biomaterials and biocompatibility 
1.3.1 Biomaterials 
1.3.1.1 Introduction to biomaterials 
The European Society of Biomaterials has defined a bio-material as a "material intended 
to interface with biological systems to evaluate, treat, augment or replace any tissue, 
organ or function of the body" 30 . 
The use of biomaterials can been traced back to over 2,000 years ago, when metals such 
as gold were used in dentistry 131 . Most early implants were doomed to failure due to 
poor understanding of the complex events involved in the interactions of a material with 
its biological environment. Over the last century, advances in the fields of chemistry, 
biology and physics have helped to further the understanding of some of these critical 
mechanisms that occur at a biomaterial surface. This understanding has provided the 
basis for the development of biomaterials with properties tailored to their specific 
application. In modem times, biomaterials have become an integral part of medicine, 
with applications in the implantation of medical devices, artificial organs and prostheses, 
as well as in the controlled delivery of drugs, and as scaffold for tissue engineering. 
Millions of devices and implants are used every year in applications as diverse as blood 
vessel replacement, catheters, contact lenses, joint prostheses, dental filling material and 
blood bags. The safety and efficiency of drug delivery can be enhanced by the use of 
biomaterials (mainly polymers), which allow a better control over the duration and 
localisation of drug release. In tissue engineering, scientists use biomaterials as 
scaffolds, to provide structure and a suitable environment for the growth of living cells 
to create viable skin, bone, cartilage, tissues as well as blood vessels. 
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Biomaterials can be made of various synthetic or natural materials such as pure metals, 
metal alloys, ceramics and polymers. Before the 20th  century, wood, ivory and common 
metals (iron, gold, silver, copper) were used to make simple prosthetic devices to fix 
teeth, noses or bones. Most of these materials lacked the desired mechanical properties; 
however, the development of several metal alloys and coatings at the beginning of the 
20th century led to materials with enhanced corrosion resistance, strength and stiffness, 
allowing the development of several skeletal prostheses and orthopaedic implants. 
Bioceramics, which include glasses, have been used in medical applications throughout 
history. These were traditionally used outside the body as containers for tissue-culture, 
eyeglasses or porcelain crowns in dentistry. The applications of bioceramics and 
bioactive glasses as implants were only developed in the late 1960s. At that time, 
researchers were searching for chemically inert materials for long-term survival of 
implants. The use of hydroxyapatite (a naturally occurring ceramic material) which is 
the mineral component of bone was investigated for this purpose. Following 
implantation of this material into bone tissues, it was noticed that these ceramics resisted 
rejection and were actually bonding to bone. Since then, many different classes of 
bioceramics have been developed, and they are now routinely used as coating materials 
in orthopaedic devices and as bone fillers. When compared to metallic or polymeric 
materials, bioceramic materials successfully reduce implant rejection and inflammatory 
reactions; however, their main limitations come from low fracture toughness, low 
mechanical strength and the relative difficulties in processing them. 
1.3.1.2 Polymers as biomaterials 
Polymers can encompass a wide range of physical and chemical properties; they can be 
used either directly or coated onto other materials, they are readily functionalised and 
they can be degraded by the body after a desired period. Additionally, they are easily 
processed and come in many different forms including solids, fibres, films and gels. As a 
result, biopolymers are currently the materials of choice for thousands of medical 
applications (Table 1.1). 
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Initially utilised for their mechanical properties and high chemical resistance, 
biocompatible polymers are used as components of prosthetic devices including hip 
implants, artificial lenses, vascular grail and catheters. More recently, new drugs 
(protein or peptide-based) have been developed that require novel formulations for 
efficient delivery. This discovery has led to the widespread use of biodegradable 
polymers for the controlled release of drugs and gene therapy. Additionally, in tissue 
engineering, polymers provide structures onto which three-dimensional tissues and 
organs can theoretically be generated. 
Polymers Applications 
Cellulose and derivatives Membrane for dialysis 
Poly(alkyl cyanoacrylates) Wound closure, drug delivery 
Poly(amides) Sutures 
Poly(carbonates) Device housings 
Poly(ethylene oxides) Coatings for tissue engineering 
Poly(ethylene terephthalate) Surgical mesh, vascular prostheses 
Poly(lactic acid) Tendon repair, sutures, drug delivery 
Poly(lactic/glycolic acid) Drug delivery, sutures 
Poly(methyl methacrylate) Intraocular lenses, contact lenses, bone cement 
Poly(urethanes) Catheters, vascular prostheses, coatings, heart valves 
Poly(vinyl chlorides) Tubing, blood bags 
Silicones Catheters, artificial hearts 
Ultra high molecular 
weight poly(ethylene) 
Hip & knee bearing surfaces 
Table 1.1 Some of the most widely used polymers and their biomedical applications. 
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1.3.2 Biocompatibility 
All biomaterials are by definition biocompatible, but each individual application requires 
a material that complies with specific mechanical, chemical and biological parameters, 
hence the meaning of the term 'biocompatibility' depends on its specific application. A 
definition of biocompatibility has been given by D.F. Williams: "Biocompatibility is the 
ability of a material to perform with an appropriate host response in a specific 
application" 130 
Since then, several defmitions of biocompatibility have been published which refer to 
specific applications of the biomaterials, such as the biocompatibility of short-term 
implantable devices' 32 . However, most recent definitions usually describe two main 
principles, the 'biofunctionality', which refers to the ability of the material/device to 
perform with an appropriate host response in a specific application (as in the first 
definition), and the 'biosafety' which relates to the exclusion of any harmful effect of the 
material/device on the organism. For a material to be deemed biocompatible, it must 
encompass specific properties such as: 
• Lack of cytotoxicity 
• Inhibition or promotion of cell-material interactions as required 
. Minimal immune response and inflammation 
Optimal chemical, physical and mechanical properties 
In order to study the complexity of the factors involved in biocompatibility testing, it is 
essential to understand some of the steps involved in the mechanisms induced when a 
biomaterial is implanted into a body, commonly referred to as the 'foreign body 
response' (Figure 1.6). 
The first event following implantation is the non-specific adsorption of proteins onto the 
surface of the implanted material. These adsorbed proteins then mediate adhesion of a 
number of different cells (monocytes, leukocytes and platelets) which may result in the 
upregulation of certain cytokines and instigate a subsequent proinflammatory process. 
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Inflammatory processes usually involve the differentiation of monocytes into 
macrophages, whose role is to clean wound sites by phagocytosing foreign materials, 
dead cells and bacteria. In the presence of an implant that is much larger than the 
macrophages, such phagocytosis is impossible. As a result, a chronic inflammatory 
process is initiated by fusion of adhered macrophages into multinucleated foreign body 
giant cells. These cells secrete cytokines and degradative agents such as superoxides and 
free radicals that can damage the implant. The final stage of the foreign body reaction 
involves the formation of an avascular collagen shell deposited around the foreign body 
in order to isolate it from the host tissues. The encapsulation of the foreign material can 
result in several undesirable reactions such as chronic pain, device rejection and failure 
(e.g. sensor function may be prevented by its encapsulation). 
1. Implantation of the biomaterial 2. Protein adsorption 3. Cells including neutrophils and 
macrophages interrogate the 
biomaterials 
(Biomaterial) (JBiomateriai) (Biomaterial) 
t0 tls t=3Omintolday 
4. Giant cell formation and S. In response to cytoklnes, 6. The biomaterial is encapsulated 







t = I to 5 days t = 5 to 14 days t = 3 weeks 
Figure 1.6 illustration of the foreign body response. 
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1.3.3 Blood compatibility 
Another essential aspect of biocompatibility is the compatibility of a material that comes 
into contact with flowing blood, usually referred to as haemocompatibility. In order to 
understand the intricacies involved in haemocompatibility, it is essential to study some 
of the bodies regulation mechanisms involved in wound healing and protection against 
intrusion by foreign organisms. In short, when a foreign material comes into contact 
with blood, there is a rapid adsorption onto its surface of plasma proteins such as 
albumin, fibrinogen, immunoglobulin G and fibronectin. A proportion of these proteins 
are then displaced by less abundant proteins like factor XII (Hageman factor) and high 
molecular weight kininogen (HMWK) 133 . Upon activation of factor XII (XIla), several 
regulatory systems are initiated, namely the coagulation cascade, fibrinolytic system, 
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Figure 1.7 A simplified representation of activation of regulatory systems following 
contact with a foreign surface. 
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The coagulation cascade (Figure 1.8) involves the activation of soluble plasma 
proteins, and leads to the formation of a fibrin clot that stops blood from flowing. This 
cascade process can be triggered by either exposure to factors derived from damaged 
tissue (extrinsic pathway), or by surface-mediated reactions (intrinsic pathway). Both 
pathways lead to the formation of thrombin which in turn induces the formation of fibrin 
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Figure 1.8 Simplified schematic representing the coagulation cascade, by activation of 
Factor XII (due to the presence of a foreign surface that initiates the intrinsic pathway), 
or by activation of Factor VII (due to a trauma (tissue damage) that initiates the 
extrinsic pathway). 
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The fibrinolytic system uses plasmin (a serine protease) to cleave the fibrin network 
and ultimately degrade unneeded blot clots. 
{_Plasminogen_] 
Endothelial cell factors I 
Blood clotting factors 
rasnn1 
IFibrin degradationl L Airin] 	 ' L products  j 
Figure 1.9 Simplified schematic representing the fibrinolytic system 
The kinin system activates the formation of kallikrein which amplifies the activation of 
the coagulation and fibnnolytic system. Additionally, kallikrein cleaves HMWK to 
produce bradykinin, which is a potent inflammatory mediator that induces vasodilation 
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Figure 1.10 Simplified schematic representing the kinin system 
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The complement system is an essential part of the immune response which recognises 
and clears pathogens from the body. The classical pathway of the complement system 
can be activated by the action of factor XII fragment (XIIf) on Complement 1 (Cl). 
However, it has also been shown that in presence of foreign material, activation of the 
complement system acts primarily via an alternative pathway, by the activation of 





(Factor XIIa + Factor XIIf) 
Cl. 
C2 	C2. 
C3. & C. & CS. 	
Peptde mediators of inflammation, 
phagocyte recruitment 
Membrane Activation Complex 
yses of pathogens and cells 
Induce leukocytes adhesion 
	
1 	 ____ 
_________ C4b2a _________ c4b2a3b 
c4 T c4b 
CU 	
TV:) r (CS  
Ca 	 Ca. 	 CS 	 CBb 	 (MAC) 
C8a 	 es 
C36 	L3 C3b8b 	C4b2a35 	 CS 	Ca C3 	 Ca _________ b 	\ (Ca coflvscta.) 	 (C6 c000axtas.) 




Figure 1.11 Simplified schematic representing the complement system. 
The interaction of a foreign material with the complement system is sometimes referred 
to as "immunocompatibility". It must be emphasised that the complement system plays a 
major part in the inflammatory response, and hence influences both the 
haemocompatibility and biocompatibility of biomaterials' 36• 
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The four regulatory systems described above are intricately related, with common 
factors at different levels. These regulatory systems will control the extent of clot 
formation and the inflammatory response to a foreign material, which is ultimately 
linked to the haemocompatibility of a biomaterial. 
The two major risks associated with poorly haemocompatible materials are: 
• the formation of a large clot or thrombus' 37  which can block the flow of blood 
through the circulatory system. Additionally, such thrombi can be carried 
through the vascular system and lead to blockage in other parts of the body 
leading to embolisation and possible fatal injury' 38 . 
the development of a chronic wound through continuous inflammation may lead 
to prolonged suffering for the patient, and may also lead to complications such as 
infections 139,  sepsis and possible malignancy 140 . 
From these considerations, Labarre defined a haemocompatible surface as "a surface 
able to keep under control coagulation and inflammation processes at its interface with 
normal blood, in given haemodynamic conditions" 41 . 
Both biocompatibility and haemocompatibility of biomaterials are dependent on initial 
protein adsorption steps, and as a result, the performance of these materials is highly 
dependent on surface features such as surface area, crystallinity, hydrophobicity, surface 
roughness, and surface chemistry. In recent years, many researchers have investigated 
the modification of the surface properties as a strategy to control the host response at the 
interface with the biomaterial. 
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1.3.4 Strategies to enhance the biocompatibility 
Biomaterial scientists have developed several strategies to enhance the blood and 
biocompatibility of foreign surfaces. One of the most popular strategies uses the 
hydrophilicity or hydrophobicity of the material surface to alter the adsorption of 
proteins. Alternative approaches have been developed to improve the biocompatibility 
by enhancing the cellular recognition of the materials. Additionally, haemocompatibility 
has been drastically improved by the use of small molecules that interact with the 
coagulation cascade or inflammatory host response. 
1.3.4.1 Modifying protein adsorption 
Proteins irreversibly bind onto hydrophobic surfaces, whereas adsorption of proteins 
onto hydrophilic surfaces is usually limited and reversible. A popular method of 
reducing protein adsorption involves increasing the hydrophilicity of the surface by 
functionalisation of the surface with hydrophilic polymers such as poly(hydroxyethyl 
methacrylates) (PHEMA), poly(ethylene glycol) (PEG or PEO) and their derivatives. 
These polymeric chains can be immobilised onto a material surface through both 
covalent and non-covalent interactions using a variety of methodologies including 
grafting "' ,coating, and self-assembly' 43 . 
The opposite approach consists of generating highly hydrophobic surfaces. These 
surfaces irreversibly bind proteins and facilitate the formation of passivating layers that 
lower platelet adhesion and activation, subsequently enhancing the 
haemocompatibility 144" 45 . 
Instead of functionalising the surface of materials, another approach aimed at improving 
biocompatibility consists of producing bulk polymers that can control protein 
adsorption: 
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• Hydrogels are water-swollen polymeric networks prepared from hydrophilic 
monomers; they are insoluble due to the presence of chemical or physical cross-
links. They have been widely used as biomaterials as they present tissue-like 
properties and good biocompatibility' 46" 47 . These hydrogels can be synthesised 
from cross-linked acrylate and methacrylate monomers, or from co-
polymerisation of polyethylene glycol with another monomer such as poly(a-
hydroxy acid) 148 or poly(lactic acid) (PLA) 149. Modification of synthetic 
procedures, such as the polymerisation conditions and the amount of cross-
linker, can afford easy control of a wide range of properties. 
• Microdomain containing polymers are co-polymers composed of both 
hydrophilic and hydrophobic moieties. The presence of these microdomains 
confers upon these polymeric materials a unique organisation of proteins 
adsorption. These materials have been shown to provide reversible platelet 
attachment whilst preventing platelet activation 150. The most popular of these 
polymers are poly(urethanes), which contain both hard (hydrophobic) and soft 
(hydrophilic) segments. Alternative examples are co-polymers of hydroxyethyl 
methacrylate (HEMA) and styrene' 51 . Unlike hydrogels, these materials have 
many desirable properties such as high elasticity, tensile strength and 
durability ' 52 . As a result, these materials have found widespread use in blood-
contacting applications where prolonged non-thrombogenicity is desired. 
1.3.4.2 Increasing cellular recognition 
Cellular adhesion is controlled via the interaction of extracellular matrix proteins with 
cell-surface receptors such as integrins and selectins. 
One of the most commonly used strategies for increasing cellular recognition involves 
mimicking the binding sites of integrins by use of small peptide sequences. The most 
general peptide sequence used is arginine-glycine-aspartic acid (RGD), which promotes 
the adhesion of most cells, whereas other sequences have been shown to promote 
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specific cellular processes, for example, VTXG promotes platelet adhesion 153  and 
IKVAV promotes neurite extension of neurons 
Oligosaccharides are the primary ligands for selectin cell-receptors' 55. Scientists have 
successfully functionalised PEO hydrogels with different densities of oligosaccharides in 
order to promote hepatocyte adhesion, and subsequent culture 156 . 
1.3.4.3 Strategies to enhance haemocompatibility 
Researchers have developed various methodologies to interfere directly with the 
coagulation cascade and inflammatory responses in order to improve the 
haemocompatibility of biomaterials. A widely used methodology for this purpose 
consists of immobilising heparin onto the surface of implanted materials. Heparin is a 
well-known anti-coagulant that regulate the activity of inhibitors of the coagulation 
system, resulting in the neutralisation of thrombin 157 . 
Finally, haemocompatibility has been improved by loading biodegradable materials with 
drugs that act on the inflammatory response. Nguyen et al. observed reduced platelet and 
leukocyte activation and deposition on poly(L-lactic acid) (PLLA) stents loaded with 
two different anti-inflammatory drugs, curcumin and paclitaxel' 58 . 
1.3.4.4 Future directions in biomaterial design 
Biomaterials were traditionally designed and selected for their inertness. A better 
understanding of the body response to foreign materials has allowed the development of 
several strategies to synthesise or functionalise materials with enhanced 
biocompatibility. Recent advances in tissue engineering and drug delivery has driven 
researchers to develop a new range of biomaterials with additional characteristics such 
as stealth properties, responsiveness and specificity' 59 . The so-called "smart materials" 
are capable of undergoing modifications triggered by changes in their biological 
environment. For example, a drug encapsulated within a biocompatible polymer matrix 
can be released within the patient at a specific site in response to a local change in pH 160 , 
and sheets of cells can be released from their substrate in response to a change in 
temperature ' 61 . The design of the biomaterials of tomorrow will rely more than ever on 
the exchange and integration of knowledge from researchers in various areas of science. 
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1.3.5 High throughput technologies and biocompatible polymers 
1.3.5.1 High throughput synthesis 
The generation of new materials represents an area where a large parameter space can be 
investigated including composition, synthetic parameters, purification, and processing, 
thus it is particularly suited to the application of combinatorial and high throughput 
methodologies. Major advances in the field of material synthesis were achieved with the 
development of automated synthesis platforms 162  allowing a series of discrete materials 
to be synthesised in parallel under very controlled conditions. Additionally, the synthesis 
of materials presenting gradients of compositions or properties is unique to the material 
field. Indeed, instead of synthesising a series of single compounds with slightly different 
properties, it is sometimes possible to generate a material showing a gradient of 
properties across its surface. For example, Washburn et al. generated thin-films of 
164 polymers showing gradients of crystallinity 163  using a custom built flow-coater, while 
vapour deposition of inorganic compounds has been used for the generation of new 
luminescent materials 165 
1.3.5.2 High throughput screening 
The rapid synthesis of hundreds of new materials is useless if the analysis and screening 
of these materials' properties does not achieve a similar throughput. As a result, many 
analytical apparatus have been automated to allow the analysis of a variety of parameters 
with minimal operator intervention. For materials synthesised as single compounds, the 
screening apparatus can be coupled with autosamplers (e.g. gas chromatography and 
differential scanning calorimetry (DSC)), or the materials can be placed into multiwell 
plates or arrayed onto surfaces (e.g. Fourier transform infrared spectrophotometer (FT-
IR), matrix-assisted laser desorption/ionization time-of-flight mass spectrometer 
(MALDI TOF-MS)). Many physico-chemical properties can thus be analysed in a high 
throughput manner with commercial apparatus. 
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However, due to the wide range of tests necessary to evaluate biomatenals, there is no 
single apparatus capable of biocompatibility assessment. Most biocompatibility 
evaluations involve the study of several biological responses at the interface with the 
biomaterial. To reduce the cost of analysis and the amount of material required, most 
methodologies begin with the formation of biomaterial films. Traditional methods for 
the generation of such films used spin-coating 166  which is time-consuming and difficult 
to automate. High throughput approaches in many areas of biology have led to the 
development and widespread use of multiwell plate systems. These have subsequently 
been adopted in biomaterial research where, for example, a series of polymer solutions 
can easily be transferred into the wells of a microplate using an automated liquid 
handling station, followed by simple solvent casting to form a thin polymer film. 
1.3.5.3 High throughput analysis 
As more and more data are generated, it has become essential to develop computer 
programs that facilitate interpretation of the results. Traditionally, developed as stand-
alone, these software use a variety of visualisation options to enhance the understanding 
of the results and accelerate the identification of hits. However, recent advances in 
chem-informatics and molecular modelling have led a few companies to develop 
integrated solutions for material research. These complex software programs are 
sometimes integrated with several apparatus and can perform a range of applications 
from the modelling and design of experiments (DoE), to the control of synthetic 
parameters, and the collection of data and final analysis and interpretation. 
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1.3.5.4 Conclusions 
The field of combinatorial and high throughput material research is still very much in its 
infancy. Many developments that originated from the pharmaceutical research have now 
been adapted to the field of material research. However, due to the complexity and 
diversity of biocompatibility testing of biomaterials, it has been difficult to standardise 
platforms allowing high throughput determination of in vitro properties of biocompatible 
materials. Over the coming years, it will be essential for this field to undertake some 
kind of standardisation in order to allow researchers to share their results and hopefully 
develop a better understanding of the factors affecting the biocompatibility. Ultimately, 
the generation of scientific consensus should allow bio- and chem-informatic researchers 
to development new molecular modelling platforms able to predict the biocompatibility 
of materials prior to their synthesis. Together with advances in cellular biology, the 
biomaterial sciences of tomorrow will address several issues in medicine from the 
generation of artificial organs via tissue engineering to the development of new therapies 
aided by the controlled release of drugs and genetic materials. 
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1.4 Aim for the thesis 
The aim of this thesis was to development high throughput methodologies to test the 
biocompatibility of libraries of polymers. 
The first step of this approach was to investigate the use of a contact microarrayer to 
pattern libraries of polymers. Following optimisation of the printing parameters, it was 
shown that this platform could be used to carry out high throughput physico-chemical 
characterisations of the arrayed polymers. 
The polymer microarray platform was subsequently adapted for the study of cellular 
adhesion. It was shown that this assay could be multiplexed with more than one cell line. 
The polymer microarray for cellular adhesion was applied to the identification of 
polymers that support: 
• the immobilisation of adherent immortalised cell lines. 
• the immobilisation and growth of human primary renal tubular epithelial cells. 
• the immobilisation of non-adherent immortalised cell lines. 
• the immobilisation of mouse bone marrow dendritic cells and the subsequent 
study of cellular phagocytic activity on the identified polymers. 
The polymer microarray for cellular adhesion was applied to the identification of 
polymers with potential applications in the field of stem cell biology: 
• for the selective enrichment of multipotent mesenchymal stromal cell population 
from human bone marrow. 
• for the maintenance of the undifferentiated phenotype of mouse embryonic stem 
cells cultured in vitro. 
Finally, the scope of the polymer microarray was widened by adapting it to the adhesion 
of proteins onto polymer libraries. 
CCk 
Chapter 2: Development of polymer 
microarrays 
2.1 Development of polymer microarrays 
In order to develop a high throughput method for the study of protein adsorption and 
cellular adhesion onto polymers, while minimising the quantities of polymers, reagents 
and cells used, it was decided to develop a highly miniaturised and parallel platform. To 
this end, a microarray platform where each polymer could be immobilised as a 
microscopic spot was investigated. It was decided that both protein adsorption and 
cellular adhesion onto the different polymers would be evaluated by fluorescence 
measurements, which provided a common and versatile tool. The first three parameters 
investigated during the development of this method were: the surface onto which the 
polymers were printed, the solvent used to prepare the polymer solutions, and the 
printing conditions used by the microarrayer. It is important to note that these three 
parameters are not independent of each other and will influence the quality and 
reproducibility of the final polymer microarray. 
2.1.1 Surfaces 
The first step in the development of the polymer microarrays was to identify two 
substrates, one giving low protein adhesion, and the other preventing cellular binding in 
order to achieve a low fluorescent background and easy spot localisation. Initially the 
polymer microarray was developed for the study of protein adsorption, and it was later 
adapted for the study of cellular adhesion. 
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2.1.1.1 Surfaces for the study of protein adsorption 
The first step in the development of this method was to identify a substrate with low 
protein adhesion in order to achieve a low fluorescent background. Protein adhesion to 
different substrates was measured by assessment of the fluorescent background resulting 
from incubation with fibrinogen (25 j.ig.mL5 labelled with AlexaFluor® 647 in PBS at 
pH 7.40. A large number of surfaces were investigated including functionalised glass, 
metal, and polymeric surfaces (Table 2.1). 
Material Nature of surface 
Intensity of the 
background (a.u.) 
Glass 
Aminoal kylsi lane 1 400 000 
Superfrost Plus 800 000 
Polysine 110 000 
Metal  
Aluminium 28 000 
Solid steel 20 000 
Polymeric 
film 




Blocking buffer-coated 20 000 
Gold-coated 6 000 
Table 2.1 Background intensity (arbitrary units) determined using [Fg]=25 ug.mE'; 
incubation 3 Hr @ 37°C; fluorescence determined using Cy5 filter and area: 0 250 pm. 
(The details of the materials can be found in Chapter 6) 
The results of these incubations (Table 2.1) showed that many of the different 
functionalised glass substrates gave very high background intensities. Both metal 
surfaces gave reasonably low background intensities, but the roughness of the surfaces 
resulted in poorly reproducible printing. Two polymeric films made of materials used in 
disposable syringe filters for low protein binding were also investigated. The results 
obtained with these films were poor as poly(vinyldifluoride) (PVDF) gave a high 
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background, and the poly(ethersulfone) was inadequate for this method as it was auto-
fluorescent at the studied wavelength. Finally, standard glass slides were coated with 
gold and a blocking buffer' 67 . The latter was efficient for reducing protein binding but 
the blocking buffer layer dissolved locally upon polymer printing. Gold coated slides 
produced very promising results since the intensity of the background was by far the 
lowest achieved (Table 2.1). However, these low fluorescent intensities do not result 
from low protein adsorption but from well studied phenomenon of quenching of the 
fluorescent dye when in close contact with a noble metal surface (Förster Quenching) 168-  
172 As a result it was decided that further method development and optimisation would 
be carried out on gold coated glass slides for protein adhesion studies. 
2.1.1.2 Surfaces for cellular adhesion 
In order to develop a cell-based microarray format, the substrate had to comply with 
several requirements. Firstly, the substrate had to be unaltered by the contact printing of 
the polymer solution in organic solvent, which ruled out the use of polymer coatings 
such as poly(hydroxyethyl methacrylate) p(HEMA)' 73 which could be dissolved locally 
and give rise to polymer mixtures. Secondly, a substrate with low levels of background 
cell binding had to be developed to facilitate data analysis and thirdly, the substrate had 
to be stable under UV-irradiation to allow sterilisation prior to the plating of the cells. 
Several functionalised and gold-coated glass slides were investigated for this 
application, most of which provided a suitable surface for polymer printing, and could 
be readily sterilised under UV-irradiation, but unfortunately they did not prevent cellular 
adhesion. As a result, several substrate modifications used in cellular patterning 
applications were investigated. The following substrates were prepared and tested: 18 --
functionalised slides, perfluoroalkylthiol monolayers on gold coated slides" and Silane-
PrepTM slides dip-coated with a layer of agarose gel. The Cl 8-functionalised slides, as 
expected, were highly hydrophobic and were able to reduce non-specific binding, but 
not all cell lines could be blocked in this manner. The use of perfluoroalkylthiol-
modified slides inhibited cellular adhesion, however it was impossible to use UV-
irradiation for sterilisation as this degraded the surface. The best results were obtained by 
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dip-coating aminoalkylsilane slides (Silane-Prep TM ; Sigma) with a thin film of agarose 
(Figure 2.1). Although agarose gels have been used to amplify loading on DNA 
arrays ' 2 , and are known to inhibit cellular adhesion in a number of different formats 20" 74, 
agarose had not been directly used as a substrate for cell-based microarray assays. 
Importantly agarose is readily sterilized by UV irradiation and does not dissolve in most 
organic solvents. 
A 	 B 	 C 
Figure 21 Non-specific cell binding reduction using an agarose-coated substrate. Non-
processed images obtained with STRO-I+ cells stained with CeliTrackerThi  Green on 




In order to study the effect of different polymer solvents on the quality of the printing, 
polymer solutions were prepared at 1.0 % w/v and subsequently printed using 150 I.Lm 
solid pins (Genetix). The 1.0 % w/v concentration was selected as it was the single 
highest concentration allowing good solubilisation across the various polymer libraries. 
A variety of solvents were investigated. Initially, poly(acrylates) (Appendix II) were 
printed after dissolution in three different alcohols (methanol (MeOH), ethanol (EtOH) 
and isopropanol (IPA)) each mixed with 10% water, and poly(urethanes) (Appendix I) 
were printed in tetrahydrofuran (THF), dichioromethane (DCM) and chloroform 
(CHCI 3). Both methanol and isopropanol-based polymer solutions gave regular spots. 
However, polymers prepared with the ethanoic mixture tended to spread when spotted 
onto gold-coated substrates. Printing of poly(urethanes) in THF, DCM and chloroform 
was shown to be difficult as solvent evaporation prevented uniform printing, especially 
for large numbers of samples. Additionally, when the printing was satisfactory, it was 
noticed that upon drying, ring formation 175  could be observed. As a result, the use of a 
low volatility solvent suitable for both libraries of polymers was investigated. N-methyl-
pyrrolidinone (NMP) was selected as over 90 % of the polymers from both libraries 
were soluble in this solvent, and its boiling point (202 °C /1 atm) prevented rapid solvent 
evaporation which allowed large numbers of polymers and microarrays to be printed in a 
single run. In order to fully remove the solvent following printing of the polymer, the 
arrays were dried under vacuum at 45 °C overnight. 
2.1.3 Printing and washing of the polymer microarray 
Printing was carried out using a Qarray (Genetix) contact microarrayer. This arrayer 
allows the control of a variety of parameters including inking time, stamping time, 
number of stamps per spot and washing conditions. 
Two types of microarraying pins were investigated: 
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• Split pins (75 .tm aQu, Genetix, UK) contain a slit that act as reservoir for the 
solution to print. Using these it is possible to print more than one spot per inking 
and to control the spot size by changing the stamping time (the time during 
which the pin needle is in contact with the substrate). Unfortunately, their design 
was not compatible with the printing of polymer solutions combined with the use 
of the integrated washing station, since following pin washing with ethanol or 
water (the only solvents compatible with the washing station), polymers 
(especially polyurethanes) precipitated inside the slit making any further printing 
impossible. The only solution to this problem was to sonicate the pins 
extensively in NMP in order to remove any precipitate. Since this prohibited the 
development of a high throughput method for the generation of polymer arrays, 
the use of another pin design was investigated. 
• Solid pins (150tm aQu, Genetix, UK), whose design is very similar to sewing 
pins, were investigated. Using solid pins, the main factors affecting the shape and 
uniformity of the printed spots were the nature of the solvent and substrate used. 
Since the gold-coated substrate and NMP solvent were selected, it was very 
difficult to tune the spot size using solid pins (unlike split pins, the stamping time 
has hardly any effect on the size of spot printed using solid pins). The only 
parameter investigated was the use of more than one stamp per spot providing 
more than one deposition of polymer solution in the same position. It was found 
that best spot uniformity was obtained using 5 stamps per spot. 
Finally as mentioned above, the washing station was only compatible with ethanol and 
water. This represented a major problem especially when washing followed 
poly(urethane) printing as it caused precipitation and subsequent cross-contamination of 
the next samples. As a result, it was decided that when printing more polymer samples 
than the number of pins available at the time (16 pins), manual washing of the pins using 
a cloth and acetone was necessary following the automatic washing step. 
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2.1.4 Evaluation of spot size reproducibility 
In order to determine the reproducibility of the printing method using the parameters 
selected above (NMP as solvent and solid pins to deliver the polymer solutions), an 
array containing 128 different poly(urethanes) (Table 6.4) each printed as four replicate 
spots was generated on gold-coated slides. To allow rapid evaluation of spot size (FIPS 
software, LaVision Biotech) the array was incubated with fibrinogen labelled with 








Figure 2.2 Fluorescent scan of a polymer microarray containing 128 polyurethanes 
showing the adsorption ofAlexaFluor ® 647 labelledfibrinogen. Each polymer is printed 
as 4 identical spot vertically. 
The average diameter for 120 different polymers was evaluated and the overall mean 
diameter and standard deviation calculated (the diameter of 8 remaining polymers could 
not be measured as they showed no protein adhesion). Due to the low resolution (10 tm) 
of the Bioanalyser 4F/4S scanner, the diameters were evaluated to the nearest 10 Am. 
Each set of four spots prepared from the same polymer were of similar diameter (+1-10 
Am) (Table 6.4). Mean spot diameter over the whole array (120 polymers) was 306 Am 
with a standard deviation of 20 Am, which gave a coefficient of variance of about 6 %, 
which was satisfactory when considering the high throughput with which the array was 
generated. As a result, all subsequent array printing described in this thesis were 
generated using the parameters described above. 
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2.2 Physical characterisation of polymer spots on the 
microarray 
Characterisation of the printed polymer spots on the microarray was explored as a 
potential means of high throughput physical and chemical characterisation. This 
included scanning electron microscopy to study the morphology of the printed spots, 
Fourier transform infrared (FT-IR) microscopy and time-of-flight secondary ion mass 
spectroscopy (TOF-SIMS) to study the composition of the surface of the printed 
polymer spots. 
2.2.1 Scanning Electron Microscopy 
Scanning electron microscopy (SEM) uses finely focused electron beams to scan across 
a sample to produce high resolution images. Unlike traditional optical microscopes that 
use light waves to create a magnified image, SEM creates a 3-dimensional image with a 
resolution of several nanometres. Since the SEM microscope illuminates the samples 
with electrons, the samples have to be made to conduct electricity in most cases. This is 
undertaken with a sputter coater which deposits a thin film of conductive material such 
as gold or carbon black onto the sample. 
Prior to scanning, polymer microarrays were covered with a thin film of gold using a 
sputter coater. The coated array was cut into two pieces in order to fit in the sample 
holder; finally, the piece of microarray was inserted in the vacuum chamber and 
subsequently scanned. This allowed the study of spot morphology in the microarray 
format. Out of 48 different polymer spots recorded, most showed smooth and uniform 
surfaces, and only 10 spots were non-uniform or with a globular surface. (Figure 2.3). 
When the composition and molecular weight (27 to 170 kDa) of these 10 irregular spots 
were studied, no clear correlations were found. It was therefore impossible to draw any 
clear conclusions as to why these polymers failed to produce uniform spots upon 
microarray printing and drying. However, scanning electron microscopy provided a 
convenient method to aquire morphological information at the micrometer scale on large 
number of printed polymer spots in a single experiment. 
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Figure 2.3 Scanning electron micrographs of polymer spots printed on gold-coated 
slides. (A) a uniform and smooth spot of PU-12; (B) a non-uniform spot of PU-i 79; (C) 
a uniform spot of PU-63 with a globular surface; (D) Higher resolution micrograph 
showing the globular surface of spot C. 
.0 
2.2.2 FTIR microscopy 
Fourier transform infrared (FT-IR) spectroscopy is an invaluable tool in organic 
structure determination, based on the interaction of IR radiation with matter. A molecule 
absorbs infrared radiation when the vibration of the atoms in the molecule produces an 
oscillating electric field with the same frequency as the frequency of incident IR 
radiation. Typical infrared spectroscopy involves recording absorption information 
across a range of frequencies (4000 to 400 cm') in order to obtain a spectrum from 
which absorption bands (related to specific bond vibration and stretching) can be 
correlated to chemical bonds within a compound. An FT-IR microscope consists of a 
FT-lR spectrometer coupled to a light microscope with an integrated CCD camera and 
automated X-Y-Z stage. This type of platform allows the automated IR spectroscopic 
analysis of large areas, and subsequent mapping of functional groups. As a result, an FT -
IR microscope can be programmed to visualise functional group distribution across an 
array of polymer spots. As a proof of concept, an entire spot of 2BCg7-1 .0 
poly(acrylate) was mapped by following the absorption corresponding to the carbonyl 
functionality (1727 cm) of the methacrylate-based monomers and a 3-dimensional 
projection was obtained (Figure 2.4). 




Figure 2.4 FTIR microscopy of a po1y(acy1ate) spot of 2BCg7-1.0; (A) FTJR 
transmittance spectra taken in the middle of the polymer spot; (B) 3-dimentional 




TOF-SIMS combines two analytical techniques: SIMS involves bombarding a surface 
with primary ions (such as Gallium, Ga 4), which transfer energy to surface atoms 
through a collision cascade allowing fragmentation and subsequent emission of clusters. 
of atoms. These clusters are subsequently analysed using TOF mass analysis, which is 
based on the fact that ions with identical energy and different masses travel with 
different velocities allowing the generation of a mass spectrum in which each band 
corresponds to a cluster of different mass/charge (m/z). This technique was applied to 
determine the surface composition of an arrayed series of poly(acrylates) synthesised 
using different ratios of 2-methoxyethyl methacrylate (MEMA) and diethylaminoethyl 
methacrylate (DEAEMA) (MEMAIDEAEMA mol. % = 100/0; 95/5; 90/10; 85/15; 
80/20; 75/25; 70/30; 65/35). 
All of the polymer spots revealed strong mass ions at m/z = 59 and 69, respectively, for 
C2H4-0-CH3 ions from MEMA and for the main methacrylate chain ions ('C 4H50). All 
of the polymer spots containing DEAEMA presented additional mass ions at m/z = 72, 
86 and 100 corresponding to the side chain ions N(C2H5)2, CH 2-N(C2H5)2 and C2H4-
N(C2H5 )2, respectively. As a result, the polymer spot surface composition was calculated 
from the intensity ratios of the peaks (m/z = 100/59). The molecular percentages of 
DEAEMA obtained experimentally were plotted against molecular percentages of 
DEAEMA introduced during polymerisation (Figure 2.5). The analysis showed that the 
ratio of DEAEMA calculated from the recorded spectra were higher than the ratio of 
DEAEMA monomer introduced during polymerisation. These results are likely to be 
due to the fragment ion (m/z = 100) containing diaminoethyl functionality, which was 
more easily fragmented than the fragment ion containing the methoxy group (m/z = 59). 
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Figure 2.5 (A) ions assigned by TOF-SIMS, (B) example of TOE-SIMS spectrum for a 
poly(MEMA-co-DEAEMA) copolymer, (C) compositional analysis of the polymer spots: 
experimental compositions obtained from the TOE-SIMS analyses versus theoretical 
compositions obtainedfrom the amount of monomers used in the polymerisation. 
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23 Conclusions 
A high throughput method allowing the patterning of large numbers of polymers on a 
microscope slide was developed using a contact microarrayer. Several parameters 
(surface, solvent, pins and printing conditions) were optimised in order to generate 
polymer microarrays with uniform and reproducible features. The best results were 
obtained by preparing polymer solutions in NMP as solvent and printing using solid 
pins. Using different surfaces, these polymer microarrays can be used for different 
applications; gold coated surfaces can be used for the evaluation of protein adsorption, 
whereas agarose coated slides can be used to study cellular adhesion. Additionally, it 
was shown that the polymer microarrays can be used to study the properties of the 
printed polymers. Scanning electron microscopy allowed the study of the the printed 
spots morphologies. However, from the chemical composition and molecular weight of 
the printed polymer, it was impossible to draw any clear conclusions as to why specific 
polymers failed to produce uniform and smooth spots. Chemical functionality and 
composition analyses were undertaken using Fourier Transform Infra Red (FT-IR) 
microscopy and time-of-flight secondary ion mass spectrometry (TOF-SIMS). FT-IR 
microscopy allowed the characterisation and mapping of chemical functionality across 
the printed polymer spot whereas TOF-SIMS provided semi-quantitative informations 
regarding the surface composition of the polymer spots. These experiments emphasise 
the versatility of the polymer microarray platform which can be utilised for both 
biological and chemical high throughput experimentations. 
I ME 
Chapter 3: Screening of biocompatible 
polymers for cellular adhesion 
Following the successful patterning of polymer solutions to generate a polymer 
microarray, this platform was used to identify new polymers that support the adhesion 
and/or growth of a variety of cells, ranging from immortalised adherent cell lines to the 
more challenging primary and non-adherent cells. 
3.1 Assay development 
3.1.1 Introduction 
Initial work was carried out on arrays of 120 poly(urethanes) each printed as four 
identical spots using available immortalised adherent mammalian cell lines (BI6FIO and 
ND7). In order to evaluate cell adhesion on the different polymer spots, fluorescent 
probes such as CellTrackerTM (Molecular Probes, Invitrogen) were used to label the 
cells. CellTrackerTM can freely pass through cell membranes, but once inside, it is 
transformed into cell impermeant reaction products, preventing leakage and/or 
contamination of adjacent cells. Additionally, the fluorescently labelled cells can be 
easily fixed with aldehyde fixatives permitting long-term storage and visualisation. 
Most developmental work was carried out using a low resolution scanner (BioAnalyser 
4F/4S with FIPS, LaVision) as it was the only available analysis system at the time. Cell 
binding was evaluated by integrating the fluorescence intensity across the whole area of 
the spot. The mean fluorescence intensity and coefficient of variation for each set of four 
identical polymer spots was then calculated. Background corrections were carried out by 
subtracting the mean fluorescence intensity of 32 "background spots" from the mean 
fluorescence intensities calculated for each library member. 
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3.1.2 Assay description 
Following preparation of the polymer arrays on the agarose-coated substrate, each 
polymer microarray slide was covered with a suspension of labelled cells (typically 106 
cells / slides in 15 mL cell culture medium). After 24 hours of incubation, the 
microarrays were rinsed in PBS to remove any non-specific binding, and the cells were 
fixed in 4.0 % w/v p-formaldehyde solution for 15 minutes. Excess p-formaldehyde was 
removed with PBS, and water was used to remove traces of salt prior to drying and 
scanning. 
3.1.3 Reproducibility study 
Initial experiments were carried out to evaluate the reproducibility of the method, both 
intra and inter-slide. The intra-slide reproducibility was assessed by calculating the 
coefficient of variation among the four identical spots of each polymer, whereas the 
inter-slide reproducibility was evaluated by calculating the correlation coefficient when 
plotting the background corrected fluorescence intensities for each of the 120 polymers 
(Table 6.6) resulting from the same experiment run on two identical arrays. 
The initial screening was performed using B16F1O and ND7 mouse cell lines stained 
with CellTrackerTM Green and Orange, respectively. The average intra-slide variation 
was minimal for ND7 cell stained with CellTrackerTM Orange (average CV of 14 % and 
15 % for slide I and 2, respectively), while in the case of B16F1O cells stained with 
CellTrackerTM Green, the average CV were 36 and 32 % (for slide 3 and 4, respectively). 
The inter-slide reproducibility, (Figure 3.1 and Table 6.6) evaluated using two identical 
slides, gave correlation coefficients of r0.85 and 0.79 with ND7 and B l6FlO cells, 
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Figure 3.1 Scatter plot representing inter-slide reproducibility. Each data point 
represents the background corrected mean fluorescence intensity of each polymer 
arising from the binding of ND7 cells stained with CellTrackerTM  Orange, from 
experiments run on two identical arrays. 
3.1.4 Effect of staining on cellular adhesion 
The possible effect of the stain on cellular adhesion was assessed by comparing ND7 
adhesion using CellTrackerTM Orange to the adhesion of ND7 cells stained with 
CellTrackerTM Green. When comparing the cellular adhesion of these two experiments, 
the correlation coefficient was r 2=0.73, which showed that the nature of the stain had 
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Figure 3.2 (A) Scatter plot representing the effect of the stain on cellular adhesion. 
Each data point represents the background corrected mean fluorescence intensity of 
each polymer arising from the binding of ND7 cells stained with CellTrackerTM Green 
(B) and CellTrackerTM Orange (C) from experiments ran on two identical arrays. 
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3.1.5 Multiplexing of adhesion 
Evaluation of the feasibility of simultaneous screening of two different cell lines was 
carried out using a mixture of ND7 and B16F1O cells (labelled with CellTrackerTM 
Orange and Green, respectively, and containing I .5x I06 cells of each lineage) plated 
onto the polymer array. The slide was scanned using both Cy3 and FITC filters and the 
cellular adhesion for each cell line was evaluated as described previously (see section 
3.1.3). In this duplex experiment, the intra-slide reproducibility was similar to the single 
cell experiments (average CV's calculated from the four identical polymer spots were 13 
% and 27 % for ND7 and B16FI0, respectively). Comparison of the duplex and single 
cell experiments gave correlation coefficients for ND7 and BI6FIO cells of r 2=0.83 and 
r=0.68, respectively (Figure 3.3 and Table 6.8) which were only slightly lower than the 
inter-slide reproducibility observed for a single cell line. These discrepancies are 
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Figure 3.3 Scatter plot comparing the ND7 adhesion screen with the results obtained 
from ND? duplexed with BI6FIO. Each data point represents the background corrected 
mean fluorescence intensity of each polymer arising from the binding of ND7 cells 
stained with CellTrackerTM  Orange run twice, in the presence of ND 7 only (Single) and 
as a mixture ofND7 and BI6FJO cells (Duplex). 
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3.2 Applications of cellular adhesion screens 
The polymer microarray was used to identify new materials onto which human primary 
renal tubular epithelial cells could be cultured. A library of 120 poly(urethanes) (Table 
6.9) was printed onto agarose-coated slides. The cells were plated at 10 5 cells per slide 
and incubated for 5 days. Following fixation and permeabilisation, the cells were 
incubated with CAM5-2 an anti -cytokeratin monoclonal antibody and visualised using 
AlexaFluor® 488 labelled IgG antibody. Finally, Hoechst 33342 was used to stain the 
nuclei. Analysis was carried out using the high resolution HCS platform and the 
PathfinderTM software. This platform is based on a fluorescent microscope with an X-Y-
Z stage, and allows the automated capture of single images (0.46 mm 2)  for each polymer 
spot with a resolution of 0.58 pm (Figure 3.4). 
Figure 3.4 Primary renal tubular epithelial cells on polymer array. (A) Cells on an 
array containing 60 polymers each printed as 4 replicate spots; one polymer spot with 
no background subtraction. (B) Nuclei stained with Hoechst 33342. (C) Cam5-2 
antibody staining with AlexaFluor®488 secondary antibody. (D) Composite image of (B) 
and (C) (the bar represents 100 pm). 
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Cell compatibility was evaluated as the total number of cells immobilised onto each 
polymer spot. Several poly(urethanes) were shown to provide significant cell 
attachment, with a mean over the four identical polymer spots of up to 153 human renal 
tubular epithelial cells (Table 6.9). The 6 poly(urethanes) showing the highest number 
of bound cells (more than 140 cells per spot) all contained 4,4'-
methylenebis(phenylisocyanate) (MDI) (PU-l8; 161; 165; 182; 195; 217), while the diol 
PTMG (650 Da or 1000 Da) was present in four of these top six polymers. It was 
possible to elucidate the effects of the molecular weight (MW) of the polyol by studying 
the relationship between cellular adhesion and composition of twelve different polymers 
all prepared from poly(tetramethylene glycol) (PTMG) and 4,4'-methylene 
bis(phenylisocyanate) (MDI) using ethylene glycol (EG) or propylene glycol (PG) or no 
chain extender. When considering each series of four polymers prepared from the same 
chain extender, the highest binding of renal tubule epithelial cells was observed with 
PTMG with a MW of 650 Da (Figure 3.5). In conclusion, to obtain a polyurethane that 
provides good cellular adhesion for the culture of human primary renal tubular epithelial 
cells, it should be synthesised from the aromatic monomer MDI as diisocyanate, and a 
relatively short polyol such as PTMG 650. 
180 
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Figure 3.5 Influence of the poiyoi molecular weight on the adhesion of human renal 
tubular epithelial cells. Average number of cells bound to each 4 identical polymers 
spots plotted against the molecular weight of the PTMG (the error bars represent the 
standard errors). 
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3.3 Immobilisation of non-adherent cells 
Non-adherent cells include a large number of therapeutically important cell lineages, 
such as several cancer cells, blood cells and stem cells. Recent advances in cell-based 
assays have demonstrated a need for substrates providing immobilisation of these non-
adherent lineages " 376 . Traditional immobilisation of non-adherent cells is based on 
electrostatic interactions using highly positively charged surfaces such as poly-L- 
177 or polyethylenimine (PEI) 178 . One of the major drawbacks of this approach is 
the risk that cell health and cycles may be modified by such strong interactions. As a 
result, there is a need for new materials providing mild immobilisation of non-adherent 
lineages for several applications, including simple phenotypic studies by confocal 
microscopy, and the development of innovative cell-based assays. 
3.3.1 Initial investigation 
Preliminary investigations were carried out using three immortalised non-adherent cell 
lines: JURKAT (human leukaemic T-cell lymphoblast)' 79, JY (human B-cell 
lymphoblast)' 8° and RMA-S (murine T-cell lymphoma) ' 81 " 82 . Each cell line was stained 
with CellTrackerTM Green and was plated (106  cells / slide) onto an array of 120 
poly(urethanes), each printed as four identical spots on agarose coated slides. Following 
24 hours of incubation, the polymer microarrays and bound cells were washed and fixed 
prior to scanning with a low resolution scanner. Cell binding was evaluated as described 
previously (see section 3.1.1). With JURKAT cells, none of the 120 polymers provided 
cellular adhesion, however both RMA-S and JY cells showed significant polymer-
specific immobilisation (Table 6.10). The immobilisation of these non-adherent cells 
was shown to be highly dependent on both the structure and properties of the polymer 
and the nature of the cells investigated (Figure 3.6). The selectivity toward RMA-S and 
JY cell lines was remarkable, PU- 198, 199 and 202 bound RMA-S only, whereas PU-
194, 195, 207 and 210 bound predominantly JY cells. PU-21 I and 214 were the only 
two polymers to give moderate cellular immobilisation for both cell lines. When 
analysing the composition of the polymers which showed selectivity for a cell line, it 
was found that the polymers selective toward RMA-S all contained long PTMG as 
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polyol (PTMG 1000 or 2000), and diethyl bis(hydroxymethyl)malonate (DHM) as chain 
extender; whereas three out of four of the polyurethanes selective toward JY contained 
the highly hydrophobic monomer 2,2,3,3,4,4,5,5-octafluoro- 1 ,6-hexanediol (OFHD) as 
chain extender. 
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Figure 3.6 Polymer specificity for 2 non-adherent cell lineages. Scans (non-processed) 
were obtained for cell lines stained with C ellTrackerTM Green over an array of 16 
polymers each printed as four spots. Microarray screening shown with (A) JY cells, and 
(B) RAM-S cells, (C) schematic representation of the array, (D) cell binding expressed 
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3.3.2 Immobilisation of mouse bone marrow dendritic cells 
Dendritic cells (DC) play a central role in the initiation of immune responses and in the 
maintenance of immune tolerance to "self" 183  As professional antigen presenting cells, 
they can engulf particulate matter such as pathogens, necrotic and apoptotic cells by 
phagocytosis, then process these targets and present them at the cell surface bound to 
MHC class I or MHC class II molecules ' 84 . This ability means that DC are intensively 
studied as targets for vaccine design, particularly for vaccines against tumours. Dendritic 
cells are a rare constituent of any organ, and one of the most common experimental 
sources is to purify the immature, highly phagocytic cells from mouse bone marrow. 
However, immature murine bone marrow dendritic cells (BMDC) are extremely 
sensitive to stimuli that cause maturation 185 , which affects their ability to capture 
antigens by phagocytosis, while immobilisation is quite generally complicated by the 
fact that cellular behaviour may be modified by interactions with the materials used to 
coat the substrates 88 '89 . However, the immobilisation of DC would be important for 
several applications, ranging from simple phenotypic studies by microscopy, to the 
development of innovative cell-based assays. A library of 120 poly(urethanes) was 
screened using the microarray platform, in order to identify polymers able to immobilise 
the BMDC. The validity of the selected polymers was confirmed by studying the 
phagocytic activity of the BMDC cells while immobilised onto the selected polymer 
surfaces (Figure 3.7). 
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Figure 3.7 General protocol for the identification of substrates for phagocytosis studies; 
(A) microarray binding assay allowed for the selection of the best binding polymers, (B) 
the selected polymers were spin coated on coverslip, following sterilisation, these were 
incubated with BMDC, prior to be supplied with latex beads for phagocytosis 
evaluation. 
3.3.2.1 Polymer microarray screening 
A polymer microarray containing 120 poly(urethanes) each printed as four identical 
spots, was incubated with 4.106  stained BMDC at 37 °C with 5.0 % CO2 for two hours. 
Following washing, the cells were fixed, rinsed and further stained with a 0.5 .tg/ml 
solution of 4',6-diamidino-2-phenylindole (DAPI). Image capture and analyses were 
carried out using the high resolution HCS platform and the PathfinderTM software. Cell 
compatibility was determined by identifying the polymer spots with the most adhered 
cells using both the DAPI and FITC channels (Table 6.11). Three different 
polyurethanes (PU159, PU166 and PU174) were shown to immobilise more than 10 
cells per spot (mean across four identical spots). The cell compatibility of these three 
polymers was further evaluated by studying the phagocytic activity of immobilised 
BMDC on different surfaces. 
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3.3.2.2 Phagocytic study of immobilised BM])C 
The selected polymers (PU159, PU166 and PU174) were spin-coated onto glass 
coverslips (22 mm diameter) to provide a thin film of polymer. Additionally, three types 
of control coverslips were prepared, one set of non-coated glass coverslips (incubated in 
PBS alone), and two sets coated with two different grades of commercially available 
poly-L-lysine (histology and tissue culture grades). BMDC were plated and allowed to 
adhere to the different coverslips. Cells were then supplied with 3.0 jim diameter latex 
microspheres and incubated for 30 min at 37 °C. Post-incubation, the cells were fixed 
and stained for the endoplasmic reticulum protein calnexin, which provides a convenient 
counterstain revealing the presence of internalised microspheres (Figure 3.7). 
Phagocytic capacity was determined by confocal microscopy and counting of the 
number of microspheres that had been completely internalised (Table 3.1). 
Number of 
Number Microspheres 
Treatment Adhesion internalised 
of cells / Cell 
microspheres 
Control 1 
Poor 73 324 4.4 
(incubated in PBS) 
Control 2 
Good 312 421 1.3 
Poly-L-lysine, (histology) 
Control 3 
Poly-L-lysine, Excellent 529 684 1.3 
(tissue culture) 
PU 159 Good 297 969 3.3 
PU166 Excellent 556 1249 2.2 
PU174 Good 301 1073 3.6 
Table 3.1 Phagocytosis of latex microspheres by immobtitsea J3MDU on azjjerent 
substrates. Qualitative evaluation of BMDC adhesion, number of BMDC in the fields of 








Figure 3.8 Coiifiwal laser scanning microscopy (bottom), with corresponding phase 
contrast (top) images of BMDC adhered to coverslips and stained with anti-calnexin 
antibodies to reveal the presence of internalised microspheres. (A), (B) and (C) images 
taken with an x40 objective, coverslips treated with PBS alone; with poly L-lysine (tissue 
culture grade) and PUI 74, respectively. (D) PU] 74, images taken with an xIOO 
objective. The fluorescence image shows in more detail two internalised microspheres 
(arrows). The asterisk denotes the position of a microsphere that has bound to the cell 
surface (shown in the corresponding phase contrast image), but has not been 
internalised. 
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Interestingly, the greatest phagocytic capacity (an average of 4.4 microspheres per cell) 
was observed in cells that had adhered to coverslips treated with PBS alone (Figure 3.7, 
A). However, the degree of adhesion of cells to this substrate was very poor, and the 
cells were liable to be washed away from the coverslip both during the assay, and 
afterwards during staining. Poly-L-lysine of both grades greatly improved adhesion, but 
there was a concomitant decrease in the phagocytic capacity to an average of 1.3 
microspheres per cell (Figure 3.7, B). Although many microspheres were bound to the 
cell surface, closer examination of optical sections revealed that most had not been 
internalised. One possible explanation is that the physical restriction of cell movement 
caused by adhesion to a substrate inhibits the cytoskeletal rearrangements necessary 
during phagocytosis. In support of this idea, phagocytosis decreased to zero when the 
concentration of poly-L-lysine was increased ten-fold. Similar signalling pathways are 
involved in both cell adhesion to a substrate, and adhesion to a particle to be 
phagocytosed 186 . Whereas cell adhesion can stimulate membrane extension, as for the 
filopodia and ruffles that engulf a particle, there are also cases where adhesion can 
inhibit membrane protrusion, such as the inhibition of cell migration in culture caused 
by cell-cell contacts' 87 , which may provide an explanation for the observed decrease in 
phagocytosis by cells adhered to poly-L-lysine. In addition to reducing the phagocytic 
capacity, poly-L-lysine caused greater background binding of microspheres to the 
coverslip than was observed for the polymers and PBS control. This is most likely due to 
charge interactions, since the microspheres carry a net negative charge, and lysine is a 
positively charged amino acid at physiological pH. 
By contrast, phagocytic capacity was much greater for the three polymers, with average 
values of 3.3 and 3.6 microspheres per cell for PU 159 and PU174 (Figure 3.7, C and D) 
respectively, although these values were still less than that observed in the PBS control 
sample (Table 3.1). Adhesion, defined as the number of cells in a field of view, was 
greater for PU 166 than PU159 and PU174, but this was accompanied by a decrease in 
phagocytic capacity to 2.2 microspheres per cell. Taken together with the results for 
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poly-L-lysine, it appears that there is a trade-off between the degree of adhesion and 
phagocytic capacity. However, while adhesion to PU 166 was as good as to tissue-culture 
grade poly-L-lysine, PU166 enabled almost double the phagocytic capacity. These 
observations suggest that the poly(urethanes) are superior to poly-L-lysine for the 
adhesion of BMDC, because they mediate good adhesion whilst allowing much greater 
phagocytic activity. Interestingly, all three selected polymers were synthesised from the 
same monomers: PTMG as polyol and MDI as diisocyanate. 
3.4 Conclusions 
The polymer microarray platform was successfully used for the screening of cellular 
adhesion. It was shown that this very high throughput platform gave good 
reproducibility and also versatility since it can be used with a large range of fluorescent 
markers (dyes and antibodies). Additionally, the wide range of properties encompassed 
by the polymer libraries allowed the identification of several polymers that provided 
immobilisation of both adherent and non-adherent cell lineages. Finally, the platform 
was successfully utilised with clinically derived cells to identify new polymeric 
materials for (a) the growth of primary renal tubular epithelial cells and (b) the gentle 
immobilisation of BMDC, allowing enhanced phagocytosis and phenotypic studies. 
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Chapter 4: Polymer microarrays applied to 
stem cells 
4.1 Introduction 
Stem cells possess the capability of self-renewal and are also capable of differentiation 
to produce one or more types of mature cell, and are classified according to both their 
potency and source188189. 
Potency describes their ability to differentiate into different cell types. Totipotent stem 
cells are produced by the first few divisions of the fertilised egg cell arising from the 
fusion of an egg and a sperm cell. These cells can grow into any type of cell without 
exception. Pluripotent stem cells are the descendants of totipotent cells, and they can 
grow into any cell type with the exception of totipotent stem cells. Multipotent stem 
cells can only produce cells within a closely related cell family. For example, 
haematopoietic stem cells (HSC), can give rise to all blood cells including red blood 
cells, white blood cells and platelets. Unipotent stem cells can only produce one cell 
type. They are distinguished from non-stem cells by their self-renewal properties. 
Stem cells can be derived from a number of sources. Adult stem cells are usually 
multipotent, and they are scarce among differentiated cells in almost all tissues °. As 
well as their complex isolation, one of the main difficulties in the use of such cells is 
their resistance to culture outside their original environment. Embryonic stem cells 
(ESC) are isolated from the inner mass cells of an early stage embryo (sometime called a 
blastocyst). ESC are totipotent, which confers them with much greater developmental 
potential than that of adult stem cells. Under specific conditions, they can easily be 
multiplied and maintained in culture. Cord blood stem' 9 ' cells are derived from the 
blood of the placenta and umbilical cord after birth. They are considered to be 
multipotent. Compared to adult stem cells, they offer the advantage of being more easily 
isolated, however, their number is limited. Cancer stem cells are the fourth source of 
stem cells, and are formed from malignant transformation of adult stem cells. These are 
suspected to be the source of some or all tumours 192 ' 193 . 
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The therapeutic use of stem cells began in the 1970's with the transplantation of HSC 
into patients with diseased blood or bone marrow'. Following many advances in the 
field of medical biology, stem cells became the subject of extensive research and is now 
been investigated in many therapy areas 195..97,  from the development of new treatments 
to the study of development and gene control, and also, potentially, for drug and toxicity 
studies' 98200 . However, in order to fulfil these expectations, several limitations in stem 
cell methodologies have to be addressed. 
The main limitations in the use of adult stem cells arise from their limited availability, 
and their complicated isolation. These difficulties are also related to their expansion ex-
vivo, and thus their potential has to be demonstrated outside diseased blood and bone 
marrow treatment. 
Conversely, embryonic stem cells have far greater potential. They can potentially 
develop into any cell type, and they are capable of dividing and renewing themselves for 
long periods of time in vitro providing an almost unlimited source of cells. However, 
human embryonic stem cells have only been isolated recentl?°',  and many factors 
including the control of their differentiation have to be investigated before useful 
applications can be developed. 
The aim of the two studies undertaken in this chapter were to apply polymer microarray 
technology to the identification of novel materials for stem cell research. The first study 
involved the identification of materials that allowed selective enrichment of stromal 
stem cells (STRO- 1+) from nucleated marrow cells. The second study investigated novel 
materials that could support the growth of embryonic stem cells and maintain their 
undifferentiated phenotypes. 
- 81 - 
4.2 Selective enrichment of multipotent mesenchymal stromal 
cells (STRO-1) 
4.2.1 Introduction 
Adult stem cells have been found in organs all over the body
0
'202 . One of the most 
studied sources of adult stem cells is the bone marrow, which is the tissue at the centre 
of large bones. The bone marrow contains several types of stem cells or progenitor cells. 
Among the most important of these are the haematopoietic stem cells (USC) which 
produce all of the different blood cell types. It has been demonstrated that bone marrow 
stromal cells provide the environment for HSC differentiation 203 . In addition, these bone 
marrow stromal cells can generate bone, cartilage and fat cells 204 . Whether stromal cells 
are best classified as stem cells or progenitor cells for these tissues is still in question. 
There is also a question as to whether bone marrow stromal cells and so-called 
mesenchymal stem cells are in fact the same population. Until the stem cell activity of 
the bone marrow stromal cell population, or any subpopulation, is clearly demonstrated, 
it has been agreed by the International Society for Cellular Therapy (ISCT) that this 
heterogeneous population should be defined as multipotent mesenchymal stromal cells 
(MSC) 205 
In order to study and potentially develop useful applications for MSC, it is essential to 
isolate this particular population which represents only a small proportion of the cells 
present in the bone marrow (about 7 % of the unselected human bone marrow 
mononuclear cell)206. Currently, enrichment of human MSC is carried out from 
unselected human bone marrow mononuclear cell preparations by immunoselection with 
a STRO- 1 monoclonal antibod? 07  which recognises a cell surface antigen expressed by 
MSC 206-208  This methodology is expensive and time-consuming as it requires the use of 
flow cytometry to select the STRO- 1 positive population (STRO- 1+). Additionally the 
purified population end up labelled which may not be desirable. 
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In the previous chapter (see section 3.3.1), it was demonstrated that several polymers 
showed specific adhesion of given cell lines. Thus, in this study, the enrichment of 
human progenitor cells from unselected human bone marrow mononuclear cell 
preparations was investigated by means of specific adhesion to polymeric surfaces. The 
first step of this study was to screen a library of poly(urethanes) printed in a microarray 
format for binding to both unselected human bone marrow mononuclear cell preparation 
and the STRO- 1 + fraction isolated by magnetically activated cell sorting (MACS). 
Subsequently, polymers selected in the polymer microarray screen were coated onto 
coverslips to provide a large surface, and the experiment repeated in order to confirm the 
initial results. 
4.2.2 Microarray screens 
The screen with the STRO-1+ cellular fraction was used to identify polymers showing a 
high affinity for the STRO-l+ cells, whereas the experiment run with unselected human 
bone marrow mononuclear cell preparations was used to evaluate whether the cellular 
adhesion to these polymers was specific for the STRO-l+ fraction. Detection of these 
two cellular preparations was facilitated by selectively immunolabelling STRO- I+ cells 
using STRO-1 mouse monoclonal primary antibod?07, followed by the (FITC)-
conjugated AffiniPure F(ab')2 fragment Goat anti-mouse 1gM and the nuclear stain 
Hoechst 33342. Analysis was carried out using the high resolution HCS platform and the 
PathfinderTM software. In the first screen (STRO- I+ cells only) all cells were fluorescent 
at both wavelengths (FITC and DAPI) whereas in the screen with human bone marrow 
mononuclear cells, all nuclei were stained with Hoechst 33342 and only STRO-l+ cells 
showed FITC fluorescence (Figure 4.1). Unselected human bone marrow mononuclear 
cell preparations and STRO- 1 + cellular fraction isolated by magnetic activated cell 
sorting (MACS)208  were incubated for 17 hours on two identical polymer microarrays 
containing 120 poly(urethanes) each printed as four identical spots. 
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Figure 4.1 Selective immobilisation oJ Sire-i + cells on PU-16. (A), (B) and (C were 
performed with Stro- 1+ cells isolated by MA CS; (E) and (F) were performed using 
unselected human bone marrow mononuclear cell preparations containing FITC-
immunolabelled Stro-I + cells. 
The first screen (STRO-l+ fraction only) was used to visually identify the polymers 
showing the highest degree of STRO-1+ adhesion. The second screen (human bone 
marrow mononuclear cell preparation) was subsequently used to visually evaluate which 
polymers bound to STRO-l+ selectively. These two screens showed that only a few 
polymers promoted the adhesion of STRO-l+, within these, PU-16, 17 and 61 exhibited 
highest selectivity for STRO-l+ and hence were selected for further study. 
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4.2.3 Coverslip experiments 
In order to further confirm the results of these experiments, and study the possible scale-
up of the method as a means of cell enrichment, the three selected polymers (PU 16, 17 
and 61) were spin-coated onto glass coverslips. The polymer-coated coverslips were 
subsequently incubated with unselected bone marrow mononuclear cell preparations 
(from 3 individuals) in which the Stro-l+ cells were immunolabelled (as described 
above in section 4.2.2). Control experiments were carried out by incubating polymer-
coated coverslips with non-immunolabelled unselected human bone marrow 
mononuclear cell preparations, in order to obtain the background cell intensity on each 
of the poly(urethane) substrates. 
Analysis of 5 randomly selected areas (1230 by 940 gm) on each coverslip was earned 
out using the high resolution HCS platform and the PathfinderTM software. Quantitative 
analysis involved measurement of the background corrected FITC intensity of each 
immobilised STRO-l+ cell. For a cell to be deemed as STRO-l+, its background 
corrected FITC intensity had to be over the mean plus standard deviation of the control 
cells. Although the results from patient to patient showed variation in terms of overall 
immobilised cell density and STRO-l+ proportion, the overall results showed significant 
level of enrichment of the STRO-1+ population (Figure 4.2). 
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Figure 4.2 Enrichment of Stro-l+ osteoprogenitor cells on PU-16 coated-coverslip 
performed using unselected human bone marrow mononuclear cell preparations. (A), 
(B) and (C) using FITC-immunolabelled and DAPI-stained Stro-1+ cells; (D), (E) and 
(F) control (non-immunolabelled, DAPJ-stained bone marrow mononuclear cells); (G) 
Overall proportion of Stro-] + cells immobilized on coated-coverslips. 
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4.2.4 Conclusions 
Using polymer microarray screening for cellular adhesion, it was possible to identify 
polymers showing some selectivity toward the STRO-1+ cell fraction. The microarray 
results were further confirmed by scaling up the experiment on coverslips. 
The coverslip experiments showed that up to 50 % of the immobilised cells from human 
bone marrow mononuclear cell preparation were STRO- 1+, which represents a 
significant enrichment compared with about 7 % in the unselected fraction. Interestingly, 
when the structures of the three selected polymers were analysed, it was observed that 
they all contained hydrophilic chains of poly(ethylene glycol) (PEG 2000 or PEG 900) 
as the polyol and 4,4'-methylene bis(phenylisocyanate) (MDI) as the diisocyanate. The 
presence of MDI as hard segments within the selected polyurethanes was consistent with 
previous findings (section 3.2 and 3.3.2), in which the selected polymers providing good 
cellular immobilisation also contained the MDI monomer. However, the presence of 
highly hydrophilic long chains of PEG was unexpected, since these polyols are 
commonly utilised to reduce both protein and cell adhesion in a variety of applications. 
Despite their relative cellular selectivities, the efficacy of the selected polymers is far 
that provided by flow cytometry isolation, which achieves nearly pure STRO-l+ 
population. It is believed that further development in the design of these polymers could 
enhance their properties. This approach is based on interactions of polymeric materials 
with specific cellular population and has many advantages compared to expensive and 
time-consuming enrichment via flow cytometry methods. Additionally, identification of 
polymers capable of binding and enriching the STRO-1+ population from unselected 
human bone marrow mononuclear cell preparations has several implications in the fields 
of tissue engineering and orthopaedics, where the polymer could be utilised as a scaffold 
or coating for bone regeneration applications 206 . For such an application to be developed 
many additional experiments are required, including the study of the immobilised 
progenitor cells' fate and the evaluation of cytotoxicity and blood compatibility of the 
polymeric materials. 
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4.3 Novel substrates for embryonic stem cell culture 
4.3.1 Introduction 
Traditional methods of mouse embryonic stem cell (mESC) culture that maintain the 
undifferentiated phenotype of the cells involve culture on a layer of feeder cells. 
However, several reports 209,210  indicate that the feeder layer could be replaced by the 
addition of leukaemia inhibitory factor (LIF) 211,212  to the growth medium. In the 
absence of the feeder layer, mESC are usually cultured on protein (gelatine, collagen) 
coated surfaces. 
In this study, the use of polymeric materials as novel substrates for the growth of mESC 
was investigated. The performance of these materials was evaluated in terms of the 
conservation of the undifferentiated phenotype in the presence and absence of LIF. 
The study was carried out on a library of 124 poly(urethanes) using a modified mESC 
line (Oct4-GFP). Octamer-4 (Oct4) 213214 is a transcription factor of the POU family (a 
group of eukaryotic transcription factors containing a bipartite DNA binding domain 
referred to as the POU domain) 215 . This protein is critically involved in self-renewal of 
undifferentiated mESC, thus it is used as a marker of the pluripotent state 216217 . Oct4-
GFP cells have green fluorescent protein (GFP) 218219 transcription under the control of 
the Oct4 promoter to give a fluorescent read out of the undifferentiated state of mESC's. 
Following stem cell differentiation, the level of Oct-4 expression decreases rapidly as 
does the GFP expression, which reduces the overall fluorescence of the cells 220. As a 
result, it is possible to follow the differentiation of these mESC cells by following the 
intensity of the fluorescence associated with the expression of GFP (Figure 4.3). 
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Figure 4.3 mESC grown on gelatine-coated dishes, at the top, bright field microscopy, 
at the bottom, fluorescence microscopy using a FITC filter. (A) an undifferentiated 
colony of Oct4-GFP cells expressing GFP (FITC fluorescence), (B) a colony showing 
partially differentiated phenotype and (C) a colony showing a fully differentiated 
phenotype. 
The first step of this study involved a polymer microarray adhesion screen using the 
Oct4-GFP cells to identify which polymer supported the adhesion and growth of 
undifferentiated mESC's in presence or absence of LIF in the growth medium. 
Following the initial screen the best candidates were selected and the experiment was 
scaled up using polymer-coated coverslips. Following an inconclusive microscopy 
study, a clonal growth experiment was designed to confirm the initial observations on 
the microarray. 
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4.3.2 Polymer microarray adhesion screening 
The first screen involved plating 10 5 Oct4-GFP cells per slide on 14 identical polymer 
microarrays containing 124 poly(urethanes), each printed as 4 identical spots. Each pair 
of slides was incubated for a different time period, from 24 hours up to 7 days. Seven 
different time points were assessed with 2 slides per time point. Half the slides were 
incubated with a medium containing LIF, whereas the other half were incubated for 24 
hours only with LIF-containing growth medium, after which the medium was changed to 
a growth medium without LIF. 
At each time point, two slides (one incubated with LIF and one without) were washed 
and the cells were fixed using 4.0 % p-formaldehyde solution in PBS. Using a 
fluorescent microscope, the cells on the array were visualised for adhesion and 
expression of GFP. Out of 124 poly(urethanes), 52 showed immobilisation of mESC on 
at least one of the 14 polymer microarrays. By monitoring the expression of GFP in the 
experiment without LIF in the growth medium, 4 poly(urethanes) (PU 190; 206; 214; 
221) were selected as potential substrates, as they seemed to maintain undifferentiated 
cellular phenotypes. Following the experiments in presence of LIF, PU 161 was selected 
as a negative control as the cells bound to this polymer differentiated and stopped 
expressing GFP after a few days of incubation. 
A 	 B 	 C 
Figure 4.4 mESC grown on three different polymer microarray spots, at the top, bright 
field microscopy, at the bottom, fluorescence microscopy using the FITC filter. (A) an 
undifferentiated colony of 0c14-GFP cells expressing GFP (FITC fluorescence), (B) a 
partially differentiated colony and (C) a fully differentiated colony of Oct4-GFP cells. 
maim 
4.3.3 Coverslip experiments 
In order to scale up the experiment, the five selected polymers were spin coated onto 
glass coverslips (19 mm diameter). 
4.3.3.1 Microscopy 
The coated coverslips (two for each polymer, 5 polymers selected) were placed in a 12-
well plate, and the two remaining wells were coated with 0.2 % gelatine which was used 
as a control. Following sterilisation under ultraviolet (UV) irradiation, IO cells were 
plated in each well; half the samples were incubated with LIF-containing growth 
medium, whereas the other half were incubated without LIF. mESC media were changed 
every 48 hours. Each plate was incubated for 5, 7 and 9 days respectively, after which 
each well was rinsed, the cells were fixed and their nuclei stained with Hoechst 33342. 
After 9 days of incubation, the cells reached confluency and colonies started detaching 
during the rinsing step on several coverslips, and as a result these coverslips were 
discarded. Coverslips with attached colonies were mounted on standard microscope 
slides using the Aquatex mounting medium. Cells growing on top of each coated 
coverslip were visualised using both DAPI and FITC channels of the high resolution 
HCS platform and PathfinderTM software. Coverslips incubated in LIF-containing 
medium showed a large proportion of GFP expressing colonies. Unfortunately, in the 
absence of LIF, very large discrepancies in differentiation were observed depending on 
the area visualised within the same coverslip (Figure 4.5). 
It was hypothesised that such discrepancies could arise from an autocrine effect. Indeed, 
mESC produce LIF, and when these cells are cultured at high density, the autocrine 
effect has been demonstrated to be sufficient to maintain mESC pluripotentiality 221223 . 
As a result, it was impossible to draw any clear conclusions from this experiment. It was 
thus decided to design an experiment using a much lower cell density and a different 
marker of the undifferentiated phenotype in order to confirm the results obtained on the 
polymer microarray, that suggested these polymers could adhere mESC while 
maintaining their undifferentiated phenotype. 
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A 	 B 	 C 	 0 
Figure 4.5 mESC grown for 9 days on the same PU22 I-coated coversl:p in the medium 
without LIF. Top to bottom show the same areas visualised using DAPL FITC filters and 
composite of the two previous images, respectively. (A) Fully differentiated colony, (B) 
and (C) partially differentiated colony, and (D)fully undifferentiated colony. 
4.3.3.2 Clonal growth experiment 
The clonal growth experiment consisted of plating cells onto the coverslips at very low 
density (50 cells/coverslip) and incubating over 9 days in order to form colonies from 
single cells. The experiment was run both in the presence or absence of LIF on each of 
the polymer-coated coverslip. To increase the confidence in the results, a total of 3 
replicate experiments were carried out. At the end of each experiment, alkaline 
phosphatase activity was used to assess the pluripotentiality of the mESC grown in each 
colony209. The alkaline phosphatase detection kit (Sigma, UK) is a histochemical semi-
quantitative test to assess the alkaline phosphatase activity of cells. Following fixing, 
each colony was stained according to manufacturer protocols and their pluripotentiality 
was assessed by evaluating the proportion of stained cells within each colony (Figure 
4.6). Colonies showing a fully undifferentiated phenotype (more than 70 % stained cells) 
were scored as "I ", partially differentiated as "2" (between 70 % and 30 % stained cells) 








Figure 4.6 mESC colonies stained with alkaline phosphatase, (A) fully undifferentiated, 
(B) partially differentiated, and (C) fully differentiated colonies. 
Following scoring for each colony on each set of three identical polymer-coated 
coverslips, the average scores in presence and in absence of LIF in the growth media 
were calculated (Table 4.1). 
Phenotype scoring in Phenotype scoring in 
PU 
presence of LIF absence of LIF 
190 1.37 3.00 
206 1.30 2.75 
214 1.59 3.00 
221 1.93 2.78 
161 2.11 3.00 
0.2%gelatine 1.58 3.00 
Table 4.1 Results of alkaline phosphatase phenotype scoring of mLU colonies grown 
for 9 days in presence and absence of LIF. 
The results obtained in the presence of LIF in the growth medium confirm the results of 
the polymer microarray screen for 3 out of 4 of the poly(urethanes) selected (i.e. PU 190; 
206 and 214), as their phenotype scoring is below or equal to the one obtained using 
traditional mESC culture on 0.2 % gelatine coated wells. Additionally, the negative 
control (PU 161) was, as expected, the worst performing surface in this experiment with 
most colonies partially differentiated. 
In absence of LIF in the growth medium, most colonies were scored as differentiated 
with a phenotype scoring above 2.75. PU 190 and 221 scores were slightly lower than on 
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0.2 % gelatine, but due to the semi-quantitative analysis, these results are not significant 
and none of the selected polymer or control was successful at maintaining 
undifferentiated phenotype in absence of LIF. 
Using the polymer microarray approach it was possible to successfully identify novel 
surfaces suitable to support the growth of mESC in undifferentiated phenotypes in the 
presence of LIF. Unfortunately, none of the polymeric materials selected were able to 
support the growth of mESC while maintaining their pluripotentiality in the absence of 
LIF. When the compositions of these polymers were analysed it was observed that three 
(PU 190, 206 and 22 1) contained the same diisocyanate and chain extender, namely HDI 
and OFHD. The presence of OFHD, which is a highly fluorinated diol, was unexpected 
as many surfaces designed to prevent cellular adhesion uses such fluorinated 
hydrocarbon chains". With growing interest in the control mESC differentiation, the 
polymer microarray platform could be utilised to study the fate of cells grown on 
polymers and potentially identify new materials able to support the differentiation of 
mESC toward specific cell lineages. 
4.4 Conclusions 
The area of stem cell research is currently one of the most exciting and controversial 
fields of science. Indeed, since their first discovery, numerous reports promoted the huge 
impact that stem cell-derived therapies could have on the wellbeing of humanity. 
Additionally, stem cells are proving to be essential tools in understanding critical 
biological pathways, and also have a role to play in the development of improved 
toxicological tests, which have the potential to reduce animal experimentation. However, 
this field is still in its infancy, and many limitations will have to be overcome before 
useful applications are available. The main challenges that scientists are faced with 
today are the isolation, characterisation and culture of specific stem cell subpopulations, 
together with the control of their development towards specific cell lineages. To 
accelerate this research, scientists are using the most advanced technologies available, 
amongst which microarrays have a crucial part to play. Indeed, DNA microarrays have 
been extensively used to monitor the expression of genes in various stem cells in order 
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to develop a database 224, which allows better understanding and characterisation of stem 
cell populations 225 . Other microarray platforms are also ideally suited to the acceleration 
of research, such as the MSC transfection array developed by Yoshikawa et al.226 . In our 
approach, we demonstrated that the polymer microarray for cellular adhesion provided a 
high throughput platform for the identification of new materials with potential in stem 
cell research. Indeed, novel biomaterials have an essential role to play, not only as new 
substrates to control the fate of cultured stem cells in vitro, but also as matrices in the 
burgeoning field of tissue engineering 227  As was the case in the field of microarrays, to 
rapidly succeed, stem cell research will have to embrace the latest technological 
advances and promote the exchange of knowledge between scientists all over the world. 
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Chapter 5: Development of polymer 
microarrays for protein adsorption studies 
In chapter 3 and 4, it was found that the polymer microarray platform could be used to 
study the adhesion of a whole range of mammalian cell lineages onto the polymer 
libraries. In this chapter, several parameters were optimised in order to study the 
adsorption of proteins onto the polymer microarray. The study of protein adsorption 
represents an important part of biocompatibility evaluation of polymers; these in vitro 
experiments could therefore be used to study polymers that come in contact with blood 
and body fluids. 
5.1 Coverslip optimisation 
In order to minimise consumption of expensive protein solutions, it was decided to apply 
a coverslip after protein solution application to allow the formation of a uniform thin 
film of solution above the microarray spots. Three types of coverslip were investigated, 
a standard glass coverslip, and two plastic coverslips designed for DNA hybridisation, 
HybriSlipstm and GeneFrame®.  Three identical polymer microarrays, containing 15 
polyurethanes each printed as 24 identical spots were printed on the slide as three 
clusters of 4 x 2 spots and incubated with fibrinogen labelled with AlexaFluor ® 647. 
Following washing and drying, the slides were scanned and the standard deviation (Std 
Dev) and coefficient of variance (CV) calculated from the integrated intensity resulting 
from the 24 identical spots for each of the 15 polymers (Table 5.1). The general scheme 
and a description of the main steps involved in the polymer microarray for protein 
adsorption experiment are presented in figure 5.1. 
S. 
GeneFrame® H briSlipTM Standard 	_____ _Glass 
PU- 
Mean Std Dev I CV Mean Std Dev CV Mean Std Dev CV 
8 537381 165912 31 382221 163935 43 562671 380190 68 
12 1 	89530 34500 39 78344 35275 45 1 	64491 25830 40 
16 34652 18505 53 17422 2310 13 213127 281902 132 
23 115161 19549 17 108749 40129 37 473192 612770 129 
25 1590214 217379 14 534172 290152 54 1103488 417419 38 
28 444867 123920 28 255981 90438 35 709675 921472 130 
37 922071 138212 15 406169 55318 14 935809 698411 75 
63 1 	95392 65622 69 36110 36530 101 30251 3798 13 
65 1154731 155388 13 502970 72223 14 515644 94890 18 
73 25204 5020 20 1 	18300 10207 56 15762 1444 9 
77 692787 146450 21 221143 29875 14 228222 77643 34 
79 1 	1269925 216183 17 499887 122040 24 651485 217280 33 
91 1538591 115646 8 592509 59932 10 574226 51639 9 
92 1927337 185474 10 683217 127542 19 560693 165643 30 
101 1853448 120302 6 806953 285894 35 357522 35089 10 
Mean 819419 115204 24 342943 94787 34 466417 265695 51 
Table 5.1 Mean fluorescence intensities arbitrary units), standard deviations and 
coefficients of variance resulting from the binding of labelled fibrinogen to 15 
poly(urethanes) each printed as 24 identical spots. 
Analysis showed that using a glass coverslip the reproducibility was very poor with a 
mean CV of 51 %, whereas HybriS1ips and GeneFrame ® gave CV's of 34 % and 24 %, 
respectively. When analysed in detail, it was observed that the average of all the 
integrated fluorescence with GeneFrame®  was over twice the average intensity recorded 
with Hybris1ips. In order to investigate this result, the background intensity (as 
measured in 3.1.1) was measured on the part of the coverslip in contact with the protein 
solutions. The measured backgrounds were 250,000 and 1,300,000 for GeneFrame®  and 
HybriSlips, respectively. 
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The high background intensity measured for the HybriSlips was related to the high 
protein adhesion on the coverslip and subsequent lower adhesion to the polymer spots. 
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Figure 5.1 illustration of the polymer microarray for the protein adsorption study. The 
polymer microarrays were printed on gold-coated glass slides. Following drying and 
swelling of the polymer spots, a GeneFrame®  was placed on top of the printed slide 
around the printed arrays. The protein solution was pipetted within the frame prior to 
the plastic coverslip being gently applied, in order to avoid the entrapment of air 
bubbles. Following incubation, the GeneFrame®  and coverslip were removed and the 
slide was washed using a standardised 3-baths washing technique (6.5.2); finally, the 
slide was dried under a stream of nitrogen prior to analysis using a fluorescent scanner. 
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5.2 Determination of optimal protein concentrations 
In order to determine the best concentration of labelled fibrinogen solution to use on the 
polymer array, a series of solutions of different concentrations were incubated on 
replicate arrays containing 32 poly(urethanes), each printed as 8 identical spots. The 
resulting average fluorescence intensities for each set of 8 spots were integrated and 
plotted against the protein solution concentrations (Figures 5.2 & 5.3). 
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Figure 5.2 Fluorescence intensity vs. fibrinogen concentration for the 32 printed 
poly(urethanes), using AlexaFluor® 647 labelled fibrinogen in PBS, incubated for 2 











1000000 	- 	-- - 	 - 	 - 
--151 






0 	- 	• 
0 20 	 40 	 60 	 80 	 100 	 120 
[protein] g.mL' 
rigure 3.J t luorescence miens!!)' vs. jwrinogen concenrrauon jar a rprseniuuve 
poly(urethanes), using AlexaFluor® 647 labelled fibrinogen in PBS, incubated for 2 
hours at 37 U. (A) Overall results, (B) results obtained for the lower protein 
concentrations (5 to 25 pg.mL'). 
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It was shown that a concentration of labelled fibrinogen at or below 12.5 tg.mL' was 
not sufficient, as most low protein binding polymers have a fluorescent intensity close to 
the background intensity at these concentrations, making it difficult to differentiate their 
binding properties. However, as the concentration increased, differences in the adhesion 
properties of the polymers became obvious. In order to minimise protein consumption, it 
was decided that subsequent protein adhesion studies using labelled fibrinogen would be 
carried out at 25 tg.mL' as this concentration was the lowest to give good intensity 
above background (Figure 5.3). A similar approach was used for other labelled proteins 
and a summary of the protein concentration and label used for subsequent studies is 











Erythrocyte Index  
12.5 AlexaFluor® 546 
Glycoprotein Z 2.50 FITC 
Plasma proteins 
Albumin 25.0 AlexaFluor® 546 
Fibrinogen 25.0 AlexaFluor® 647 
IgG 100 FITC 
Table 5.2 List ofproteins used in the adhesion assay together with the concentration and 
fluorescent label used. Proteins labelled with FITC were commercially available, 
however protein labelled with AlexaFluor®  dyes were labelled according to the 
manufacturer's instructions (Molecular probes). 
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5.3 Reproducibility of the protein adhesion assay 
To investigate the reproducibility of the method developed with the parameters 
described above (both inter- and intra-slide reproducibility), the same experiment was 
run on two identical slides containing a library of 119 poly(urethanes), each printed as 
four identical spots, and incubated with Glycoprotein X (2.50 ig.mL' + 0.5 % w/v 
HSA in PBS for 2 hours at 37 °C). The mean fluorescence intensity and coefficients of 
variance from the four identical spots were calculated for each polymer array. The intra-
slide reproducibility was calculated from the average coefficient of variance for the 128 
different poly(urethanes), which was 8.7 and 8.0 % for the slides 1 and 2, respectively. 
The inter-slide reproducibility was evaluated from the correlation coefficient (R 2) 
obtained when plotting the average intensity of each polymer obtained from slide I and 
2 (Figure 5.4). Both intra and inter-slide reproducibilities were shown to be satisfactory 
with an overall coefficient of variance below 10 %, furthermore, the correlation 
coefficient between the two slides was above 0.96. 
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Figure 5.4 Inter-slide reproducibility, average fluorescence intensities ('a. u.) resulting 
from the binding of Glycoprotein X to two identical microarrays containing 128 
poly(urethanes). 
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5.4 Duplexing of the protein adhesion assay 
In order to investigate the potential for multiplexing of the protein adhesion assay on a 
polymer microarray (i.e. using more than one labelled protein solution on a single array), 
a model experiment was carried out using two mixtures of two proteins with different 
fluorophores: 
System 1: on library PA  (Table 6.18) 
Slide 1: Glycoprotein X (2.50 .tg.mL') + Glycophonn A (12.5 pg.mL') 
Slide 2: Glycoprotein X (2.50 .Lg.mL') 
Slide 3: Glycophorin A (12.5 ig.mL) 
System 2: on library PA2 (Table 6.19) 
Slide 4: Glycoprotein Y (25.0 j.tg.mL') + Glycophorin A (12.5 .tg.mL') 
Slide 5: Glycoprotein Y (25.0 .tg.mL) 
Slide 6: Glycophorin A (12.5 j.tg.mL 1 ) 
Glycophonn A was labelled with AlexaFluor® 546 and Glycoprotein X and Y were 
both labelled with FITC. 
The first protein mixture (Glycoprotein X + Glycophorin A) was incubated on the 
polymer microarray "slide 1" containing library PA I. Experiments were also run on the 
same arrays (PAl) but with a single protein solution (Glycoprotein X only, "slide 2" and 
Glycophorin A only, "slide 3"). 
The second protein mixture (Glycoprotein Y + Glycophorin A) was incubated on the 
polymer microarray "slide 4" containing library PA2. Experiments were also run on the 
same arrays (PA2) but with a single protein solution (Glycoprotein Y only, "slide 5" and 
Glycophonn A only, "slide 6"). 
Following incubation and washing, each slide was scanned, and the fluorescence 
intensity resulting from protein adhesion on each polymer calculated (Table 6.18 and 
6.19). The resulting fluorescence intensities obtained from the dual and single protein 
solutions were plotted against each other (Figure 5.5). 
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System 2 I PA2: Glycoprotein V + Glycophorin A 
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Figure 5.5 Average fluorescence intensities resulting from the adsorption of a protein, 
single versus dual protein solutions (A) System 1: Glycophorin A in presence of 
Glycoprotein X on PA]; (B) System 2: Glycophorin A in presence of Glycoprotein Y on 
PA2. 
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The one probe experiment versus the two probe experiment showed very poor 
correlation of system 1 on PA! (i.e. Glycophorin A: R 2=0. 19; Glycoprotein X: R2=0.38), 
whereas system 2 on PA2 gave a good correlation of both labelled proteins (i.e. 
Glycophorin A: R2=0.76; Glycoprotein Y: R 2=0.86). 
In conclusion, system 1 showed very large discrepancies when comparing results 
obtained with one and two probes. Such discrepancies could arise from the interaction of 
the two proteins in solution, or maybe from competitive binding onto the polymers. 
However, system 2 showed relatively good a correlation between the dual and single 
probe experiments, and as a result such a system could be utilised in order to increase 
the throughput of the screening. 
5.5 Potential diagnostic applications 
A few initial investigations were carried out regarding the potential use of the polymer 
microarrays developed, as a diagnostic tool for the identification of proteins in complex 
biological samples. Reddy and Kodadek 228 used arrays of peptoids (oligo-N-substituted 
glycines) as an identification method for proteins via a "fingerprinting" approach. In this 
study, three different fluorescently labelled proteins were initially bound in the presence 
of excess unlabelled proteins each on an array of peptoids. When comparing the relative 
intensities related to each labelled protein across the array, clear differences in protein 
adsorption were noticed. For each different labelled protein, a set of peptoids bound 
specifically one protein only (the specificity threshold was set at 10-fold the background 
fluorescent intensity). From these results, several in-depth investigations were carried 
out to confirm the potential of this method to detect unlabelled protein in complex 
biological sample. 
In our approach, only the first step of this type of study was carried out. Three identical 
arrays containing 147 poly(acrylates) were incubated with three different labelled 
proteins (Fibrinogen, Glycophorin A and Glycoprotein Y) in the presence of 1.0 % v/v 
human serum to mimic a complex biological sample. The fluorescent intensities arising 
from the adsorption of labelled protein to each polymer spot were integrated and the 
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averages for the four identical polymer spots were calculated. These protein adsorptions 
onto the polymer microarrays were presented as fingerprints/barcodes (DecisionSite, 
Spotfire, Massachusetts, US) to compare the overall profiles (Figure 5.6). To do so, the 
software used relative fluorescent intensities where each fluorescent intensity value is 
plotted as a fraction of the most intense sample. 
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Figure 5.6 Protein fingerprints showing the relative fluorescent intensity prof iles 
associated with the adsorption of each protein. A part of the barcode was expanded to 
illustrate the differences in protein adsorption over afew polymer samples. (The colour 
code is presented on the right; the intensities are expressed as a fraction of the highest 
binding polymer which is yellow). 
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The protein fingerprint for each protein adsorption showed clear differences with the 
other two proteins fingerprints. To emphasise the specificity of the polymers to the 
different proteins, a Venn diagram (Figure 5.7) was drawn that showed all polymers 
displaying a fluorescence intensity 10-fold above background intensity for each labelled 
protein. 
Glycoprotein Y 	Fibrinogen 
Glycophorin A 
Figure 5.7 Specific and promiscuous polymers. Venn Diagram presenting the number of 
specific and promiscuous polymers that adsorbed Glycoprotein X, Glycophorin A and 
Fibrinogen. 
This Venn diagram showed that 28, 6 and 4 of the polymers were specific for 
Fibrinogen, Glycophorin Y, and Glycoprotein A, respectively. 22 Polymers non-
specifically bound high amounts of the three different proteins and 23, 4 and 3 polymers 
showed high binding to two different proteins. Although our approach uses over 50-fold 
less different features than the arrays developed by Reddy and Kodadek, the percentage 
of probes that provide specific adhesion to a unique protein is proportionally higher with 
19, 4.1 and 2.7% of the probes being specific compared to 2.5, 1.6 and 0.8 %. These 
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figures suppose that the polymer microarray, even if lacking large number of probes, has 
the potential to be applied in a similar manner. However, for this platform to be suitable 
for the analysis of complex biological samples it would be beneficial to increase the 
number of different polymers, and a range of additional experiments are needed: 
The first experiment would be to confirm these adsorptions and specificities 
using unlabelled protein as it is usually difficult to label a specific protein within a 
biological sample. Label-free protein could be detected by mean of immunocomplex 
formation with relevant fl uorescentl y- labelled antibody or set of antibodies ("sandwich"-
type with secondary antibody). 
The next experiment would involve the determination of the detection limit for 
the concentration of the proteins of interest. This experiment can be carried out using 
several microarrays each incubated with the same protein at different concentration in 
serum, in order to determine the lowest concentration at which this protein is detected. 
Finally, in order to validate this method it would be essential to study the reproducibility 
of the methodology over the range of protein concentrations that are detectable. 
5.6 Conclusions 
A range of investigations was carried out to optimise protein adhesion. GeneFrame® 
coverslips were selected to minimise protein solution consumption, since these 
coverslips provided low protein adhesion and high reproducibility and the washing 
method was standardised for the consistency of the results. The different protein 
concentrations were optimised to obtain a good signal at minimal protein concentrations. 
It was shown that by using carefully selected proteins, the assay could be multiplexed 
with two different labelled proteins. From the results of these investigations and the 
work of Reddy and Kodadek, it was hypothesised that the polymer microarrays could be 
utilised as a diagnostic tool for the fingerprint detection of proteins in complex 
biological samples. Indeed, it was shown that three different labelled proteins gave three 
very different adhesion fingerprints, and it was therefore possible to identify several 
polymers with specific adhesion to a single protein. This was only a preliminary study, 
however, it seems likely that this platform could be utilised for diagnostic applications. 
Additionally, since specificity was demonstrated in these experiments, the polymer 
microarray for protein adsorption could be utilised to identify new substrates for 
applications in proteomics. Indeed, a series of polymers displaying different protein 
specificities could be used as a substrate in applications such as surface-enhanced laser 
desorption ionisation (SELDI) mass spectrometry to facilitate the analysis of 
protein/peptide mixtures in tissues or plasma. The polymer microarray assay for protein 
adhesion is a powerful tool allowing parallel screening of hundreds of polymers in a 
single experiment. Biomaterials, and especially biocompatible polymers, have an 
essential role to play in tissue engineering applications, in the delivery of new drugs 131 , 
and in stem cell research 227 . The use of polymer microarrays for protein adsorption 
tailored to the identification of specific polymer properties has potential to accelerate 
research in many areas of science. 
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General Conclusions: 
A novel method, which allows the patterning of hundreds of polymer spots on a single 
microscope slide, was developed. Several parameters including the printing conditions, 
the nature of the substrate and the polymer solvent were optimised in order to obtain 
uniform and reproducible arrays. 
From these experiments, it was concluded that different applications (i.e. cell or protein 
immobilisation studies) may require different substrates. Protein adsorption studies 
showed very low levels of background auto-fluorescence when performed using gold-
coated slides. In contrast, cell adhesion studies required agarose-coated substrates to 
achieve minimal non-specific adhesion. Additionally, it was shown that these polymer 
microarrays were suitable for the high throughput characterisation of the polymer spots, 
including their morphology, surface composition and functional groups, by SEM, TOF-
SIMS and FT-JR. respectively. 
The microarray platform was subsequently optimised for cell adhesion screens, where 
the immobilisation of living cells was evaluated by fluorescent visualisation on each of 
the printed polymers. The platform was then used to identify novel substrates for the 
culture of human primary renal tubular epithelial cells in vitro, and for the gentle 
immobilisation of mouse bone marrow dendritic cells. Interestingly, some structure-
activity relationships were observed for the polymers selected for the different 
applications. Indeed, for both cell types, the best results were obtained with 
polyurethanes containing PTMG as polyoi and MDI as diisocyanate. These microarrays 
may bring further understanding of the factors involved in cellular adhesion of specific 
cell lines, and could subsequently help in the development of new polymers with 
enhanced properties. 
In order to further demonstrate the versatility of the polymer microarray, this platform 
was applied to the field of stem cell research. In the first application, the selective 
immobilisation of a specific adult stem cell population (STRO-l+) from human bone 
marrow was studied. Using the microarray platform, three polyurethanes were shown to 
provide selective adhesion, and these results were confirmed on a larger surface using 
coverslips. These experiments showed that up to 50% of the immobilised cells were part 
of the STRO-l+ population. Interestingly, the structure-activity investigations yielded 
some unexpected results, since the three selected polymers were prepared from long 
hydrophilic chains of poly(ethylene glycol). 
The second study involved the identification of novel substrates for the culture of 
undifferentiated mouse embryonic stem cells (mESC) in vitro. mESC are usually 
cultured on a layer of feeder cells or on gelatine in the presence of the LIF cytokine. The 
present study involved the culture of mESC on several polymer microarrays over a 9 day 
period, in order to identify polyurethanes promoting the adhesion and growth of these 
cells in their undifferentiated phenotypes. Following the selection of the most promising 
candidates, the experiment was repeated on larger surfaces using polymer-coated glass 
coverslips. The visualisation of FITC and DAPI to determine the phenotype of the 
cellular colonies was not sufficient to draw clear conclusions due to very large 
discrepancies in differentiation within the same coated coverslip. Therefore, in order to 
confirm the microarray results, a clonal growth experiment was carried out where each 
colony was grown from single cells to reduce the autocrine effect, and visualisation was 
carried out using the alkaline phosphatase assay. The clonal growth experiment showed 
that in the absence of LIF, none of these substrates were able to maintain cellular 
pluripotentiality. However, in the presence of LIF, 3 out of 4 of the polymers identified 
using the microarray screen performed at least as well as the gelatine substrate for the 
culture of mESC. 
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Finally, the polymer microarray platform was adapted for the high throughput evaluation 
of protein adsorption. The platform was optimised in order to reduce protein solution 
consumption, while maintaining a high degree of reproducibility. It was shown that this 
platform could be easily multiplexed by careful selection of the labelled proteins. To 
conclude, a proof of concept experiment based on some previously published work was 
carried out to evaluate the possible use of polymer microarrays in the fingerprint 
detection of proteins in complex biological fluids for diagnostic applications. The 
different proteins tested in this preliminary study showed very different adhesion 
profiles. Therefore, such an approach could be suitable for the fingerprint detection of 
proteins in complex biological fluids. 
The polymer microarray is a very interesting platform for the characterisation of printed 
polymers. Indeed, it was demonstrated throughout this thesis that the platform provides 
an ideal format for the parallel screening of large numbers of polymers. The polymer 
microarray was shown to be suitable for several physico-chemical determinations, 
including spot morphology and surface composition. Perhaps more importantly, this 
platform is suitable for the screening of novel cellular substrates. Such a tool could be of 
particular interest in medical research, when only a very limited number of cells are 
available and no commercial substrate is suitable. Additionally, the polymer microarray 
platform has a great flexibility, and these microscopic polymer spots could be used in 
conjunction with other biomolecules to study a range of microcellular environments. 
Using the results of structure activity relationship investigations, it may be possible to 
synthesise novel materials with enhanced properties, and to further our understanding of 
the complex factors controlling the interactions of biomolecules and living cells with 
their environments. Advancing knowledge in these areas of science is an essential part 
of tomorrow's medicine, for which clinicians envision the use of synthetic substrates as 
scaffolds for the growth of human organs, and the development of a range of therapies 
based on the careful control of a stem cell's fate. 
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Chapter 6: Experimental 
6.1 General information 
6.1.1 Equipment 
UV-visible spectrophotometer: Agilent 8453 UV (Agilent Technologies) 
QArray tmm microarrayer (Genetix) 
BioAnalyzer 4F/4S white light scanner and FIPS software (LaVision BioTech) 
HCS platform and PathfinderTM software (IMSTAR) 
Biosafety cabinet: HERAsafe KS 18 class II (Heraeus) 
Incubator: HERAceII 150 (Heraeus) 
Vacuum oven: Vacutherm VT6025 (Heraeus) 
6.1.2 Polymers 
The 	polymer 	libraries 	(poly(urethane) 229 , 	 poly(acrylate) 230 	and 	grafted 
poly(allylamine) 23 ' libraries, respectively, Appendix I, II and III) were synthesised by 
Jean-Francois Thaburet, Hitoshi Mizomoto and Ann Jasmine Jose and were generated as 
part of a previous project.Most polymer had been previously characterised in terms of 
molecular weight (by gel permeation chromatography), wettability 229 and glass 
transition temperature (by differential scanning calorimetry). 
6.1.3 Chemicals and solvents 
Unless specified, the chemicals, solvents used in all the experiments were obtained from 
Sigma-Aldrich. Phosphate buffer saline (10 mM phosphate, 27mM KCI, 137 mM NaCl, 
pH 7.4) is referred to as PBS throughout. 
6.1.4 Microscope slides and coverstips 
Unless specified, aminoalkylsi lane microscope slides were obtained from Sigma- 
Aldrich, gold-coated slides were obtained from Asahi Kasei and the coverslips from 
VWR 
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6.1.5 Cell culture media and supplements 
Unless specified, all cell culture media were from Sigma-Aldrich and all supplements 
added to the culture medium were supplied by Gibco, Invitrogen. 
Unless specified each culture media (Table 6.1) was supplemented with 10 % v/v heat 
inactivated fetal calf serum, penicillin (100 U s.mL'), streptomycin (100 mg.mU') and 
L-glutamine (4mM). 




HeLa RPMI 1640 
JURKAT RPMI 1640 
RMA-S RPM! 1640 






Table 6.1 Name of the cell lines used and their corresponding culture medium. 
Dubelcco 's modified Eagle's medium (DMEM) and Glasgow's modified Eagle's 
medium (GMEM). 
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6.2 Experimental for Chapter 2 
6.2.1 Labelling of fibrinogen 
A solution of fibrinogen from human plasma (F3879, Sigma-Aldrich) was prepared (2 
mg.mU' in 0.85 % w/v NaCI). In order to achieve solubilisation, the solution was 
warmed to 37 °C. Once solubilised, the solution was filtered though a syringe filter (0.45 
p.m PVDF filter, Whatman). To 750 p.L of this solution, 50 AL of sodium bicarbonate 
solution (1.0 M) was added. This solution was then transferred to a vial containing 0.10 
mg of AlexaFluor® 647 succinimidyl ester (A20173, Molecular Probes, Invitrogen) and 
the reaction mixture was stirred at room temperature for I h. 
The reaction mixture was loaded onto a column packed with Sephadex G, BioGel P 
resin (Molecular Probes, Invitrogen). Using an elution buffer (0.01 M K 3PO4, 0.15 M 
NaCl, pH 7.2, 0.20 mM NaN3), the unreacted dye was separated from the labelled 
protein. 
The fraction containing the labelled protein was collected, a small aliquot was diluted 10 
fold and analysed using a UV spectrophotometer. Absorbance was measured at 280 and 
650 nm (A280 and A650). The protein concentration [Fg] and degree of labelling were 
calculated as follows: 
[Fg] = (A280-(A650x0.03)) x dilution factor / EFg 
With: CFg = 513,000 cm 'M4 
232;  dilution factor = 10; A280= 0.240; A 650 = 0.808 
Degree of labelling = (A65oxdilution factor) / (CAIxa ix[Fg]) 
With EAIexa647 = 239,000 cmM' 
233;  MW F5 = 340,000 cm'M' 232;  [Fg] = 4.21xl0 M. 
The labelling gave about 8 moles of AlexaFluor® 647 dye per mole of fibrinogen. The 
labelled protein solution was divided into small aliquots and frozen at -80 °C. 
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6.2.2 Surfaces for protein adsorption 
The suppliers and references of the different surfaces used in this experiment are 
summarised below: 
Material Nature of surface Reference Supplier 
Glass 
Aminoalkyl si lane S4651 Sigma-Aldrich, 
Superfrost Plus 631-0108 VWR 
Polysine 631-0107 vw 
Metal 
Aluminium NA University of Southampton's workshop 
__________________  
Solid steel NA University of Southampton's workshop 
Polymeric 
film 
PVDF FV301490 Goodfellow 








Gold NA University of Southampton's 
physical chemistry department 
Table 6.2 Suppliers and references of the different materials used in the protein 
adsorption study. 
The metallic surfaces (aluminium and steel were cleaned by sonication in a bath of 
tetrahydrofuran (THF)) were obtained from the workshop of the department of 
chemistry (University of Southampton, UK). 
The commercial blocking buffer 167  (used in immunoassays to prevent the non-specific 
binding of protein or antibody onto surfaces) was diluted 2 times to obtain x5 blocking 
buffer. Superfrost Plus slides were incubated in the diluted blocking buffer (30 min @ 
37 °C) and rinsed in PBS before use. 
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Gold-coated slides used for the determination of a suitable surface for protein adsorption 
microarray were prepared in the department of electrochemistry (University of 
Southampton), further experiments were carried out using gold-coated slides prepared 
by Asahi Kasei. First, a layer of chromium was deposited onto the glass; this provided 
an adhesion layer for the subsequent gold deposition. The slides were rinsed in PBS 
prior to use. 
6.2.2.1 Background protein adhesion 
Each cleaned surface was incubated with AlexaFluor 647 labelled fibrinogen (25.0 
.tg.mL' in PBS, 3 h @ 37°C). Following incubation, each surface was rinsed in PBS 
and deionised water before drying under a stream of nitrogen. Evaluation of protein 
adhesion was carried out using the Cy5 filter and the low resolution scanner 
(BioAnalyzer 4F/4S, LaVision BioTech). Background protein adhesion was evaluated 
using FIPS (LaVision BioTech), integrating the fluorescence intensity over a circular 
area of diameter 250 gm. 
6.2.2.2 Evaluation of printing quality on low background surfaces 
Metallic and glass coated surfaces giving low background fluorescence intensities were 
re-prepared and printed using the Qarray' ini microarrayer with a few poly(acrylates) 
(3n9, 50, 7e7, 5AC9) dissolved in isopropanol/water, (90/10; 10 mg.mL 1 ). Spot 
uniformity was evaluated visually (Leica LEITZ DM 1L inverted configuration 
microscope). 
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6.2.3 Surfaces for cellular adhesion study 
6.2.3.1 Substrate preparation 
The activation of aminoalkylsilane slides was carried out according to the method of 
Beier9. The slides were activated by disuccinimidylcarbonate in presence of excess 
diisopropylethylamine (50 and 150 mM, respectively, in DMF, 4 h (a RT). After 
activation, they were treated immediately with 1-octadecylamine (Clariant) (2.0 mM in 
1.0 % v/v diisopropylethylamine in DMF, 4 h @ RT). Finally, the alkylated slides were 
washed by shaking in a bath of dimethylformamide (DMF), followed by shaking in a 
bath of acetone, before drying under a stream of nitrogen. These slides were referred to 
as C  8-functionalised slides. 
A perfluoroalkyithiol monolayer was formed by immersing the gold coated slide into a 
solution of 1 H, 1 H,2H,2H-perfluorodecanethiol (Fluorochem, 1.0 mM in methanol, 4 h 
@ RT), followed by rinsing in methanol and drying under a stream of nitrogen. These 
slides were referred to as perfluoroalkylthiol-modified slides. 
Coating with agarose was achieved by manually dip-coating the slide in agarose Type I- 
B (1.0 % w/v in deionised water @ 65°C) followed by removal of the coating on the 
bottom side by wiping with a clean piece of tissue. After drying overnight at room 
temperature, the coated slides could be stored in microscope slide storage boxes 
(Simport, VWR) at RT or used immediately for printing. These slides were referred to as 
agarose-coated slides. 
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6.2.3.2 Evaluation of background cell binding 
The substrates were printed (Qarraymini, Genetix) using solid pins (K2785, Genetix) 
with 8 polymers (4 poly(acrylates) and 4 poly(urethanes)) (10 mg.mL' in NMP) (Table 
6.3) each printed as 4 identical spots using the conditions described in 6.3.1. Following 
printing and drying, the arrays were incubated with different cell lines (HEK293, HeLa, 
and N137) in culture medium (Table 6.1) under cell culture conditions (24 h @ 37 °C, 5 
% CO2). Following incubation, the cells growing on the surface were washed in PBS 
and cellular binding to the substrates was assessed visually using a microscope (Leica 
LEITZ DM I  inverted configuration microscope). 
To illustrate the evaluation of background cell binding (Figure 2.1), an experiment was 
carried out by comparing the adhesion of cells onto 3 identical polymer arrays printed on 
different substrates. Three arrays of 120 poly(urethanes) were prepared using the 
conditions described in chapter 6.3.1 on the following substrates: standard glass slide 
(AA00000IO2E, Menzel-Glãser), C 18- functional ised slide and agarose-coated slide. 
STRO- I+ cell fraction were isolated and cultivated as described in chapter 6.4.1. STRO-
1+ cells (3 x 106  cells) were stained with CellTrackerTM Green (C2925, Molecular 
Probes, Invitrogen) according to the manufacturer's protocols. The stained cell 
suspensions were directly plated onto each polymer arrays (I x 107  cells in 1 .5 mL a-
MEM / slide) and placed in an incubator (19h @ 37 °C, 5 % CO2). After washing by 
dipping in PBS, the cells were fixed in an aqueous solution of p-formaldehyde and 
sucrose (3.7 % w/v and 4.0 % w/v, respectively) for 15 mm, rinsed and stored in PBS at 




The effect of solvent type on the quality of the printing was evaluated using gold coated 
slides and by the preparation of polymer solution of poly(acrylates) and poly(urethanes) 
















NMP r-- 	I 
Table 6.3 Different solvent and solvent mixtures used to dissolve the corresponding 
polymers. 
For each solvent system, polymer solutions were printed as 4 identical spots using 150 
j.Lm aQu solid pins (K2785, Genetix) using the following parameters: 
Inking time = 100 ms 
Stamping time = 100 ms 
I Stamp / Spot 
Following drying under vacuum (12 h @ 45 °C I 200 mbar), the quality of the printed 
spot was evaluated by microscopy. 
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6.2.5 Printing and washing 
Polymer solutions were prepared at 10 mg.mL in NMP. Polymer printing was carried 
out using the QArraytmm' microarrayer (Genetix). The pins used were 75 .tm aQu split 
pin (K2800, Genetix) or 150 .tm  aQu solid pins (K2785, Genetix). 
Printing with split pin required a blotting step which involved printing several spots 
(typically 20 spots) on a "dummy" slide to remove the excess of polymer solution in the 
slit prior to printing on the target slide in order to obtain reproducible spot sizes. Optimal 
spot reproducibility was obtained using the following parameters: 
Inking time = 200 ms 
Stamping time = 1 ms 
1 Stamp / Spot 
Using the solid pins, optimal spot reproducibility was obtained using the following 
parameters: 
Inking time = 200 ms 
Stamping time = 10 ms 
5 Stamp / Spot 
Washing and drying of the pins using the integrated washing/drying station was carried 
out using the following parameters: 
Ethanol: 5000 ms 
Compressed air 10000 ms 
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6.2.6 Evaluation of printing reproducibility 
126 different poly(urethanes) and 2 poly(acrylates) solutions (10 mg.mL' in NMP) were 
prepared and placed in high sample recovery polypropylene 384-well microplates 
(X7050, Genetix). The polymer arrays were fabricated by contact printing (QArray m , 
Genetix) with 16 aQu solid pins (K2785, Genetix) using the following printing 
conditions on gold-coated slide: 5 stamping per spot, 200 ms inking time and 10 ms 
stamping time. Each solution was printed as four identical spots giving a total of 512 
spots. The polymer array was made of two fields of 16 x 16 spots with a spot-to-spot 
distance of 1120 J.tm. Once printed, the slides were dried overnight under vacuum (12 h 
@ 45 °C / 200 mbar). 
The study of spot size reproducibility was undertaken by incubating the polymer 
microarray with a solution of AlexaFluor® 647 labelled fibrinogen ({Fg] = 25 tg.mL' 
in PBS, 3 h @ 37 °C). Following incubation, the slide was washed, dried and visualised 
with a BioAnalyzer 4F/4S white light scanner (LaVision BioTech GmbH, D) using the 
Cy5 filter. Spot size evaluation (measured as diameter with 10 tim increment) was 
carried out with the FIPS software (LaVision BioTech GmbH, D). 
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01 
Field 1 
61 69 791 871 391 441 481 53 201__ _ 241 281 _331 41 81 121 16 
59 67 77 85 38 43 47 51 19 23 27 31 3 7 3e9 15 
57 65 73 83 371 41 461 50 181 221 26 30 _2 6 1 10 14 55 63 71 81 351 40 451 49 171 211 25 291 1 5 9 13 
Field 2 
137 141 1451 1491 1211 1251 1291 133 1051 1091 1131 117149DMI 931 7 101 
136 140 144 148 120 124 128 132 1041 3e7l 1121 116139DMI 921 96 100 
135 139 143 147 119 123 1271 131 103 1071 1111 1151 39DEJ 911 95 99 
134 138 142 146 1181 122 1261 1301 1021 1061 1101 1141 89149DEJ 94 98 
Field 1  
320 330 3101 3301 3301 3001 3101 3001 2801 3401 3201 3001 3401 3101 3101 300 
310 310 310 300 310 260 300 300 320 300 290 3201 300 
320 320 300 310 3301 330 300 320 300 310 320 L 320 320 320 310 320 300 3201 340 3301 360 300 1 	290 3601 300 3101 310 
Field 2 
300 290 3001 : 	 2901 2801 2401 2801 2601 3001 3001 2801_ 3001 2901 3201 3001 300 
280 320 320 280 300 280 300 300 300 310 300 290 280 310 320 320 
300 320 320 3201 310 240 280 3001 300 3201 3101 2901 3101 3201 310 340 
300 290 2901 3101 340 3201 3201 3301 3101 3101 3001 2701 3001 2701 3201 310 
Table 6.4 Spot size evaluation. (A) printed poly(urethane) samples (Appendix I), (B) 
corresponding spot diameter (,um). The 8 empty cells correspond to the polymer spots 
that could not be measured. 
6.2.7 Physical characterisation of polymers on the microarray 
Physical characterisation of the polymers on the microarray was carried out using 
polymer microarrays printed using the conditions described above in section 6.2.6. 
6.2.7.1 Scanning Electron Microscopy 
Polymer microarray slides printed with poly(urethanes) were cut in two using a glass 
cutter and mounted onto carbon coated specimen tubs prior to sputtering with a thin 
layer of gold. Scanning electron micrographs were recorded using a JSM 5910 Scanning 
Electron Microscope (JEOL). 
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6.2.7.2 FTIR microscopy 
FTIR microscopy was carried out using a FT-IR PerkinElmer 2000 Spectrometer 
combined with an AutoIMAGE FT-IR microscope (PerkinElmer). Spectra were the sum 
of 16 scans recorded between 4000-650 cm -1 with a resolution of 8 cm -1 . Spectral 
processing was carried out using the AutoIMAGETM Software (PerkinElmer). 
6.2.7.3 TOF-SIMS 
The array was prepared in our laboratories using the condition described in section 6.2.6 
using a series of 8 poly(acrylates) copolymers. The TOF-SIMS analyses were ran in 
Asahi Kasei, Fuji, Japan. Time of flight secondary ion mass spectrometry (TOF-SIMS) 
was performed on a TRIFT-Ill (Physical Electronics) using the following conditions: 
Primary ion: Ga+ 
Primary beam energy: 15 kV 
Primary beam current: 600 pA 
Secondary ion polarity: positive 
Charge neutralisation: 28 eV electron beam 
Mass range: 0.5-200 Da 
Analysis area: 120 x 120 p.m 
Beam diameter: 1 p.m 
Accumulation time: I mm 
% DEAEMA theoretical 0% 5% 10% 15% 20% 25% 30% 35% 
Ratio, (100/59) 0.02 0.10 0.15 0.25 0.32 0.45 0.59 0.73 
Rati02 (100/59) 0.00 0.10 0.10 0.28 0.75 1.04 1.30 1.51 
Average 0.01 0.10 0.12 0.26 0.53 0.75 0.95 1.12 
% DEAEMA experimental 1 	1.4%1 8.9%1 11.1% 20.7%1 34.8%1 42.7% 48.6%  
Table 6.5 TOE-SIMS analysis of polymer spots. Ratio calculated from the intensity of 
peak 100 divided kv the intensity of peak 59, and corresponding mol. % DEAEMA 
determined experimentally. 
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6.3 Experimental for Chapter 3 
6.3.1 Polymer microarray fabrication 
The polymer arrays were fabricated by contact printing (QArraym, Genetix) with 16 
aQu solid pins (K2785, Genetix) using polymer solutions (10 mg.mL'in NMP) placed 
in polypropylene 384-well microplates. The following printing conditions were used on 
agarose-coated slides, 5 stampings per spot, 200 ms inking time and 10 ms stamping 
time. The typical spot size was 300 .Lm in diameter with spot-to-spot distances of 
approximately 1120 gm allowing up to 512 polymers to be printed on a standard 25 x 75 
mm slide. 120 poly(urethanes) were printed in quadruplicate within 2 fields of 16 x 16 
spots, with two pattern of 4 x 4 spots left empty. Once printed, the slides were dried 
under vacuum (12 h @ 45 °C / 200 mbar) and sterilised by exposure to UV irradiation 
for 20 min prior to use. 
6.3.2 Cell culture 
Immortalised mouse adherent cell lines (ND7 and B16F1O, kindly provided by Salim 
Khakoo, Cancer Research, Southampton, UK) were grown in DMEM growth medium 
supplemented with heat inactivated fetal calf serum (10 % v/v), penicillin (100 
units.mL- 1 ), streptomycin (100 mg.mL) and L-glutamine (4 mM) at 37 °C with 5 % 
CO2. Cells were stained with C ellTrackerTM Green or Orange (C2925 or C2927, 
Molecular Probes, Invitrogen) according to the manufacturer's protocols. Prior to 
seeding onto the polymer array, cells were suspended in growth medium (1.0 x 10 6 
cells/slide 15 mL). The slides were subsequently placed in an incubator (24 h @ 37°C, 
5% CO2). After a controlled washing in PBS (30 mL, 2 min shaking on a microplate 
shaker at 600 rpm), the cells were fixed in an aqueous solution of p-formaldehyde and 
sucrose (3.7 % w/v and 4.0 % w/v, respectively) for 15 mm, rinsed and stored in PBS at 
4 °C. Image capture was carried out with a BioAnalyzer 4F/4S white light scanner using 
the FITC or Cy3 filters. 
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Slide number Slide 1 Slide 2 Slide 3 Slide 4 
Slide detail SO ND7 Track 0 S12 ND7 Track 0 SIl B16F10 Track G S12 B16F1O Track G 
Filter used CO CY3 FITC FITC 
PU  F CV 	I F-B F 	JCV F-B F 	jCv F-B F 	ICv F-B 
3  315 411 119 3131 46 116 245 11 20 227 17 21 
4  1 -19 199 15 3 224 17 -1 314 24 108 
8  1 -15 186 4 - 243 36 18 220 16 14 
9 220 3 24 215 24 19 456 40 2311 330 42 124 
10 232 10 35 233 5 37 320 31 951 299 37 94 
12 854 36 658 627 24 430 37 41 911 232 18 27 
13 203 3 7 204 7 71 221 2 -5 198 4 -7 
14 196 8 0 176 4 -201  1 -11 27 2422 
15 - _29 214 4 171 257 - 32 236 _14 31 
16 512 12 315 
- 
439 31 242 297 29 72 261 40 55 
17 _235 11 39 210 7 14 - -18 202 -4 
18 523 9 327 
- 
461 2 265 221 - -4 217 12 121  
19 254 - 58 - - 61 625 114 41 
20 220 9 24 259 35 - 396 40 1711 569 55 364 
22 259 31 63 223 16 27 200 5 -25 258 24 521  
23 284 10 88 2191 6 22 375 40 150 275 29 6 
24 256 10 60 231 5 35 411 37 186 405 58 199 
25 205 4 9 220 12 24 244 18 19 374 54 168 
28 303 37 106 203 7 6 265 27 40 2 
29 432 24 235 483 27 27 1006 42 781 1061 50 85 
30 251 22 54 215 10 18 222 13 - 826 89 62 
31 221 3 25 212 5 224 61 1 
33 211 9 14 225 4 29 351 67 126 206 1 3 0  
35 243 9 46 2271 5 30 243 28 17 220 22 14 
37 212 19 15 261 40 65 705 39 480 568 62 363 
38 212 9 16 199 11 3 245 9 19 347 47 14 
40 177 3 - 186 6 - 111 - 17 104 
41 268 17 72 244 16 47 314 61 89 206 7 1 
43 344 19 148 451 29 255 217 1 -91 291 19 85 
45 295 30 98 223 12 27 306 76 8 -14 
46 231 3 35 232 12 36 272 40 4 -15 
47 194 1 - 193 16 -3 586 29  360 300 64 94 
48 192 4 -4 215 9 19 47 19 231 335 55 129 
49 234 11 38 199 2 2 4311 55 206 282 25 76 
50 228 15 32 212 5 16 6251 79 39 456 4025 
53 375 38 178 245 22 49 2081 -  -17 201 6 -5 
55 846 30 650 584 33 388 2931 51 671 219 8 14 
57 222 7 26 214 9 18 419 39 1941 378 44 172 
59 224 4 27 263 25 67 618 22 393 771 63 566 
61 253 9 57 244 9 47 _223 1 - 196 -10 
63 326 6 129 3451 6 148 244 31 18 215 9 9 
65 1020 16 84 8571 10 660 766 64 540 949 32 74 
67 206 8 9 2211 11 25 282 19 57 326 28 12 
69 238 7 42 266 22 69 570 52 345 1001 28 79 
71 193 4 -4 200 8 41 2921 78 66 11 7 - 19  
73 202 9 5 206 11 10 184 -  -41 222 271 161  
77 195 10 210 8 14 486 43 261 383 35 177 
79 253 19 57 291 10 95 1065 76 839 992 16 786 
81 280 40 84 443 30 246 23 24 10 217 22 11  
83 212 9 15 226 14 30 233 15 8 303 45 97 
85 2351 81 38 2101 11 14 301 40 76 354 35 149  
87 180 3 -17 2021 16 6 317 31 92 275 29 69  
89 199 13 3 2051 7 81 2391 22 141 522 122 316  
91 192 4 - 237 37 41 2471 20 21 242 111 361  
92 184 5 -13 195 7 -1 4201 57 195 378 28 17 
93 203 10 6 241 9 45 384 27 158 398 45 19 
94 201 4 5 207 10 10 274 22 48 211 22 5  
95 753 14 556 787 17 591 418 17 192 736 67 53 
96 331 23 135 486 10 290 1110 83 885 1331 64 112 
97 250 1 54 478 21 28 1279 38 1054 1037 68 83 
123 199 2041 17 71 241 11 15 210 5 
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Slide number Slide 1 Slide 2 Slide 3 Slide 4 
Slide detail Sli N07 Track 0 S12 N07 Track 0 SIl B16F10 Track G S12 B16F10 Track G 
Filter used CY3 _•Cy3 FITC FITC 
PU F CV I F-B F JCV F-B F CV F-B F CV F-B 
159 1088 19 891 1045 16 848 1035 66 810 873 57 667 
160 442 15 246 453 19 257 401 52 176 245 19 39 
161 569 10 372 641 5 445 1756 58 1530. 1356 21 1150.  
162 482 24 286 304 18 108 698 61 473 475 30 270  
163 207 5 11 206 5 9 274 25 48 222 10 16 
164 554 28 358 404 13 208 54 51 289 838 63 632  
165 619 34 423 513 21 3171 629 67 404 317 36 ill 
166 379 161 183 5381 33 3411 519 115 293 359 35 153  
167 248 9 51 240 11 43 567 54 341 511 34 306 
168 361 16 165 393 14 197 422 55 196 1081 43 875  
169 192 4 -4 216 17 19 253 15 271 218 1411 12  
170 227 11 30 221 6 24 2381 18 - 260 121 - 541 
171 209 6 13 239 11 42 3261 37 1001 287 261 811  
172 269 24 73 299 28 102 705 47 480 510 331 304 
174 4441 248 491 9 295 606 57 381 511 541 30 
175 224 71 27 2081 5 12 356 59 131 201 5 5 
176 207 61 10 191 - 275 29 50 242 15 36 
177 803 22 607 1205 - 1009 1313 19 1088 1338 18 1132  
178 236 13 40 221 6 24 595 96 369 244 12 - 38 
179 243 4 47 224 6 28 338 28 113 432 75 226  
180 220 5 24 241 3 441 1 - 211 9 5 
181 211 10 15 197 11 0 306 41 81 252 21 46 
182 902 20 706 1211 19 1014 2793 33 2567 2794 12 2588 
183 466 50 269 456 29 259 1232 19 1006 724 17 519  
184 308 151 111 3851 29 189 1285 17 1060 995 17 78 
185 667 12 471 32 439 1156 25 931 1341 20 113 
186 400 32 203 392 26 195 1413 27 1187 723 47 517 
187 220 5 24 193 4 4 216 22 -10 189 9 -7 
188 224 2 28 1 - 202 9 -231 196 4 -101  
189 289 17 93 304 7 107 1075 71 8491 533 34 32 
190 828 23 632 732 20 536 844 52 618 1045 21 83 
191 352 26 156 232 18 36 488 69 263 577 75 372  
192 220 101 24 2311 22 34 278 21 53 294 47 8 
193 751 10 555 833 18 637 1064 35 838 857 36 651  
194 1413 18 1216 1261 19 1065 1495 24 1270 1566 24 1360  
195 885 16 689 1451 30 1255 1971 45 1745 1452 12 1 46 
196 463 29 267 385 8 1891 9681 13 743 1821 391 16151  
197 191 2 -6 201 8 5 234 12 91 260 171 54 
198 235 8 39 242 11 46 263 45 37 426 58 220  
199 229 11 33 242 16 46 246 26 21 197 5 
200 890 161 694 8781 10 682 3948 42 3723 2667 37 246 
201 209 8 12 1 - 305 31 80 323 42 117 
202 219 3 22 209 4 12 178 3 -47 185 5 -2 
203 955 25 759 848 9 652 678 6 453 758 26 552  
204 295 7 99 310 1141 7451 71 520 637 73 431  
205 220 1 24 251 14 551 2321 9 71 438 901 2331  
206 632 14 435 673 29 476 1220 8 994 926 201 7211  
207 270 20 74 379 34 183 368 24 143 320 18 114  
208 928 221 732 8521 18 656 2001 10 1775 1759 20 15541  
209 384 10 188 312 24 116 478 52 252 544 44 3381  
210 1063 15 867 901 24 705 720 60 495 1024 50 818  
211 1113 13 917 1016 19 819 740 101 514 410 28 205  
212 199 8 2 187 2 - 310 20 85 238 25 3i  
213 239 11 42 246 11 491 2271 7 2 337 49 132  
214 1346 28 1149 929 14 7331 12491 54 10231 1189 22 983  
215 464 12 268 340 62 143 609 40 384 414 45 20 
216 22 
11 
3 19 5 1 274 36 4 210 6 4 
217 67 479 7541 15 558 9011 69 676 16331 421 1428 
Mean Background 196 1 196 225 206 
Mean CV 14 15 36 32 
Table 6.6 Cell adhesion reproducibility study. F: integrated mean fluorescence 
intensities, CV: calculated coefficient of variance, F-B: background corrected mean 
fluorescence intensities. 
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Slide number Slide 2 Slide 5 
Slide detail S12 ND7 Track 0 S12 ND7 Track G 
Filter used Cy3 FITC 
PU F 	JCV F-B F 	JCV F-B 
3  313 46 116 533 60 223 
4  199 15 3 265 30 -45 
 186 4 -10 259 21 -5 
215 2419 304 64 -7 
10 233 5 37 275 29 -36 
12 627 24 430 2016 49 170 
13 204 77 283 1 -7 
14 1761 4 -201 - 11 -10 
15 - 14 4 17 2251 9 -8 
16 439 31 242 7621 33 452  
17 210 7 14 5201 68 2 10  
18 461 2 265 337 19 26  
19 229 3 33 231 1 -79 
20 259 35 62 251 11-60 
22 223 16 27 371 38 61 
23 219 6 22 596 15 285  
24 231 5 35 392 28 81  
25 220 12 24 371 40 60 
28 203 7 6 -32 
 
279 
483 27 287 1363 31 1052  
30 215 10 - 405 _22 - 4 
- 31 212 - - _12 -60 
- 33 2251 _4 29 216 _11 -95 
35 27_ 5 30 - _534 
37 2611 4065 388 79 781 
38 113 1 -931  
40 -  11 420 6 109  
41 _1 7 41 _2 103  
43 k451 292555 267 
45 1 74  146 
46 1 304 38  -6 
47  1 - - 300 4 -11 
48 215 9 19 245 21 -66 
49 199 2 2 3261 25 1 
50 212 5 16 3281 32 1 
53 245 22 49 467 19 156 
55 584 33 388 927 50 61 
57 214 9 18 429 62 11 
59 263 25 67 344 32 33 
61 2441 9 47 27 25 - 
63 345 6 148 25 9 -25  
65 857 10 660 152 19 1191 
67 221 1 251 2811 -30 
69 - 22 69 582 15 271 
71 200 _8 4 743 7 4 
73 206 11 10 368 32 58  
77 210 8 14 495 20 1 84  
79 2911 10 95 733 32 422  
81 443 30 246 1066 52 7561  
83 226 14 30 339 39 2 
85 210 11 141 5891 57 27 
87 202 16 6 418 33 10 
89 205 7 8 311 34 0 
91 237 37 41 326 32 16  
92 195 7-1 394 32 8 
93 2411 9 45 289 13 -221  
94 207 1010 298 2 - 13  
95 787 17 591 1011 26 700 
96 486 16 1 290 5261 32 2 15  
97 478 211 2811 7621 55 451  
123 204 17 1 7 21 28 
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Slide number Slide 2 Slide 5 
Slide detail S12 ND7 Track 0 S12 N07 Track G 
Filter used Cy3 FITC - 
PU F 	JCV F-B F 	JCV F-B 
159 1045 16 848 19301 48 1619  
160 453 19 257 1041 32 730 
161 641 5 445 1650 26 133 
162 304 18 108 857 65 546 
163 206 5 9 335 24 2 
164 404 13 208 728 12 47 
165 513 21 317 1400 16 1089  
166 5381 33 3411 577 39 266  
167 240 11 43 5401 67 230 
168 393 14 197 1392 51 1082  
169 216 17 19 552 37 241 
170 221 6 24 482 46 171  
171 239 11 42 47 33 106  
172 299 28 102 429 32 118  
174 491 9 295 41 48 155 
175 2081 5 121 278 3 -3 
176 191 436 29 125  
177 1205 3 1009 3440 52 3129  
178 221 6 24 3651 7 551 
179 224 6 28 770 22 459  
180 241 3 44 652 1 10 341  
181 197 11 0 391 65 80  
182 1211 19 1014 4612 79 4 
183 4561 29 259 803 72 492  
184 385 29 189 878 34 567 
185 636 32 439 3056 39 2745  
186 392 26 1951 5201 20 209  
187 193 4 -4 2 -51  
188 192 8 5 271 49 4 
189 304 7 17 826 37 F-16  
190 732 20 536 1762 29 1452  
191 2321 18 36 390 33 80  
192 231 22 34 383 72  55 
193 83 18 _637 2628 - 237 
194 1261 -  10651 3092 64 27811  
195 1451 30 12551 20291 28 17191  
196 35 8 189 1024 20 71 
197 201 8 5 416 41 1 05  
198 242 11 46 268 1 -43  
199 242 16 46 389 39 78  
200 878 10 682 3256 43 294 
201 - 8 -7 416 10 105  
202 209 4 12 324 22 1 
203 8481 9 6521 12461 7 935  
204 310 5 14 708 48 398  
205 251 14_ 55 - 1 -1 
206 673 29 476 171 35 1360  
207 - 79 34 183 522 41 211 
208 852 18 656 1777 42 1466  
209 312 24 116 756 77 44 
210 901 24 705 1956 14 164 
211 10161 19 8191 14671 29 1156  
212 187 2 -91 2381  2 - 731  
213 246 11 49 499 53 1881  
214 929 14 733 1007 27 696  
215 6 14 
216 197 5 1 317 41 
217 754 15 558 2006 12 1696 
Mean Background 196 - 311 - - 
Mean CV 15 34 
Table 6.7 Effect of the stain on cellular adhesion. F: integrated mean fluorescence 
intensities, CV. calculated coefficient of variance, F-B: background corrected mean 
fluorescence intensities. 
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Slide number Slide 2 Slide 4 Slide 6 Slide 6 
Slide detail Sl2ND7 Track 0 SI2B16F1O Track G SIl ND7+B16F1O Sli ND7+B16F1O 
Filler used .zL ±iIcL !!1c. - 
Pu F CV F-B F 	JCV F-B F 	JCV F-B F CV 	I F-B 
3  313 46 116 227 17 21 232 6 10 481 301 282 
4  199 15 3 314 24 106 266 29 45 194 1 -5 
8  186 4 - 10 220 16 14 23.4 11 131 206 6 7 
9 215 24 19 330 42 124 293 21 72 236 22 37 
10 233 5 37 299 37 94 212 11 - 1 -10 
12 627 24 430 232 18 27 418 20 197 521 10 322 
13 204 7 7 1 -7 217 10 -4 200, 4 1 
14 176 4 -20  2271 - _24 221 2551 37 34 180 -1 
15 214 4 17 236 14 31 2211 9 0 20 
16 439 31 242 261 40 55 297 9 76. 397 10 19 
17 210 7 14 202 -  -4 300 38 791 217 - _1 
18 461 2 265 217 12 12 308 48 861 327 12 12 
19 229 3 33 625 114 419 249 25 28 217 12 1 
20 259 35 62 569 55 364 226 9 5 1 -11 
22 223 16 7 258, 24 52. 221 4 0 225 8 26.  
23 219 61 22 275 29 69 228 4 7 269 8 701  
24 231 5 35 405 58 199 228 7 7 246 11 471  
25 - 12 24 374 54 168 2 2 _69 227 7 2 
28 203 7 6 208 4 22 - _ 25 66 
29 483 27 287 1061 50 855 537 64 316 458 30 26 
30 215 10 18 826 89 620 273 20 52 220 3 2 
31 212 5 16 224, 6 18 238 10 17 220 10 2 
33 225 4 29 206 13 01 245 38 24 188 4 -1 
35 227 5 30 220 22 14 232 17 11 225 101 2 
37 261 40 65 568 62 363 330, 26 109 258 16 6 
38 199 11 - 347 47 141 286 31 65 173 4 -2 
40 186 6 -11 309 17 104 27 17 26 187 -11 
41 244 16 47 206 7 1 250 30 29 198 1 -1 
43 451 29 255 291, 19 65 259 28 38 345 48 147 
45 223 12 27 1 -14 246 27 25, 293 21 94 
46 232 12 36 191 7, -15 - - - 194 3 -5 
47 193 16 - 300 _64 94 - 40 118 192 1 -7 
48 215 9 19 335 55 129 27 21 26 198 1 -1 
49 199 2 2 282 25 76 215 9 - 1 -6 
50 212 5 16 456 40 251 309 20 88 235 16 37 
53 245 22 49 2 -5 263 35 42 306 16. 10 
55 584 33, 388 219, - 14 269 23 _47 456 
- 2 
57 214 9 18 378 44 172 - - 118 235 10 36.  
59 263 25 67 771 _63 5661 408 23 187 _283 19 84 
61 244 9 47 196 - -10 225 19 4 206 - 7 - 
63 345 6 148 215 9 9 243 12 22 294 9 9 
65 857 10 660 949 32 744 342 28 121 732 _20 53 
67 221 11 25 326 28 121 342 25 120 248 25 4 
69 266 22 69 1001 _28 795 401, 46 180 229 15 3 
71 200 8 4 191 7 - 15 199  1 -22 212 11 
73 206 11 10 22227 161 215 1 -7 173 4 -2 
77 210 8 14 383 35 177 228 13 7 212 16 13 
79 291 10 95 992 - 786 17 125 260 27 _6 
81 443 30 246 217 22 11 229 21 8 275 15 76 
83 226 14 30 303 45 97 1 -25 195 10 -4 
85 210 il l 14 354 35 149 286, 19 65 208 8 
87 202 16 6 275 29 69 226 21 5 176 8 -22  
69 205 - 8 522 122 316. - 22 1 192 7 -6 
91 237 37 41 242 11 -  242 33 20 172 9 -26 - 
92 195 7 -1 378 28 173 280 23 59 214 21 15 
93 241 9 45 398 45 192 260 7 39 215 9 17 
94 207 10 10 211 22 5 194 5 -27 176 6 --22 
95 787 17, 591 736 67 530 735 43 514 558 17 3 
96 1 	4861 101 2901 13311 64 1126 787 28, 5651 497 9 298  
97 1 	4781 211 2811 10371 68 832 , 692 531 4711 322 40 124 
123 1 2041 171 71 2101 51 41 239 171 171 203 4 4 
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Slide number Slide 2 Slide 4 Slide 6 Slide 6 
Slide detail S12 ND7 Track 0 S12 B16F10 Track G Sli N07 + B16F1O Sli ND7 + 1316F10 
Filter used F!TC - FITC - 
PU F CV F-B F 	jCV F-B F CV F-B F CV F-B 
159 1045 161 848 873 57 667 647 69 426 695 14 496 
160 453 191 257 245 19 39 365 72 143 340 23 141 
161 641 5 445 1356 21 1150 811 39 5901 476 16 2771  
162 304 18 108 475 30 270 671 63 4501 411 28 21 
163 206 5 9 222 10 16 259 29 381 201 1 
164 404 13 208 838 63 632 556 55 335 438 19 23 
165 513 21 317 317 36 1111 40 18 390 1 191 
166 538 33 341 359 35 1 5 6 334 325 33 12 
167 240 1 43 511 34 306 50 2 28 277 1 7 
168 393 14 197 1081 43 87 5 44 377 451 2 25 
169 216 17 19 218 14 216, 6 -5 201 12 2  
170 221 6 24 260 12 54 2351 13 14 200 1 
171 239 11 42 287 26 81 380 11 159 248 27 4 
172 299 28 102 510 33 304 369 34 147 215 13 1 
174 491 9 295 5111 54 305 425 31 203 319 111 12 
175 208 5 12 201 - 235 20 14 208 
176 191 5 - 242 15 36 240 9 19 193 6 -6 
177 1205 3 1009 1338 18 1132 795 60 574 611 18 413 
176 221 6 24 244 12 38 252 5 31 218 5 19 
179 224 6 28 432 75 226 317 26 96 231 8 33 
180 241 3 44 211 9 5 226 12 5 196 1 -3 
181 197 11 0 252 21 46 257 23 36. 222 11 23 
182 1211 19 1014 2794 12 2588 1044 58 823 853 12 654 
183 456 291 259 724 17 519 685 51 464 398 28 199 
184 385 29 189 995 17 789 371 - 4 - 149 _243 - 44 
185 636 32 439 1341 20 1135 513 48 292 516 10 317 
186 392 26 195 723 47 517 293 38 72 1 -10 
187 193 4 -4 1 -17 - 270 _49 _200 13 _1 
188 192 8 - 196 4 -10 201 20 -20, 1 - 
189 304 7 107 533. 34 328 308 9 87 235 10 36 
190 732 20. 536 1045 21 839 344 39 123 451 28 25 
191 232 36 577 75 372 373 47 152 222 9 2 
192 231 22 34 294 47 89 232 14 11 203 8 4 
193 833 18 637 857 36 651 379 40 158 517 9 31 
194 1261 19 1065 1566 24 1360 971 20 750 716 14 51 
195 1451 30 1255 1452 12 1246 750 47 529 550 16 35 
196 385 8 189 1821 39 1615 549 40 3281 370 21 17 
197 201 8 5 260 17 54 244 33 23 187 8 -1 
198 242 11 46 426 58 220 229 16 8 192 6 -6 
199 242 16 46 197 5 -9 257 22 36 207 
200 878 10 682 2667 37 2461 1103 72 882 749 17 551 
201 190 8 -7 323 42 117 240 14 19 226 12 2 
202 209 4 12 1 -21 233 35 12 182 6 -1 
203 848 9 652. 758 26 552 276 14 55 540 7 341 
204 310 114 637 73 431 2821 10 61 239 5 4 
205 251 14 55 438 90 233 193 4 - 207 4 
206 673 29 476 926 20 721 403 34 182 418 14 21 
207 379 34 183 320 18 114 370 48 149 282 37 8 
208 852 18 656 1759 20 1554 605 75 384 671 12 47 
209 312 24 116 544 44 338 356 48 135 298 18 9 
210 901 24 705 1024 50 818 661 48 440 575 13 37 
211 1016 19 819 410 28 205 553 52 332 _660 32 46 
212 187 2 - 238 25 33 195 9 -26 184  6 -14 
213 246 11 49 337 49 132 275 29 - _225 10 27 
214 929 14 733 1189 22 983 783 39 562 521 22 322 
215 340 62 143 414 45 208 446 27 225 224 15 25 
216 197 5 210. 6 4 231 24 2 7 3 
217 754 15 55 16 42 1428 455 59 234 4 22 266 
Mean Background 1% - - 2061  - 221 - - 199 - - - 
Mean CV 15 32 28 13 
Table 6.8 Multiplexing of cellular adhesion. F: integrated mean fluorescence intensities, 
CV: calculated coefficient of variance, F-B: background corrected mean fluorescence 
intensities. 
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6.3.3 Applications of cell adhesion screening 
The preparation of human primary renal tubular epithelial cells and incubation with 
polymer microarrays were carried out by Sara Campbell in the Renal Group (University 
of Southampton, School of Medicine). 
Macroscopically normal kidney tissue was obtained following nephrectomy for renal 
cell carcinoma. Cortical tissue (2.0-5.0 g) was taken into chilled DMEMIHam's F12 
media containing penicillin (200 units.mL'), streptomycin (200 mg.mL) and finely 
chopped using cross blades. The chopped tissue was washed three times with the above 
media with centrifugation (250 x g) between washes, before being subjected to 
enzymatic digestion in an orbital incubator (1 hour @ 37 °C) using collagenase type IV 
(0.10 % w/v, Worthington, Lorne Laboratories) in PBS. The disaggregated cell mixture 
was centrifuged at 250 x g for 5 mm. The resulting cell pellet was resuspended in media 
and passed sequentially through 70 and 40 im sieves. After further centrifugation at 250 
g for 5 minutes, the cell pellet was resuspended at a density of 10 5 cells.mU' in a fully 
defined DMEM/Ham's F12 medium containing glutamine (2.0 mmol), penicillin (100 
units.mU'), streptomycin (100 mg.mL'), epithelial growth factor (EGF) (10 ng.mL'), 
hydrocortisone (36 ng.mL), human insulin (5.0 j.tg.mL), prostaglandin-E i (PGE 1 ) ( 10 
ng.mL), sodium selanite (5.0 ng.mL), iron loaded transferrin (5.0 j.tg.mL') and tn-
iodothyronine (T3) (5.0 pg.mU') in 25 cm2 filtered culture flasks and incubated at 37 °C 
with 5 % CO2. Cultures were inspected on a daily basis and the media changed every 48 
h until grown to confluence. At confluence the cultures were passaged using trypsin 
(0.050 % w/v), EDTA (0.20 % w/v) in PBS and, after washing with PBS-containing 
trypsin inhibitor (0.15 % w/v, Sigma-Aldrich) the cells were resuspended (1.0 x 10 5 
cells/slide) in the growth media on the polymer slides. The growth media was changed 
every 48 h and the cells were incubated onto polymer arrays for a total of 5 days. 
Following washing in PBS, the cells were fixed in p-formaldehyde (3.7 % w/v) for 15 
mm, permeabilised with Triton-X 100 (0.10 % v/v) for 2 min and washed 3 times in 
PBS. The slides were blocked with goat serum (5.0 % v/v in PBS) and incubated with 
CAM5-2 (low molecular weight cytokeratin) monoclonal antibody (Cambridge 
Bioscience) overnight at 4 °C and visualised using an AlexaFluoi) 488 labelled IgG 
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antibody (Molecular Probes, Invitrogen) for 30 mm. The cell nuclei were stained with 
Hoechst 33342 (0.050 g.mL', Sigma-Aldrich) for 10 mm. The analysis was carried out 







x (Os) x (Ext) 




PEG 400 1401 none 0485 0515 0000 0.3 05 
PPG 2000 1401 none 0485 0515 0000 18 1, 7 
PEG 400 BICH none 0485 5515 5000 0.0 0,0 
PPG 2000 BICH none 0485 0510 - 0000 11.5 2.9 
10 P1MG 2000 BICH none 0485. 0515 0000.  35 2.61 
12 PEG 900 TDI none 0.485 0515 0000 19 1 
13 PEG 400 701 none 0 2515 0000 370 2 1 1  
14 PPG 2000 TO] none 0. 0515 0000 233 
15 PTMG 2000 TD( none 04 0515 - 0000 29.3 14,2 
16 PEG 2000 MDI none 0 4a5 0515 0000 00 
17 PEG 900 MDI none 0485 0515 0000 168 IQX 
18 PEG 400 MDI none 0485 0010 0000 3435 41.1 
19 PPG 2000 MDI none 0.485 0.515 0.000 635 2 
20 P1MG 2000 MDI none 0485 0515 0000 64.8 109  
22 PEG 900 P01 none 0485 2.515 0000 2.3 29 
23 PEG 400 P01 none 0485 0515 0000 873 1 9.7  
24 PPG 2000 P01 none 0 485 0515 0.000 300 14 
25 P1MG 2000 P01 none 0,485 0515 0000 178 14 
28 PEG 400 HMOI none 0485 05151 0000 28 
29 PPG 2000 HMDI none 0485 0515 0000 1 0 08 
30 PTMG 2000 HMDI none 0 485 0 515 0000 15 4 
31 PEG 2000 1401 ED 0250 0 520 0 230 0.0 0.0 
33 PEG 900 14131 ED 0250 520 0 230 0.3 0.5 
35 PEG 400 1401 ED 0250 0 520 0 230 8,5 3.7 
37 PPG 2000 1401 ED 0.250 0.520 0.230 23.0 78 
38 PPG 2000 HDI ED 0,250 0 520 0230 0.0 
40 P1MG 2000 HDI ED 0250 0.520 02301 0.0 ao 
41 PEG 2000 BICH ED 0 250 0 520 0 230 02 0.0 
43 PEG 900 EICH BD 0.250 0 520 0.230 00 07 
45 PEG 400 BICH ED 0250 0 520 0 230 0.8 I 
46 PEG 400 BICH ED 0.250 0.520 0230 12.5 3.7 
47 PPG 2000 BICH ED 0250 0520 0230 165 120 
48 PPG 2000 BICH ED 0.250 0.520 0.230 6.5 6.2 
49 P1MG 2000 BICH SD 0.250 0520 0230 41.3 105 
50 P1MG 2000 BICH ED 0.250 0,520 0230 480 556 
53 PEG 900 TDI SD 0.250 0520 0 230 0.3 0.5 
55 PEG 400 TDI RD 00250 0520 0230 545 21.0 
57 PPG 2000 TDI BO 00250 0 520 0 230 1012 321 
59 P1MG 2000 101 ED 0250 0.520 0230 121.8 45,1 
61 PEG 2000 MDI ED 0250 0 520 0230 5.0 1.2 
63 PEG 900 MDI 90 0250 0,520 0230 23.0 
65 PEG 400 MDI ED 0 520 02301 790 23.2 
67 PPG 2000 MDI ED  0.2 83.5 2 
00 
69 P1MG 2000 MDI ED 0 0 
12.6
 
61 5 2 
71 PEG 2000 P01 ED  0 
73 PEG 900 P01 ED 
r0) 
0230 00 
77 PPG 2000 P01 SD -  64 7 
79 P1MG 2000 P01 ED  0 30 5 I 	2 
81 PEG 2000 HMDI SD  0230  
83 PEG 900 HMDI SD 0250 0 520 0 1 
85 PEG 400 HMDI BD 0520 0 103 294  
87 PPG 2000 HMDI SD 0520 0 11 8 20,2 
89 P1MG 2000 ((MDI SD 0520 0.230 246 20,6 
91 P1MG 650 HOl 80 0 0515 0000 20 1.4 
92 P1MG 1000 1401 ED 0485 0515 0,000 41.0 354 
650 EICH ED 0485 0515 000 50 4.2 
ffi95 ffPTMG 
 1000 RICH 50 048 0515 0000 248 179 
650 MDI BO 0485 0515 0000 45 2114 












97 PHNGAD 1800 BICH DMAPD  18 121 
123 PPG 2000 MDI OMAPO  
N 
2 2 
158 P1MG 250 MDI OFHD  7 9,7 
P1MG 250 MDI RD  108 27 
160 P1MG 250 MDI EG  1325 I K 
161 P1MG 650 MDI EG 0250 0520 0,230 150 IK 
162 P1MG 1000 MDI EG 0250 0520 0230. 833 1111 
163 P1MG 2000 MDI EG 0250 1063 44.9 
164 P1MG 250 MDI PG 0250 2 119 5 19. 
165 P1MG 650 MIDI PG 02 0 0230 1443 4, 
166 P1MG 1000 MDI PG 0250 0520 
- 
0230 850 72. 
187 P1MG 2000 MDI PG 0222 0520 0 230 74 3 22. 
168 P1MG 250 BId-I none 0485 1 593 70. 
169 P1MG 650 RICH none 0485 0 0 I. 
770 P1MG 7000 RICH none 0485 II 
771 PTMG 250 HDI none 04  8 24 
172 P1MG 650 HDI none 04 77 40 
174 P1MG 250 MDI none 0485 0 5 97.7 
775 P1MG 650 MDI none 04 0 708 17.11 
176 PTMG 1000 MDI none 04 0 94 4.11 
777 P7MG 250 HOt NMPD 02 0 02 I 
178 P1MG 1000 HOt NMPO 0 02 1098 , 14.3 
179 P7MG 2001) 1101 NMPO 0 02 223 199 
180 P1MG 1000 RICH NMPD 0 02 3 0 24.9 
181 P1MG 2000 BICH NMPD 0 02 3 197 
182 P1MG 650 MDI NMPD 0 02 1423 10.3 
783 P1MG 1000 MDI NUPD 0 02 9 297 
184 PTMG 2000 MDI NMPD 0 0230 13 9.9 
785 PHNAD 900 MIDI OFHD 0 0330 1.6 
186 P1MG 650 RICH OFHD 0 02 298 727 
787 P1MG 7000 RICH OFHD 0 02 8 70.4 
788 P1MG 2000 BICH OFHD 0250 0 520 0230 5 1.1 
769 PPG 1000 BICH OFHD 0 170 0 520 0 330 75 0.7 
190 P1MG 650 HO) OFHD 
- 
250 - 0520 0230 590 79. 
191 P1MG 1000 HDI OKHD 0250 0520 0230 1065 16.5  
192 PTMG 2000 1401 OFt-ID 0250 0520 0230 806 26. 
793 PPG 1000 MIDI OMAPO 0 170 0520 0330 1335 22. 
194 P1MG 650 MDI OFt-ID 0250 0520 0230 558 19. 
195 PTMG 1000 MIDI OFHO 0250 0520 0230 1410 40. 
196 P1MG 2000 MDI OFHD 0250 0 0230 1175 23 
197 PTMG 650 RICH OHM 0250 0520 0230 93 II 
198 PTMG 7000 RICH OHM 0250 0 10 
799 P1MG 2000 RICH OHM 0 0 705 9. 
200 PTMG 650 1401 OHM 0. 0 02 - 7358 I. 
201 P1MG 1000 HDI OHM 02220 - 0. 1040 7. 
202 P1MG 2000 HDI OHM 0 0 - 203 26 
203 P1MG 650 MIDI OHM 0 0 463 32. 
204 PTMG 1000 MDI OHM 0 0 - 883 14. 
205 P1MG 2000 MDI OHM 0. 0230 - 693 2. 
206 PPG 1000 HOI OFHD 0250 0520 0230 - 253 33. 
207 PPG 1000 RICH OFHD 0250 0520 0230 38 77  
208 PPG 1000 MDI OFHD 0.250 0520 - - 420 37 
209 PPG 7000 1401 PG 0250 0 520 0230 645 I? 
210 PPG 1000 RICH PG 0250 0520 0230 9,5 4. 
217 PPG 1000 MDI PG 0250 0 520 0230 799 2'7 
212 PHNAD 900 HDI PG 0250 0520 0230 1258 Ill 
213 PHNAO 900 RICH PG 1 	0. 0 5201 - 02301 128 216 
274 PNNAO 900 MDI PG 0250 0 520 02301 933 24' 
215 PHNAD 900 1401 RD 0250 0520 02 21 21.7 





217 PHNAD 900 MIDI 60 0222 05201 0.2301 153 2113 
Table 6.9 List of screened polymers with monomer composition; average number and 
standard deviation of the human renal tubular epithelial cell bound to each polymer 
(average of 4 polymer spots) .Dis.: diisocyanate; Ext.: chain extender. 
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6.3.4 Immobilisation of non-adherent cells 
6.3.4.1 Initial investigation 
Non-adherent cell lines (JURKAT, RMA-S and JY, kindly provided by Salim Khakoo, 
Cancer Research, Southampton, UK) were grown in RPM! 1640 growth medium 
supplemented with heat inactivated fetal calf serum (10 % v/v), penicillin (100 
units.mU 1 ), streptomycin (100 mg.mL') and L-glutamine (4.0 mM) at 37 °C with 5 % 
CO2. Cells were stained with CellTrackerTM Green according to the manufacturer's 
protocols. Prior to seeding onto the polymer array, cells were resuspended in growth 
medium (3.0 x 106  cells/slide in 15 mL). The slides were subsequently placed in an 
incubator (24 h @ 37°C, 5% CO2). After a controlled washing in PBS (30 mL, 2 mm 
shaking on a microplate shaker at 600 rpm), the cells were fixed in an aqueous solution 
of p-formaldehyde and sucrose (3.7 % w/v and 4.0 % w/v, respectively) for 15 mm, 
rinsed and stored in PBS at 4 °C. Image capture was carried out with a BioAnalyzer 
4F/4S white light scanner using the FITC filter. 
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Slide number Slide I Slide 2 
Slide detail JY Track G RMA-S Track G 
Filter used FITC FITC 
PU F CV F-B F 	JCV F-B 
3 300 2 6 683 17 444 
4 314 1 20 676 15 4 
8 307 6 13 528 27 2891  
9 399 17 105 508 17 269  
10 320 8 26 746 19 57 
12 318 4 24 87 9 56 
13 2941 3 01 4791 17 240  
14 29 - 412 6 173  
15 328 20 34 806 14 56 
16 304 3 10 748 29 509 
17 298 6 3 273 17 34 
18 299 3 5 31 6 6 
19 327 8 33 782 16 54 
20 314 4 20 7451 9 506  
22 303 5 9 483 9 244  
23 311 3 17 326 11 87 
24 342 27 48 674 26 4351  
25 284 5 - 422 24 183 
28 28 -4 31 15 112  
29 7811 49 487 326 12 87 
30 29 -41 4661 32 22 
31 286 399 160  
33 304 2 9 332 14 93 
35 358 24 64 243 3 4 
37 534 32 240 479 23 24 
38 344 6 50 670 15 432  
40 3181 4 23 465 14 226  
41 310 7 16 4531 11 21 
43 291 2 -3 469 5 230  
45 289 2 -5 315 14 7 
46 294 7 0 290 16 51 
47 296 1 1 399 12 160 
48 315 13 21 783 23 544 
49 291 -3 704 14 46 
50 2 -5 4951 14 256  
53 2 -11 3521 24 114 
55 319 3 25 394 24 1551 
57 709 20 415 485 20 246 
59 290 4 -4 407 6 168  
61 31 29 27 231 3 
63 21 2 -3 285 15 
65 320 1 26 286 21 47 
67 415 28 1211 4291 10 190  
69 286 3 -91 364 1251  
71 302 1 8 3291 10 90 
73 298 5 4 2621 7 23 
77 397 27 103 607 14 36 
79 21 4 - 423 19 184  
81 340 4 46 377 21 1 38  
83 317 4 22 247 2 
85 300 3 5 557 26 3181  
87 440 36 146 390 8 151 
89 338 14 441 5711 13 332 
91 309 2 15 349 25 110 
92 3161 3 22 354 9 115 
93 324 6 30 413 10 174 
94 287 5 - 604 22 365 
95 470 1 176 306 4 67 
96 538 50 244 271 41 32 
97 355 51 611 546 81 307 
123 292 6 -21 414 211 175 
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Slide number Slide 1 Slide 2 
Slide detail JY Track G RMA-S Track G 
Filter used FITC - FITC 
PU F CV F-B F JCV F-B 
159 391 33 97 253 5 14 
160 280 4 -15 299 15 61 
161 582 32 288 250 9 11  
162 281 3 -13 401 i3 162  
163 274 2 -20 510 25 27 
164 295 9 0 260 6 21  
165 362 27 68 2 
166 472 28 178 289 10 50  
167 435 57 141 511 22 27 
168 306 7 12 332 11 93.  
169 313 8 19 448 25 20 
170 291 12 -3 522 19 28 
171 414 14 120 300 10 6 
172 296 11 2 476 7 27 
174 364 15 70 344 22 105  
175 293 6 - 526 11 287  
176 302 6 8 404 16 165  
177 399 47 104 272 7 33  
178 34 5 20 465 14 226  
179 324 6 30 439 5 201  
180 300 13 6 582 14 34 
181 389 34 95 482 6 243  
182 409 43 114 255 3 16  
183 563 41 269 2 
184 323 19 29 42 24 173  
165 439 33 145 436 14 197 
186 332 34 38 534 22 299  
187 373 18 79 599 28 36 
188 332 20 38 404 17 165 
189 343 33 49 3 16 76  
190 361 18 67 412 29 173  
191 276 2 -18 542 19 303  
192 280 2 -14 521 13 282  
193 553 4 259 359 11 121  
194 500 67 205 261. 1 2 
195 567 52 273 298 6 5 
196 355 11 61 360 79 12 
197 296 12 2 275 15 36  
198 287 2 -8 458 23 2 19  
199 280 _2 -14 467 16 22 
200 629 52 335 254 - - 
201 573 40 279 375 12 136  
202 265 7 -29 442 40 20 
203 393 21 99 246 1 7 
204 710 44 416 329 10 90 
205 275 2 -19 371 15 13 
206 44 18 120 274 13 35  
207 833 23 539 341 9 10 
208 466 52 172 414 . 17 1 79  
209 376 37 82 311 15 7 
210 71 60 457 309 17 70 
211 498 31 204 391 20 15 
212 288 9 -6 331 5 9 
213 302 7 7 365 23 126  
214 361 30 67 293 11 54 
215 1 	4361 36 142 245 11 6 
216 285 3 -9 -252 23 25 
217 467 33 173 23 3 0 
Mean Background 294 23 
Mean CV 16 14 
Table 6.10 Immobilisation of non-adherent cell lineages. F: integrated mean 
fluorescence intensities, CV: calculated coefficient of variance, F-B: background 
corrected mean fluorescence intensities. 
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6.3.4.2 Immobilisation of mouse Bone Marrow Dendritic Cells 
The preparation of bone marrow dendritic cells, incubation with polymer microarrays 
and phagocytosis assay and analyses were carried out by Dr. Alexandra Mant in Cancer 
Research (University of Southampton, School of Medicine). The polymer microarray 
preparation and analysis, together with the polymer-coated coverslip preparation were 
carried out by G. Toumiaire in the University of Edinburgh (Department of Chemistry). 
Preparation ofprimary murine bone marrow-derived den dritic cells: 
Bone marrow-derived dendritic cells (BMDC) were purified from the femurs of 8-12 
weeks old C57BL'6 mice, according to the method of Lutz et al. 234 and were used on 
day 10 of in vitro culture. 
BMDC polymer microarray adhesion assay: 
BMDC were stained with carboxyfluorescein succinimidyl ester (5.0 jiM, CFSE, 
Molecular Probes, Invitrogen) to monitor cell adhesion as follows: an aliquot of cells 
(4.0 x 106)  was centrifuged (5 min @ 20 °C, 300 x g) and washed once with PBS before 
resuspension in PBS (1.0 mL) containing CFSE (5 jiM) and incubating for 10 min at 
room temperature in the dark. After staining, the cells were centrifuged (5 min @ 20 °C, 
300 x g) and gently resuspended in cell culture medium (1.0 mL), RIO: RPM! 1640 
(Gibco, Invitrogen) supplemented with penicillin (100 units.mL'), streptomycin (100 
jig.mL') and L-glutamine (2.0 mM), 2-mercaptoethanol (50 jiM, Sigma-Aldrich) and 
heat-inactivated and filtered low endotoxin foetal calf serum (10 % v/v, Autogen 
Bioclear). The cells were gently pipetted onto the surface of a polymer microarray 
contained in sterile Petri dish. A further 20 mL RIO was carefully added to the dish and 
was subsequently incubated (2 h @ 37 °C, 5 % CO2). After gentle washing with R 1 
and then PBS, the cells were fixed with formaldehyde (4.0 % w/v) in PBS for 15 min at 
room temperature, then rinsed and stored in PBS at 4 °C. Adhesion was checked using a 
Zeiss Axiovert 200 fluorescence microscope. For precise quantification of cell adhesion, 
the fixed cells were further stained with a solution of DAPI (0.50 jig.niL') for 15 min at 
room temperature. Slides were rinsed and stored in PBS at 4 °C. Image capture and 
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analyses were carried out using the high resolution HCS platform (xl 0 objective) and 
the PathfmderTM software. Cell compatibility with the different polymers was 
determined by counting of the number of cells present on each spot using both the DAPI 















3 1 63 0 178 1 
4  1 65 6 179 1 
8 0 67 3 180  1 
9 0 69 1 181 
10 0 71 0 182 
12  1 73 1 183 
13  0 77 4 184  1 
14  0 79 1 185 
15  2 81 0 186  2 
16  0 83 1 187  3 
17  85 1 188  2 
18  0 87 1 189  2 
19  3 89 1 190 
20  2 91 5 191 
22  92 1 	4 192 01 
23  0 93  193 51 
24 0 94  194  7 
25  3 95  195 
28  96  7 196 
29  2 97  197 
30  123  198 
31  158 1 	4 199 
33  159 12 200 4 
35 1 160  201  6 
37 0 161  202  0 
38 1 162  203  1 
40 1 163  3 204  2 
41 1 164  205 
43 0 165 1 206 
45 1 166 1 	14 207 
46 1 167 1 208  2 
47 3 168 0 209 
48 0 169 2 210 
49 2 170 2 211 0 
50 2 171 4 212  2 
53 1 172 1 213  2 
55 1 174 11 214 2 
57 6 175 5 215  2 
59 4 176 11 216 1 _0 
61 1 177 8 217 
Table 6.11 BMDC adhesion assay on polymer microarray 
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Polymer coating of coverslips: 
Prior to spin coating on a P6708 spin coater (Speedlines Technologies), glass cover slips 
(22 mm diameter, CB00220RA 1, Menzel-Gläser) were cleaned with tetrahydrofuran 
(THF). 50 jiL of the polymer solutions (2.0 % w/v in THF) was placed onto the 
coverslips and spun for 10 s at 2000 rpm. Coverslips were dried under vacuum (12 h @ 
45 °C / 200 mbar) and irradiated with UV light for 20 min before use. 
Phagocytosis assay: 
Coverslips coated with polymer PU159, PU166 or PU174, or poly-L-lysine solution 
(0.01 % wlv, Sigma histology grade or Sigma tissue culture grade, Sigma-Aldrich, 
Dorset, UK), or uncoated (incubated with PBS alone), were sterilised by UV light for 15 
min in the bottom of a 6-well polystyrene culture plate (Greiner Bio-One). A drop of 
R 1 containing BMDC (5.0 x 105  cells/coverslip in 0.50 mL) was pipetted into the centre 
of each coverslip, and the plate incubated (37 °C, 5 % CO2) for the cells to adhere, 
taking care not to disturb the meniscus. After 30 mm, a further 1.0 mL of R 10 was added 
to each coverslip, containing 5.0 tL of 3.0 gm diameter sulphate latex microspheres 
(IDC Latex), pre-coated with passively adsorbed foetal calf serum proteins. The 
microspheres were brought into contact with the adhered cells by centrifuging the plate 
(3 min @ 20 °C, 200 g). The plate was then incubated (30min @ 37 °C, 5 % CO2). After 
the incubation, the R 10 was removed from the coverslips, which were rinsed briefly and 
gently with PBS, before being fixed with formaldehyde (4.0 % w/v)in PBS for 7 min at 
room temperature. The BMDC were permeabilised by incubating with Triton X-100 (0.1 
% v/v) in PBS for 7 min at room temperature, then washed 3 times with PBS before 
being stained with rabbit anti-calnexin antibody (Stressgen) and goat anti-rabbit 
AlexaFluor) 488 secondary antibody (Molecular Probes, Invitrogen). Nuclei were 
stained with TO-PRO®-3 (Molecular Probes, Invitrogen). 
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Quantitation ofphagocytosis: 
Coverslips were examined using a Leica SP2 laser scanning confocal microscope with a 
x40 objective. Three independent experiments were carried out, in which each coverslip 
was represented in duplicate. Phagocytosis was quantified by counting the number of 
microspheres internalised and the number of cells in a randomly selected field of view. 
Internalised microspheres were those defined as surrounded by calnexin staining in all 
three dimensions (Figure 3.7). Figures for phagocytosis efficiency were derived from 
the counts of two to four fields of view per treatment, encompassing a minimum of 73 
and a maximum of 556 cells (Table 3.1). The degree of adhesion was classified by 
comparing the number of cells present in four randomly selected fields of view for each 
treatment and checking that these were typical over the three independent experiments. 
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6.4 Experimental for Chapter 4 
6.4.1 Selective enrichment of multipotent mesenchymal stromal cells 
(STRO- 1+) 
The preparation of unselected bone marrow mononuclear cell and STRO- I+ separation, 
culturing and plating was carried out by Dr. Rahul Tare in the Bone and Joint Research 
Group (University of Southampton, School of Medicine). 
6.4.1.1 Unselected bone marrow mononuclear cells and STRO-1+ cells 
preparation 
STRO-l+ cells were isolated using the magnetically activated cell sorting (MACS) 
technique described by Stewart and co-workers (1999) '0' . In brief, red blood cells were 
removed by centrifugation using lymphoprep solution (Robbins scientific). The cells 
from the buffy coat (bone marrow mononuclear cells) were resuspended in blocking 
solution (1.0 x 108  cells per 10 mL Hank's buffered saline solution (HBSS): HEPES (10 
mM ) with fetal calf serum (FCS, 5.0 % v/v), human normal AB serum (10 % v/v), and 
bovine serum albumin (BSA, 1.0 % w/v)), followed by incubation with the STRO-1 
mouse monoclonal antibody (undiluted culture supernatant from the STRO-1 
hybridoma, provided by Dr. J. Beresford, University of Bath). Cells were then incubated 
either with MACS anti-IgM beads (1:5 dilution, Miltenyi Biotech) or with the 
fluorescein (FITC)-conjugated AffiniPure F(ab')2 fragment Goat anti-mouse 1gM, t 
chain specific (1:20 dilution, Jackson lmmunoResearch Laboratories Inc.), after washing 
the excess STRO- 1 antibody with MACS buffer (HBSS, HEPES (10 mM) containing 
BSA (1.0 % w/v)). Cell suspensions incubated with the MACS anti-IgM beads were 
added to a column within the magnet and the STRO-1 negative fraction was eluted using 
the MACS buffer. Since the magnetically labelled STRO-1 positive cells were held in 
the column under the influence of the magnetic field. The column was washed to remove 
traces of the STRO-1 negative fraction and the STRO-1 positive fraction was then eluted 
in 1.0 mL MACS buffer in the absence of the magnet. 
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6.4.1.2 Polymer microarray printing 
Polymer microarrays were prepared using the same sample and conditions as described 
in chapter 6.3.1. 
6.4.1.3 Incubation on microarrays 
STRO- I + cells, isolated using MACS, and preparations of unselected bone marrow 
mononuclear cells containing FITC-labelled STRO-1+ cells were resuspended in a-
MEM (1.5 mL / slide with 10% v/v FCS) at densities of 5.0 x 10 and 1.0 x 107  cells 
respectively. The cell suspensions were directly plated onto polymer arrays and 
incubated (19h @ 37 °C, 5 % CO). MACS-isolated STRO-1+ cells bound to the 
polymers on the slide were fluorescently immunolabelled using STRO-1 mouse 
monoclonal primary antibody, followed by the (FITC)-conjugated AffiniPure F(ab')2 
fragment Goat anti-mouse 1gM. 
6.4.1.4 Coverslips coating 
Polymer-coated coverslips were prepared using the same conditions as described in 
chapter 6.3.4.2 - Polymer coating of coverslips with the following samples: PU 16, 17 
and 61. 
6.4.1.5 Incubation on coverslips 
Each polymer-coated coverslip was placed into a well of a 6-well plate and incubated 
(19h @ 37°C, 5% CO2) with unselected bone marrow mononuclear cells (1.0 x 107  in 
1.5 mL a-MEM with 10 % v/v FCS) containing either unlabelled or FITC-labelled 
STRO- I+ cells. 
6.4.1.6 Washing, fixing and storing 
Following incubation and thorough washing with PBS, cells were fixed in p- 
formaldehyde (4.0 % w/v in PBS) for 30 mm, rinsed in PBS and nuclei were stained 
using Hoechst 33342 (0.50 tg.mL' for 15 mm, Sigma-Aldrich). Slides were stored in 
PBS at 4 °C, whereas coverslips were mounted in aqueous mounting medium 
(Aquatex®, R1329, Agar Scientific) and stored at 4°C. 
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PU16 PU17 PU61 
% STRO-1+ % STRO-1+ % STRO-1+ 
Patient 1 
Field 1 32 12 12 
Field  27 11 33 
Field 3 33 12 16 
Field  35 17 25 
Field 5 38 9 17 
Mean P1 33 12 21 
Patient 2 
Field 1 47 32 9 
Field 2 48 29 43 
Field 3 48 58 57 
Field 4 35 37 38 
Field 5 50 35 17 
Mean P2 46 38 33 
Patient 3 
Field 1 88 51 52 
Field 2 81 48 41 
Field 3 77 46 62 
Field 4 93 22 42 
Field 5 73 47 59 
Mean P3 82 43 51 
Overall Mean 54 31 35 
Standard Deviation 26 16 15 
Standard Error 15 9 9 
Table 6.12 Selective immobilisation of STRO-1 + cell on polymer-coated coverslip. 
6.4.2 Novel substrates for embryonic stem cells culture 
6.4.2.1 Oct4-GFP cells culture 
The cell line used throughout the study were modified murine embryonic stem cells 
named Oct4-GFP. This cell line is feeder-independent and was cultivated in the 
undifferentiated state on gelatine-coated (0.20 % v/v in PBS) tissue culture flasks (75 
cm2, Iwaki, Asahi Techno Glass). Cells were maintained in Glasgow minimum essential 
medium (GMEM, Sigma-Aldrich) containing minimum essential medium non-essential 
amino acids (0.1 mM), glutamine (2 mM), sodium pyruvate (1 mM), 2-mercaptoethanol 
(100 mM) and fetal calf serum (10 % v/v). This medium will be referred to as ESC 
medium. To maintain the pluripotent undifferentiated state in vitro, this medium was 
supplemented with leukaemia-inhibitory factor (LIF) (100 units.mL 1 ). The cells were 
passaged every 48 h. 
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Initial experiments carried out using the microarray platform were carried out using ESC 
medium without antibiotics (penicilin and streptomycin). As a result of bacterial 
contamination issues in absence of antibiotics, the last experiments (on coverslips) were 
carried out using ESC medium supplemented with penicillin (100 units.mL) and 
streptomycin (100 mg.mL'). 
6.4.2.2 Polymer microarray printing 
Polymer microarrays were prepared using the same conditions as described in section 
6.3.1. However, with 32 aQu solid pins (K2785, Genetix), resulting in 124 
poly(urethanes) printed in quadruplicate within I fields of 16 x 32 spots, with one 
pattern of 4 x 4 spots left empty. 
6.4.2.3 Polymer microarray screen 
A suspension of Oct4-GFP were plated (1.0 x 105 cells / slide in 15 mL ESC medium 
containing LIF) on top of the 14 polymer microarrays each in a different Petri dish (10 
mm diameter). After 24 h, the medium was changed, half the slides were incubated with 
the same ESC medium containing LIF whereas the other half were incubated with ESC 
medium in absence of LIF. Subsequently, both media were changed every 48 h. At each 
time point, two slides (one cultivated in LIF medium and one without) were rinsed in 
PBS prior to fixing in p-formaldehyde (4.0 % w/v in PBS for 15 mm). Analysis of 




























Table 6.13 Immobilisation of Oct4-GFP onpoly(urethane) microarrays. 
A: V  adhesion observed, x  no adhesion observed 
V undifferentiated phenotype observed in absence of LIE in the growth medium. 
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6.4.2.4 Polymer coating of coverslips 
Polymer-coated coverslips (19 mm diameter, CB00190RAI, Menzel-Gläser) were 
prepared using the conditions described previously (6.3.42 - Polymer coating of 
coverslips). 
6.4.2.5 Coverslip screening by microscopy 
Two of each polymer coated coverslips were placed in 12 well-plates (Iwaki, Asahi 
Techno Glass); the remaining two wells were used as controls and were coated with 
gelatine (0.20 % v/v in PBS). A total of three 12 well-plate was prepared. A suspension 
of Oct4-GFP was plated (1.0 x 104  cells / well in 2.0 mL ESC medium) in each well. 
Half the wells were incubated with medium containing LIF whereas the other half did 
not contain LIF. Both media were changed every 48 h. After 5, 7 and 9 days of 
incubation, respectively, the media were removed, the cells rinsed with PBS (2.0 mL / 
well), fixed in p-formaldehyde (1.0 mL / well, 4.0 % w/v in PBS for 15 mm) and their 
nuclei stained with Hoechst 33342 (1.0 mL / well for 10 mm, 0.5 j.tg.mL'). Each 
coverslip was mounted onto a microscope slide using Aquatex® (R1329, Agar 
Scientific) mounting medium. Cells growing on top of each coated coverslip were 
visualised using both DAPI and FITC channels of the high resolution HCS platform and 
PathfinderTM software. 
6.4.2.6 Clonal growth experiment 
Two of each polymer coated coverslips were placed in 12 wells-plate, the remaining two 
wells were used as controls and were coated with gelatine (0.20 % v/v in PBS), a total of 
three 12 well-plate was prepared. A suspension of Oct4-GFP was plated (100 cells / well 
in 2.0 mL ESC medium) in each well. Half the wells were incubated with medium 
containing LIF whereas the other half did not contain LIF. Both media were changed 
every 48 h. After 9 days of culture, each colony was screened for alkaline phosphatase 
activity according to manufacturer protocol (leukocyte alkaline phosphatase kit, Sigma-
Aldrich) and each colony was scored by microscopic examination. 
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A 161 190 206 214 221 0.2 % gelatine 
N I 	P N P N P N P N I 	P N P 
Plate 1 1 200 7 1.71 4 1.00 5 1.80 8 1.38 14 1.43 
Plate 2 1 2.00 5 1.20 4 1.50 6 1.17 5 1.40 8 1.75 
Plate 3 3 2.33 5 1.20 5 1.40 5 1.80 2 3.00 12 1.58 
Total number of colony 5 17 13 16 15 34 
Overall phenotype scoring 2.11 1.37 1.30 1.59 1.93 1.59 
B 161 i90 2 U 221 TFic, gelatine 
N I 	P N P N P N P N I 	P  N P 
Plate 1 0 NA 0 NA 4 2.75 0 NA 3 2.33 6 300 
Plate 2 1 3.00 0 NA 2 300 1 300 1 3.00 4 3,00 
Plate 3 0 NA 1 3.00 2 2.50 3 3.00 2 3.00 6 3.00 
Total number of colony 1 1 8 4 6 16 
Overall phenotype scoring -  3.00 3.00 
2.75 3.00 2.78 3.00 
Table 6.14 Clonal growth experiments. (A) In presence of LIF, (B) in absence of LIF. N: 
number of colony scored, F: average phenotype scoring on each coverslip. 
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6.5 Experimental for Chapter 5 
6.5.1 Choice of coverstips 
The printing was carried out according to the parameters previously described (6.3.1). 
Three identical polymer microarrays were prepared by printing 15 poly(urethanes) 
solutions (Table 5.1) each as 24 identical spots at different positions on the gold-coated 
microscope slides (3 sub-arrays of 4 x 2 spots per sample). 
Following drying, the arrays were incubated with 300 tL of AlexaFluor® 647 labelled 
fibrinogen (25 ig.mL' in PBS, 3 h @ 37 °C). Three different types of coverslips were 
investigated to generate a thin film of protein solution on top of the printed arrays: 
standard glass coverslip (22 x 50 mm, 1313022050A1, Menzel-Glaser), HybriSlipsTM (60 
mm x 22 mm, H18202, Invitrogen) and GeneFrame® (60 mm x 21 mm, AB-! 130, 
ABgene). 
Following washing and drying, the slides were scanned using the low resolution scanner 
and the fluorescence intensity arising from protein binding to each polymer spots 
integrated. The standard deviation and coefficient of variance (CV = % standard 
deviation / mean) were calculated from the integrated intensity resulting from the 24 
identical spots for each of the 15 polymers. 
6.5.2 Washing techniques 
Following incubation of the protein solution onto the polymer microarray, superfluous 
protein solution had to be washed away. Initial experiments were carried out using a 
stream of de-ionised water, however, this methodology was difficult to reproduce due to 
several parameters such as pressure, time and angle of incidence of the stream. In order 
to obtain reproducible results, the washing method was standardised. It comprised of 
three 50 mL tubes (sterile polypropylene centrifuge tube, FB55956, Fisher Scientific) 
containing water, PBS and water. Following dipping of the slide, each tube was sealed 
and subsequently inverted 10 times (2 seconds per stroke). After the last washing, the 
slide was dried using a stream of N 2 and was then ready for scanning. 
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etc... (to 10 inversions) 
t0 	t=ls 	t 2 
n = 0 n = I inversion 
Figure 6.1 illustration of the standardised washing technique. 
6.5.3 Determination of protein concentrations 
Five identical polymer microarrays were prepared by printing 32 poly(urethanes) 
solutions each as 8 identical spots within one field of 16 x 16 using the previously 
described conditions (6.3.1). 
Following drying, each array was incubated with a different concentration of 
AlexaFluor® 647 labelled fibrinogen solution: [Fg] = 5.0, 12.5, 25, 50 and 100 j.tg.mL' 
in PBS (300 p.L / slide, 2 h @ 37 °C using GeneFrame® coverslips). 
Following washing and drying, the polymer microarrays were scanned using the low 
resolution scanner with a Cy5 filter. The average fluorescent intensities arising from 
each set of 8 identical polymer spots were calculated on each slide (Table 6.15). These 
average fluorescent intensities were plotted against the concentrations of the fibrinogen 
solution used. 
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Fibrinogen concentration in_pg.mL-1 
PU 5.0 12.5 25 50 100 
7 14566 17909 21182 20705 30677 
8 29493 32334 251211 236368 426209 
12 18327 24240 50708 104587 115581 
16 15160 16523 45413 16816 25425 
23 20545 21725 1020971 197702 104186 
25 14121 16300 481241 19164 62881 
28 20485 20642 61896 113197 225429 
37 13902 15388 33816 19836 54498 
63 14697 14329 26685 32352 67878 
65 27237 43957 366497 840137 1286399 
73 14331 13661 19077 14144 21443 
77 14266 19939 46634 164827 173723 
79 154159 281474 581207 813478 955215 
91 21398 42510 85825 220910 291750 
92 14340 14223 102758 32653 188236 
101 17387 19992 133028 153476 405982 
102 16811 20122 391041 54494 129589 
107 15921 21986 126788 177183 250789 
154 15063 14182 38952 40946 46146 
155 16244 16137 29683 46302 100856 
156 60716 168124 258795 523776 714584 
157 187057 532127 817099 1144489 1672833 
159 214878 601370 10445171 1979599 1484462 
160 247707 493511 1207369 1289407 1550765 
163 22522 110592 162516 363398 437046 
166 17649 84224 292008 401972 481574 
171 14165 63507 93197 154722 144301 
173 15998 18241 43311 57727 77955 
191 21355 198674 488932 864142 1381533 
233 145411 12698 180641 191631 23383 
253 274741 17919 256981 341081 24416 
255 166411 13285 235821 254231 24416 
Table 6.15 Average fluorescent intensities (a. u.) for the 8 identical polymer spots arising 
from the adsorption of labelled fibrinogen at different concentrations on a library of 32 
poly(urethanes). 
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6.5.4 Reproducibility of the method 
Two identical polymer microarrays were prepared by printing 119 poly(urethanes) 
solutions each as 4 identical spots within two fields of 16 x 16 using the conditions 
described (6.3.1). 
Following drying, each array was incubated with the same solution of FITC labelled 
glycoprotein X (confidential) (300 j.tL / slide, 2.50 j.tg.mL' in 0.5 % w/v human serum 
albumin (HSA) in PBS, 2 h @ 37 °C using GeneFrame(& coverslips). 
Following washing and drying, each polymer microarray was scanned using the low 
resolution scanner with FITC filter and the fluorescence intensities arising from 
glycoprotein X adsorption to each polymer spots integrated (Table 6.16). 
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Slide I Slide 2 Slide I Slide 2 
PU F CV F CV PU F CV F CV 
150 47889  45956 6 209 32955  32563 5_ 
151 25658  24741 2 - 210 33840 19 48646 3 
152 35551  32872 _3_ 211 84591  79295 4 
153 55673  48429 _6_ 212 61889 15 53667 _3 
154 45081 - 16. 38120 3 213 76176  81094 8 
155 - 32128  31509 3 214 120014  119779 3 
156 41876  38150 8 215 43191  47421 13 
157  55492 5 216 60862  7 85244 66 
158 44876  40129 11 217 144319  143507 5 
159 - 22 61912 6 218 348500 17 335476 14 
160  30835 5 219 117169  101550 5 
161 93259 4 91254 4 220 167456  1 .60277 6 
162 
- 
84976 5 _84529 3 221 36734  36809. 5 
163 
- 
- 3 72008 5 222 46436  418371 1 
164 35869 6 30689 4 223 177949  166529 2 
165 76939 2 76173 5 224 46308  43426 2 
166 98604 2 102716 5 225 53433 12 52806 10 
167 51625 4 52043 5 226 149765  162170 5 
168 45875 7 _38098 4 228 16030  18260 7 
169 45748 51 46115 5 229 87997 14 85156 6 
170 40471 5 39721 3 230 23189 14 - 4 7 
171 55668 19 41211 4 232 44217 14 40657 9 
172 35431 4 31951 5 233 19721 12 23828 5 
173 35288 3 37383 10 234 17295 11 28120 14 
174 63887 4 69226 - - 235 42886 8 4 446 - 
175 65497  1 71427 - - 238 37163 - 4 32849 - - 4 
176 - 9 92183 - - 241 1 	341 4 101255 4 
177 _64342 41 58403 _4_ 244 92538 241 68682 - 
178 _41010 10 50903 49 245 - 60077 3 - 74 - - 
179 36973 23 35126 6 - 246 - 65175 5 - 57619 11 
180 _50558 5 42743 - - 247 54228  49646 5 
181 54576 8 47786 _1_ 248 76535 79184 17 
182 _93338 7 104584 7 249 46042  45827 7 
183 77227 -  4 82878 - - 250 53974 10 - 57209. 9 
184 107540  6 109348 - - 251 51586 13 30 
185 2 65461 - - 252 58736 38 46457 5 
186 - 10 52115 - - 253 123261  109460 4 
187 78007 64 63082 5 254 73767  34 4 
188  7 48313 13 255 65612 31 74802 32 
189 - 21 35909 6 256 188307  4 178045 5 
190  4 61273 3 257 180184 21 170769 8 
191 4 746 - 6 42374 5 258 546857 20 381081 24 
192  41 78344 3 259 799581 15 460929 37 
193 64599 - 51 61382 3 260 67487  60821 6 
194 122684  167796 7 262 84561 11 58920 5 
195 105648  116603 4 263 42033 10 37834 6 
196 155647  207234 4 264 1277122 15 1541015 17 
197 48991  4 46422 2 266 16805 6 223981 _27 
198 75222  78792 _13 267 23143  7 27927 7 
199 47181  42714 - - 268 308270  4 287010 - 
200 125748  161140 3 269 39712 7 40038 
- 
- 2 
201 33245  31951 3 270 11870  2 132048 7 
202 53523 14 52853 _10 271 2080968 16 2509736 13 
203 92243 31 94544 - - 272 66780 19 77929 4 
204 350394 7 413239 5 - 273 1 59024 5 54549 3 205 81243 1 77 - 274 60199 16 62730 13 206 20944 11 29402 - - 275 208282  242815 3 207 26408 15 341 21 278 71034  5 68118 7 208 79607 16 78250 2 277 71277 5 110711 32 
278 49138 10 48693 7 
Table 6.16 Reproducibility study. Average fluorescent intensities (a.u.) and 
corresponding coefficient of variance (CV) for the 4 identical polymer spots arising 
from the adsorption of labelled glycoprotein X on 2 identical poly(urethanes) 
microarrays. 
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6.5.5 Investigation of assay duplexing 
The investigation of the assay duplexing was run with two sets of three polymer 
microarrays prepared with from 2 different polymer libraries. Both libraries were printed 
using the previously described conditions (6.3.1). 
Library PA I: contained 176 poly(acrylates) each printed as 4 identical spots within three 
fields (two fields of 16 x 16 and one field of 12 x 16) (Table 6.17). 
Library PA2: contained 83 poly(acrylates) and 56 grafted poly(allylamines) each printed 
as 4 identical spots within three fields (two fields of 16 x 16 and one field of 3 x 16) 
(Table 6.18). 
A solution of Glycophorin A (G7903, Sigma-Aldrich) was labelled as described 
according to manufacturer protocol (6.2. 1) with AlexaFluor® 546. 
For this experiment three labelled protein stock solutions were prepared in 1.0 % v/v 
whole Human Serum (HS) (55979, MP Biomedicals, Stretton Scientific) in PBS. 
600 j.tL of AlexaFluor® 546 labelled Glycophorin A @ 25.0 j.tg.mL 
300 jiL of FITC labelled Glycoprotein X (confidential) @ 5.0 pg.mL' 
300 1tL of FITC labelled Glycoprotein Y (confidential) @ 50.0 j.tg.mL 
The solutions containing two labelled proteins were prepared by mixing 150 PL of each 
stock solution. The single probe solutions were prepared by diluting the stock solutions 
(150 tL) by a factor of two using 1.0% v/v HS in PBS. 
Each array was incubated with different protein solution (300 j.tL / slide, 2 h @ 37 °C 
using GeneFrame(V coverslips): 
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System 1: 
Slide 1: 	FITC labelled Glycoprotein X (2.50 j.ig.mL) + AlexaFluor® 546 
labelled Glycophorin A (12.5 .tg.mL') in 1.0 %v/v HS in PBS. 
Slide 2: 	FITC labelled Glycoprotein X (2.50 tg.mL) in 1.0 % v/v HS in 
PBS. 
Slide 3: 	AlexaFluor® 546 labelled Glycophonn A (12.5 .Lg.mL') in 1.0 % 
v/v HS in PBS. 
System 2: 
Slide 4: 	FITC labelled Glycoprotein Y (25.0 .tg.mL) + AlexaFluor® 546 
labelled Glycophorin A (12.5 .tg.mL') in 1.0 % v/v US in PBS. 
Slide 5: 	FITC labelled Glycoprotein Y (25.0 .tg.mL') in 1.0 % v/v HS in 
PBS. 
Slide 6: 	AlexaFluor® 546 labelled Glycoprotein A (25.0 tg.niL) in 1.0 % 
v/v HS in PBS. 
Following washing and drying, each polymer microarray was scanned using the low 
resolution scanner with: 
Slide 1: 	FITC and Cy3 filters 
Slide 2: 	FITC filter only. 
Slide 3: 	Cy3 filter only. 
Slide 4: 	FITC and Cy3 filters. 
Slide 5: 	FITC filter only. 
Slide 6: 	Cy3 filter only. 
For each scan, the fluorescence intensities arising from protein binding to each polymer 
spots were integrated (Table 6.17 and 6.18). 
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Slide 1 Slide 2 Slide 3 
Filter FITC Cy 3 FITC Cy3 
PA F CV F CV F CV F CV 
1a5 125156 4 78695 15 27400 7 37019 17 
1a7 202573 6 161189 13 119741 16 275257 28 
1a9 369002 4 478378 13 226331 13 178498 2 
1b7 32773 6 185933 6 25485 1 112173 10 
1c7 46609 7 374893 9 19411 6 42619 16 
1c9 218493 6 11917811 17 53068 20 115905 10 
2a5 32304 3 214914 12 44697 10 132240 77 
2a7 23847 6 55274 38 33661 3 50143 6 
2a9 33562 7 84392 17 32048 8 204598 23 
2b7 55545 13 589223 5 28618 6 90010 9 
2b9 59391 3 563384 8 32760 9 330162 7 
2BA7 21540 6 27768 4 18579 12 25056 19 
2BA9 24237 5 140687 9 65614 6 225709 18 
213137 23335 9 91987 17 26134 5 64295 13 
213139 29795 7 628863 10 45387 2 543289 30 
2BC9 27080 8 312720 25 65086 9 323359 11 
2BE7 64902 4 577994 12 913591 5 185210 7 
2BE9 144186 9 1821842 10 53396 16 149049 9 
2BG5 18664 11 24900 8 16232 8 16377 3 
2BG7 18157 2 24599 9 16204 5 86344 32 
2BG9 49890 5 2914715 9 33953 8 57839 11 
2c5 26165 4 131944 13 25398 6 45650 12 
2c7 40496 4 117741 7 37462 5 36095 10 
2c9 36961 7 205905 29 52368 2 364935 11 
2e7 33152 3 1119331 27 48117 3 194574 41 
2e9 28713 5 83892 6 22704 19 119788 18 
2f5 26439 23 135734 57 923664 8 3696663 6 
2f7 252034 10 585027 10 784435 5 1361849 17 
2g5 194209 9 1395650 21 260539 3 1387544 8 
2g7 190158 30 969493 16 264316 5 118656 37 
2g9 113269 13 687629 20 72370 25 428036 8 
2h5 32788 19 2537551 6 40410 11 62668 42 
2h7 225301 7 783984 9 1005665 20 3002474 21 
2h9 76693 6 849606 4 427205 11 2931275 11 
3a5 24693 - - 47208 6 26593 7 40047 25 
3a7 33022 7 285946 12 63893 11 47836 4 
3a9 34777 4 233767 15 26126 3 65149 11 
3AA5 84422 18 319474 15 30457 5 198039 24 
3AA7 51110 15 167802 35 150375 15 1151711 12 
3PA9 75791 28 312469 22 130007 13 529048 36 
3AB5 49485 17 124620 27 342252 17 161430 13 
3AB7 73580 18 224642 20 122175 15 539158 15 
3AB9 32163 10 153570 12 190360 11 127072 36 
3AC5 95720 10 310735 36 93115 2 295100 25 
3AC7 31875 16 2130811 12 239011 9 156066 17 
3AC9 27693 7 158827 13 19276 2 49599 8 
3AE5 48601 48 383069 8 253349 24 214582 12 
3AE7 28263 9 254599 6 20891 4 75588 19 
3AE9 38966 40 127812 8 95987 7 163477 25 
3b7 - 30176 6 34082 9 20548 5 23242 9 
3b9 - 	 97 16 157316 10 31805 13 29681 7 
3BA5 1 3 253431 5 16559 19 18978 3 
3BA7 1 4 4 16 21477 56886 5 
3BA9 217 5 46134 9 27884 4 30594 18 
3BBS 188 3 30082 7 15478 3 21204 3 
3BB7 19226 4 26418 10 19245 _3 - 24869 22 
3BB9 23560 2 69262 25 21918 21 23535 10 
3BC5 18709 2 25114 9 21372 4 19536 11 
3BC7 18646 5 31187 6 16343 11 20858 12 
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Slide 1 Slide 2 Slide 3 
Filter FITC Cy3  FITC Ci3 
PA F CV F CV F CV F CV 
3BC9 18178 3 25337 11 14791 2 18837 13 
3BE5 18840 4 23226 3 16487 2 21002 19 
38E7 19392 4 23204 6 16029 4 16360 4 
3BE9 24270 4 69287 12 31390 7 23252 4 
3BG5 19114 2 22692 3 16448 9 17129 9 
3BG7 20377 8 245511 6 158101 1 17180 4 
3BG9 20563 9 26759 15 47072 6 28906 40 
3c5 28896 9 76246 14 35154 12 29565 12 
30 30707 16 335428 10 57371 17 43641 23 
3c9 36060 3 137184 25 112585 6 44236 9 
3e5 	1 155516 3 1761482 2 49693 16 146389 41 
3e7 105150 12 1224817 10 171746 24 1833371 12 
3e9 35475 17 122849 7 238229 5 298992 21 
3f5 21950 9 89553 15 48717 14 160112 8 
3f7 61728 18 603636 6 80758 64 1828614 14 
3f9 42724 10 191813 19 61393 9 215413 30 
3g5 3 421 28 846902 35 20340 13 55391 8 
3g7 120588 5 2009447 3 383283 14 1630572 14 
3g9 157775 13 1872513 5 3748271 7 1648771 7 
3h7 81961 11 2813254 5 502404 2 3186196 3 
3h9 42224 14 323173 23 136994 8 900748 22 
315 77976 58 571344 6 154580 41 1401596 45 
317 68020 10 1874053 6 87184 20 678711 26 
319 31668 9 2931711 21 48655 8 456779 52 
3j5 21809 8 44156 12 34970 26 29890 10 
3j7 20094 4 63104 48 23204 25 83403 29 
3j9 64284 8 876097 50 41221 12 521738 39 
319 1544500 18 2616138 16 1305891 15 2187336 5 
3m5 151860 29 705611 22 168699 40 301843 54 
3m7 106279 7 308669 10 57909 29 371376 73 
3m9 35075 34 125534 15 170422 11 167121 18 
3n5 39226 37 85394 63 73965 19 32699 22 
3n7 1 	20889 4 39380 4 56576 6 42008 13 
3n9 125799 40 672074 28 780831 3 1105022 7 
3v5 22868 13 31637 9 33151 24 21451 6 
3v7 25907 8 50257 35 20136 2 24950 18 
3v9 50333 20 3312031 96 1 	799 18 126720 17 
3x5 96239 11 194282 16 138928 5 354342 46 
3x7 104750 10 169658 33 416222 7 352941 32 
3x9 104778 19 334738 28 126686 27 167832 33 
3z5 42015 3 83942 22 4142721 14 51374 8 
3z7 29430 12 78480 35 23205 39 41575 57 
3z9 23623 5 69067 26 82077 14 32393 17 
4a7 23568 7 280561 6 25022 7 30226 20 
4a9 24544 2 28931 4 19229 1 23096 16 
4b9 19787 4 25244 4 17292 4 22376 14 
4c5 1 	20586 7 25384 3 16985 13 20211 3 
40 21699 1 26790 4 183011 2 20349 13 
4c9 21015 5 34485 25 22798 16 21121 7 
5a7 19587 3 41782 9 18260 6 25669 10 
5a9 20522 3 726691 12 16809 . 1 38027 37 
5AA5 201496 37 660551 19 356008 19 379231 15 
5AA7 58900 2 778850 7 72187 11 175750 5 
5AA9 1 	40259 2 306823 11 44023 9 75107 3 
5AB5 49163 8 475700 5 517201 10 103606 12 
5AB7 63513 6 1055966 9 61441 6 89965 9 
5AB9 40381 7 177816 23 73835 28 173512 98 
5AC5 20881 4 1 	512081 5 34405 10 1 	52599 15 
5AC7 252201 7 1 884881 23 21498 12—T-  228 9 
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Slide 1 Slide 2 Slide 3 
Filter FITC Cy3 - FITC Cy3 
PA F CV F CV F CV F CV 
5AC9 26144 22 94524 33 67232 30 637981 3 
5AE5 35061 10 497507 21 37198 4 178041 11 
5AE7 45810 8 2277434 24 37298 9 358239 30 
5AE9 29220 12 1218309 17 19448 2 34527 14 
5b7 19541 3 25951 2 16740 6 22369 11 
5b9 19479 4 44823, 16 15858 2 22489 16 
5c5 22258. 3 418 5 186751 6 27308 16 
50 35559 9 61621 18 73963 11 103795. 6 
5c9 23263 7 61827 6 35525 12 42736 19 
5e5 26868 7 55593 9 16556 13 16068 1 
5e7 24331 13 601B4 15 21641 11 70908 20 
5f9 75668 7 124295 20 60034 16 59667 25 
5h7 25921 16 114458. 7 27077 8 271132 20 
5h9 57675 17 251733 13 172308 33 321784 15 
515 1390381 18 3180076 11 802488 4 601745 36 
5i7 61358 18 1678612 4 44350 19 66757 19 
519 55109 8 365620 6 40622 10 61043 45 
5j5 22403 3 44467 8 _20729 7 40107 24 
5j9 47296 12 171298 13 _22228 6 73813 4 
515 27458 31 101471 23 17993 2 156587 10 
517 22424 6 54382 7 22047 9 124108 13 
519 21650 4 30251 11 44217 11 223625 41 
5m7 18875 3 31561 16 22148 31 33235 47 
5m9 37086 8 281584 9 102794 9 326233 19 
5n5 19496 7 331 6 9716 76540 19 
50 22945 6 41000 8 179507 20 36808 23 
5v7 18662 4 2487 4 15686 1 17086 3 
5v9 27833 17 70713 19895 13 19430 7 
5x5 423184 5 227588 9 132326 10 1 	89452 3 
5x7 128337 12 271878 6 224726 14 236848 86 
5x9 34443 13 171493 7 32004 6 139680 20 
5z5 - 2 41505 3 24211 13 29525 18 
5z7 - 12 53657 15 19834 5 38225 14 
5z9 - 3 75058 11 17740 3 23112 11 
6a5 25254 14 870231 20 38359. 4 78238. 26 
6a9 35481 7 127&447 7 477971 18 290707 47 
6b7 19117 3 39810 5 18644 8 28084 27 
6b9 23427 10 91600 11 51042 9 165866 27 
6c5 59369 7 604660 5 98921 9 82256 27 
60 32095 8 327903 15 171863 30 80156 16 
6c9 26783 1 547677 11 72808 16 186419 23 
6e9 175002 11 2583056 8 465923 14 483575 16 
6f9 103661 10 816073 11 225580 14 367970 15 
6g9 18332 7 25426 12 83762 26 122280 35 
6h9 59238 9 893946 20 188409 23 181631 68 
7a5 41114 13 191148 13 260855 16 150451 15 
7a7 40598 9 731752 17 93793 33 205483 12 
7a9 49988 6 800337 6 5 10 104965 24 
7b5 36636 13 161473 23 58108 31 71286 8 
7b7 63593 17 930704 7 53797.  5 39261 13 
789 52597 8 812979 12 123067 18 95776 23 
7c5 49254 8 268205 5 68425 36 64602 23 
70 50967 13 405038 29 52499 9 50051 28 
7c9 57760 21 867921 21 43762 4 57525 5 
7e5 18113 3 26485 13 419837 42 442890 71 
7e7 148525 8 1110805 5 493444 16 449552 89 
7e9 6800 9 814973 6 597614 9 1 	8035221 16 
7f9 59891 16 1 	7174711 15 1 	351497 1 	7 1 2437861 7 
Table 6.17 Results for system I on PAl. F: mean fluorescence intensities, CV: 
coefficient of variance. 
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Slide 4 Slide 5 Slide 6 
Cy3  FITC FITC Cv3 
PA  F CV F CV F CV F CV 
28Ae7-1.0 346782 11 146952 8 125195 2 219221 7 
2BAe7-1 5 143567 6 100768 26 63372 9 95739 13 
2BAe7-20 53727 9 69619 6 96113 7 62732 4 
2BAg7-1 0 111462 11 110961 12_ 150573 _16_ 128445 6 
2BAg7-1.5 74781 4 83153 - - 108903 _4_ 81851 19 
2BAQ7-20 78337 6 202876 - - 226096 _5_ 62332 9 
2BCe7-1 0 136815 15 69215 - - 94274 _6 - 243898 36 
2BCe7-1.5 489923 5 89272 - - 103814 9 169663 11 
2BCg7-1.0 338278 10 225087 - - 436230 9 1088043 11 
2GA11-5 540025 34 _84335 - - 75300 4 - 122481 14 
2GA11-7 947672 42 - _21_ 148582 38 820312 _57 
2GA11-9 367744 8 90159 _66_ 63227 9 354299 
2GA12-5 2785591 9 1391442 _10 3270710 13 2598594 5 - 
2GA12-7 4234238 10 39426391 10 38969811 6 3729871 8 
2GA12-9 239801 - - 1075421 2 142360 13 315980 5 
2GA13-9 1313875 _7 367682 5= 419514 6 477844 9 
2GA14-7 3358779 _7 - 2812605 - - 2975763 5 3104752 6 
2GA14-9 225475 9 162521 7 201299 16 292661 9 - 
2GA15-7 3366777 1 3112681 - - 3314517 2 3059708 3 - 
2GA1 5-9 1 	1588449 11 92223 16 279316 6 22526631 - - 
2GA1-7 146826 29 5540 47 38433 15 193263 17 
2GA1-9 616694 7 307691 5 1 	356006 10 774093 11 
2GA2-7 24172 3 20021 13 15855 2 - 28540 22 
2GA2-9 68280 10 37334 15 51556 6 69479 9 
2GA3-7 176785 36 59011 15 76196 18 148629 13 
2GA3-9 806717 25 255286 16 22268 7 835104 18 
2GA4-5 1016542 57 374646 5 - 752239 8 982839 11 
2GA4-7 357944 9 281389 8 - 328031 5 536858 25 
2GA4-9 420675 15 458851 - - 1673281 23 470723 16 
2GA5-5 30834 7 21558 - - 17682 2 24438 9 
2GA5-7 97688 5 37750 - - 41543 12 1221545 5 
2GA5-9 501214 11 85368 _6 74631 13 707751 11 
2GA6-5 414680 3 154145 _10 214493 7 696065 6 
2GA6-7 544416 21 165023 - - 170438 5 805813 7 
2GA6-9 666118 15 207788 _13_ 375161 16 768565 12 
2GA7-5 1 	365359 15 83941 - - 90642 5 616074 11 
2GA7-7 626889 24 90119 4 la44211 13 690169 14 
2GA7-9 _381803 9 70293 - - 72428 3 521847 13 
2GA8-5 2433257 4 3117033 - - 3734986 9 2321653 2 
2GA8-9 _260689 13 162277 - - 180401 _11 352841 12 
2GA9-5 460764 10 156857 7 193078 9 - 689513 3 
2GA9-7 418446 2 212517 1 - 243814 - - 678696 10 
2GA9-9 _859105 17 395418 - - 461216 - - 1147646 12 
3BAe7-1.0 1 	1285339 13 314460 - - 362487 - - 759162 14 
3BCe7-1.0 412799 13 1 	130207 12 1557091 7_ 452912 13 
3BCg7-1.0 294077 7 211085 11 281677 14 423956 2 
3e7 1706236 8 398411 9 188526 8 981099 10 
3e9 372291 70 190988 17 152445 12 258394 19 
3GA11-9 149781 - - 51901 2 61559 16 229047 15 
3GA13-9 3709346 _7_ 1030671 13 1239605 7 3282161 4 
3GA14-5 3163126 - - 3001451 14 2805861 5 3335961 4 
3GA1-9 1 	360317 - - 107768 - - 113244 11 3730401 12 
3GA2-9 455185 8 160664 6 136872 10 4773221 13 
3GA4-9 1432490 21 108173 6 427125 4 1133113 41 
3GA5-9 1985547 6 329099 5 216522 7 1576388 28 
3GA7-9 140962 14 106427 26 81056 6 155467 9 
3GA9-5 429411 7 776207 3 698258 6 410022 14 
3GA9-7 972947 8 178151 4 247112 16 964786 6 
30A9-9 168221 4 852081 6 85434 4 238601 16 
717 1 	658059 18 112067 15 1633351 _6 471366 22 
7g7 460858 12 139374 20 143094 _8 - 747188 6 
7g9 517271 16 177700 7 214197 _7 - 437670 4 
71,7 1052885 17 332460 9 366027 18 2457193 7 
7h9 351477 14 191362 21 296271 18 1428897 4 
8e5 56057 4 30965 10 36270 13 105122 11 
8e9 175288 9 1 	36891 6 25412 8 58619 8 
81`5 1378618 17 1 2358231 20 1 	297268 15 1029651 7 
8f7 1 	322197 6 1 107717 5 1787 4 545011 34 
8f9 104510 8 44820 9 352 6 116939 3 
8q5 46893 6 1 	250731 4 1 	330371 10 59001 8 
I, 
Slide 4 Slide 5 Slide 6 
Cy3  FITC FITC  Cv3______ 
PA  F CV F CV F CV F CV 
8g7 105148 15 60256 21 77343 8 130645 5 
8g9 159010 15 54174 4 75783 16 152523 10 
8h5 26a4290 5 179100 13 293911 13 2992967 10 
81,7 1501543 7 134232 12 160682 4 3122594 7 
8h9 225996 11 68792 3 107284 7 1537994 8 
9e9 - 33779 12 27084 18 22462 13 41570 20 
915 32952 13 291291 14 294851 15 26840 4 
919 - 6 21633 3 20624 10 27408 10 
9g5 301057 17 60384 13 87981 19 624945 16 
9g9 64711 14 51080 14 52168 27 89228 55 
9P5 3459030 21 149361 Ii 187091 _14_ 4393649 10 
91,7 693057 6 230586 14 270778 - - 3693064 9 
91,9 779424 1 310474 1 381859 - - 264542 12 
1/5a 402a88 11 50829 7 47893 - - 37979 6 
1/68 831193 18 1916392 11 2183045, - - 1087168 29 
inc 365501 9 51699 2 69145 19 327331 22 
213a 418327 1' 93666 18 249580 5 40994 13 
1/4c 711402 - - 99249 10 110893 18 8481 8 
1/6a 136165 - - 337915 3 61240,4 16 	1 170726 - 5 
117'b 433402 6 110703 17 148128 13 4 
1/8c 507546 6 63878 5 73007 7 480405 24 
1/4b 	1 501495 12 	1 114290 _7_ 113201 2 657594 3 
1/5c 526149 17 80898 9 83727 8 1087469 41 
iI7a 700229 4 590746 - - 740226 11 916320 11 
1/8b 531673 3 95415 - 110288 15 697751 7 
1/4a 497165 9 148075 2 - 148446 3 699665 10 
115b 444725 14 86293 5 94927, 7 682255 19 
116c 152785 4 594903 1 972501 6 196173 7 
1/Ba 390415 28 60552 16 59875 10 493381 12 
2/5a 315184 6 39877, 20 53307 20 390270 10 
2/7b 346640 7 129295 42 648336 73 26479 12 
2/8c 412033 8 59141 4 152057 62 427293 16 
3/4c 102157 20 44254 18 37084 17 77039 14 
214c 124827 7 105618 8 211553 14 117692 16 
2/7a 131469 8 401591 11 812906, 9 163312 10 
2/8b 358553 4 156161 13 221606 18 424032 8 
2/9c 394556 4 332930 7 300893 23 523063 8 
2/4b 100354 4 217644 4 307153 11 127878 16 
2/5c 260050 24 77500 26 73984 16 454018 8 
2/8a 344274 ii 121971 19 126785 21 372114 4 
2/9b 382766 7 252335 10 289393 5 468410 23 
2/3b 522154 13 118114 28 141594 3 61 769 9 
2/5b 281253 20 49768 50 46722, 27 248933 ,  26_ 
277c 381445 6 110448 18 98779 - 13 382093 4 
2/9a 470241 8 443449, 8 502413 6 523413 5 
318b 7a4744 14 108108 6 157069 30 753108 6 
5/6b 1 	400376 4 70882 13 67319 17 405772 3 
5/7c 402987 10 129782 19 112342 15 493683 3 
6/7a 373340 13 196337 8 225604 7 454240 25 
3/8a 402042, 13 68160 6 84025 12 413535 11 
5/6a - 5 211430 6 542832. 33 112811 , - 2_ 
5/7b 345315 13 154326 21 1469121 ii 475387 - 6_ 
5/8c 276129 - - 89123, 29 935051 13 313792 6 
3/5b 410223 7 168213 7 118201 3 544793 9 
417a 231452 -  132225 8 _ 1236-7 1 ii 352792 - 8_ 
5/7a - - - 252806 10 168637 28 452840 10 
5/8b 145806 16 - 31 3448 11 
3/5a - 392418, 13 65103 27 71705 15 522144 10 
3/68 437745 3 82320 7 104264 13 524715, 5 
5/6c - 351134 9 - 4 56885 12 4471471 5 
5/8a - 6 122683, 9 133335, 11 4204 7 
6/9a 154164 24 46332 13 39911 9 202634 13 
8/9b 483127 16 398228 4 439360 7 603354 7 
6/8b 143085 ii 561572 14 1173930 16 215878 7 
7/8c 342864 16_ 120785 7 181872 4 349699 7 
6/Ba 393982 - 173114 20 155013 8 38"93 3 
778b 324796 8 193533 23 165854 17 3727 - 6 
6/7b 657657 - - 2682738 7 36 12 12606 28 
7/Be 280979 155253 8 2424 10 3212 16 
Table 6.18 Results for system 2 on PA2. F: mean fluorescence intensities, CV: 
coefficient of variance. 
SUE 
6.5.6 Potential diagnostic application 
Three identical polymer microarrays were prepared by printing 147 poly(acrylates) 
solutions (Table 6.20) each as 4 identical spots within three fields (two fields of 16 x 16 
and one field of 8 x 16) using the conditions previously described (6.3.1). 
Each printed polymer microarray was incubated for 5 minutes at room temperature with 
one of the following three protein solutions prepared in 1.0 % v/v whole Human Serum 
(HS) in PBS: 
300 liL of FITC labelled Glycoprotein Y (confidential) @25.0 g.mL' 
300 jiL of AlexaFluorg 546 labelled Glycophorin A @ 12.5 jig.mL' 
300 j.tL of AlexaFluor® 647 labelled Fibrinogen @ 25.0 ig.mL 1 
Following washing and drying, each polymer microarray was scanned using the low 
resolution scanner with the filter relevant to the fluorescent label used. For each scan, 
the fluorescence intensities arising from protein binding to each polymer spots were 
integrated and the mean fluorescence intensities calculated (Table 6.19). 
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Glycoprotern Y Gtycophonn A Fibrtnogen 
Fitterl FITC Cy3 CyS 
PA F F/B F F/B F F/B 
laS 12635.4 8 96458 5 21540 2 
1a7 245773 16 184940 10 23250 2 
1a9 344150 72 243954 13 914862 66 
1b7 79714 _5 136951 7 1774646 128 
10 78623 5 	1 153513 8 1405470 101 
1c9 117582 8 151011 8 1011447 73 
2a5 35490 2 41739 2 63299 5 
2a7 	1 34676 2 33652 -  140505 10 
2a9 48771 3 61294 3 588495 42 
2b7 51903 3 57185 3 14707 1 
2b9 43753 3 86336 5 727384 52 
2BA7 17414 1 24228 1 18902 1 
2BA9 105360 7 3 	548 21 1454879 105 
2BB7 26445 2 65418 3 24623 2 
28B9 84827 6 534959 28 1139349 82 
2BC9 72338 5 265040 14 1654332 119 
2BE7 57381 4 119551 6 101119 7 
2869 153453 10 722393 38 1036523 75 
2BG9 963146 63 2163131 115 319236 23 
2c5 25993 2 39351 2 17153 1 
20 39982 3 34028 2 20840 1 
2c9 50640 3 6 3 4 35 
2e9 1244 2 14 254 183 
215 1604 10 10 57 26 
2f7 1319 9 209871 11 64 
219 464 3 8041 5 I 91 
2g7 25297 17 22 117 - 69 
2g9 1244 8 1947 103 _1 95 
2GA1-7 1411 9 1 7 40 
2GA1-9 1927 13 16 87 1 76 
2GA2-9 71 5 5 40 
2h7 28 19 19 106 11 86 
21,9 16 11 231 123 51 37 
3a5 38087 2 4 7656 3 29506 2 
3a7 42701 3 47449 3 19105 1 
3a9 494 3 59866 3 26316 2 
3AB5 212083 14 133087 7 149572 11 
3AB7 95485 6 95366 5 780567 9  
3AB9 241229 16 96660 5 30788 2 
3AC5 67012 4 165565 9 556647 40 
3AC7 135703 9 114055 6 23612 2 
3AC9 49564 3 261742 14 37234 3 
3AE5 245149 15 124968 7 1305999 94 
3AE7 77680 5 106106 6 1117756 80 
3AE9 9866 6 65671 3 64 4 
3b7 30434 2 477 2 15733 1  
3b9 41641 3 56329 3 16258 1  
3BA5 15907 1 18&54 1 14071 1  
3BA7 54818 4 38282 2 29757 
3BB5 15335 1 201aB 1 13901 1  
3BB9 50457 3 24099 1 27855 2  
3BE7 16885 1 33668 2 17527 
3BE9 76822 5 72464 4 1"33  
3c5 42186 3 48420 3 15428 1  
30 46614 86 5 26064 2  
3c9  122 65 1134 82 




 294 15 77 6 
3f7 2  2032214 108 161 116 
319 1  4 2 8 6 
3g5 3 260 138 J44 J2 
3g7 3  2970892 158 846144 61 
- 6 880 5 2790 2 
 1 11 29460 156 104197 75 
 164 11 5771 3 4170 3 
RN7 
 lii 8 3 61947 45 
4 5 20 11 37810 27 
 1 	1 10 5 44169 32 
2 5 22546 2 
1 - 3 747023, 40 35480 3 
3j9 _140835 9 2247174 119 659245 47 
319 233860 15 1434224 76 727447, 52 
3m5 497219 32 1614549 86 983364 71 
3m7 325896 21 14287 8 85854 62 
- 163- 
Glycoprotn V Gtophonn A Fibrinogen 
Filter FITC Cy3 Cy5 
PA F FIB F F/B P FIB 
3m9 120479 8 200426 11 170805 12 
3n9 97927 6 520977 28 799250 58 
3v7 23937 2 27801 1 23892 2 
3x5 186714 12 149399 8 221763 16 
36 53127 3 62151 - 62315 4 
5a7 34676 2 33569 2 20457 1 
589 	1 27721 2 25967 1 17454 1 
5M5 144659 9 738635 39 303573 22 
5&A7 61294 4 202461 1  45433 3 
5AA9 3466 - 2 4 764 - - 169248 12 
5AB5 57439 4 84069 4 93602 7 
5AB7 45847 3 62756 3 295001 21 
5AB9 38364 3 41208 2 183593 13 
SACS 18005 1 25865 1 51160 4 
5AC7 21730 1 40962 2 48838 4 
5AC9 	1 18075 1 25398 1 14462 1 
5AE5 M820 6 70240 4 600458 58 
5AE7 38232 2 65505 3 29576 2 
5AE9 30523 2 64910 3 32596 2 
5b9 22065 1 21974 1 20479 1 
505 22892 1 24681 1 16484 1 
Sd 23564 2 25098 1 	1 17147 _1_ 
5c9 19T73 1 23950 1 	1 16969 1 
5e5 31782 2 124511 7 24666 2 
5e7 1 	39487 3 231812 36841 3 
51`9 20108 1 94 5 22985 2 
557 60128 4 29588 16 39437 3 
559 67536 4 850491 45 377333 27 
55 la4725 12 73399 4 42779 3 
57 111377 7 76 	76 40 36 26 
5j5 = 61116 3 - 19459 _1 - 
59 21554 -  - 134926 1 _7_ 52898 
515 17516 1 55399 3 22490 2 
517 20744 1 21936 1 169081 1 
5m7 2311 2 46419 2 40362 3 
5m9 278210 18 438389 23 191251 14 
505 66433 4 314106 17 50175 4 
507 51577 3_ 23344 1 16476 _1_ 
5x5 122712 8 77139 4 317822 23 
5x7 133859 9 65281 3 246302 18 
579 17327 1 22811 1 14810 - - 
6a5 1 	69883 5 59153 3 1 	20171 
639 42 5867 3 21117 2 
657 18 2/7 1 15950 
6b9 277 1 20221 
607 47434 45702 - - 20511 - - 
6c9 
699 
41249 - - 21256 2 
6e9 235 15 4 26 532143 38 
619 20 14 5 28 567691 41 
48912 3 116391 6 34051 2 
659 1 	232759 15 2661962 141 1 	425258 31 
785 8W9 6 185501 10 1 52227 4 
7a7 133447 9 178430 9 1 	269732 19 
789 296223 19 302695 16 1082503 78 
7b5 27156 2 31150 2 17274 1 
7b7 - - - 4 101618 7 
7b9 - 70344 4 151900 11 
7e9 68866 4 247548 13 1141247 82 
757 359944 24 2972705 158 1034811 74 
7h9 1 	136372 9 346037 18 1175185 85 
8e9 245311 16 164091 9 17152561 123 
865 312891 20 1995489 106 1 	1623185 117 
817 76689 5 83181 4 1 	981164 71 
869 - 6 138259 7 704368 51 
8g5 200372 13 78759 4 - 52 
8g7 199359 13 2182318 116 1288517 93 
699 90989 6 73246 4 656695 47 
8115 384833 25 3610024 192 1550943 112 
8h7 41OT78 27 2874676 153 852428 61 
8119 138129 9 1757148 93 671462 48 
9115 378303 25 3334026 177 1172237 84 
91,7 4044 
115316 
26 21926 /16 8434 61 
9119 214 14 45408 24 383 28 
Background 18848 13899 
Table 6.19 Protein fingerprint F: mean fluorescence intensities, FIB: mean intensities 
divided by background. 
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Appendix I: poly(urethane) library" 
X Hof°}'H + 2x OCN-1—NCO 
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Synthesis of the poly(urethanes) 
Polyol Dlisocyanate Chain Extender 
PEG HOt_-_01H BICH OCN ED 
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PEG: 	poly(ethylene glycol) 
PPG: poly(propylene glycol) 
PTMG: 	poly(tetramethylene glycol) 
PHNAD: poly[ 1 ,6-hexanediol/neopentyl glycol-a/t-(adiptic acid)]diol 
PHNGAD: 	poly[ 1 ,6-hexanediol/neopentyl 	glycol/diethylene 	glycol-alt-(adiptic 
acid)]diol 
Diisocyanate (Dis.): 
BICH: 1 ,3-bis(isocyananatomethyl)cyclohexane 
MDI: 4,4 '-methylenebis(phenylisocyanate) 
HDI: 1 ,6-diisocyanohexane 
HMDI: 4,4 '-methylenebis(cyclohexylisocyanate) 
PDI: I ,4-diisocyanobenzene 
TDI: 4-methyl- 1 ,3-phenylene diisocyanate 
Chain Extender (Ext.): 
ED: ethylene diamine 
BD: I ,4-butanediol 
EG: ethylene glycol 
PG: propylene glycol 
DMAPD: 3-dimethylamino- 1 ,2-propanediol 
DEAPD: 3-diethylamino- I ,2-propanediol 
DHM: diethyl bis(hydroxymethyl)malonate 
NMPD: 2-nitro-2-methyl- 1 ,3-propanediol 
OFHD: 2,2,3,3,4,4,5,5-octafluoro- 1 ,6-hexanediol 






Ratio (% mol.) Molecular weight 
Nature MW (I),) (Polyol) M (Diisocyanale) 
(Extender) 
Mw Mn D 
I PEG 2000 HDI none 48.5 51 0.0 58000 24004) 2.4 
2_ PEG 900  H1)I none 48.5 51.5 0.0 430000 92000 4.5 
3 PEG 400  HDI none 48.5 51.5 0.0 163WO 62000 2.6 
4_ PPG 2000 HI)! none 48.5 5L5 0.0 65000 32000 2.0 
- PTMG 2000  HI)! none 5 - 51.5 0.0 40000 24000 1.7 
- - 
PEG 2000 RICH none 48.5 51.5 0.0 59000 29000 2.0 
- - 
PEG 900  RICH none - 51. 0.0 228000 98000 2.3 
PE G1400  BICH none - 51.5 0.0 20(000 80000 2.2 
PPC, 2000  RICH none - 51. 0.0 43000 21000 1.9 
10 P1 %10 NICK) BICH none - 51.5 0.0 94000 44000 2.1 
12 P  TDI none - 51. 0.0 13804)0 32000 4.4 
13 PEG 400  TDI none - 5L5 0.0 38000 21000 1.8 
14 Pp ('8) TDI none - 51.5 0.0 77000 	1 36000 2.1 
IS PTMG 200o TDI none 48.5 51,5 0 0 53000 28000 1.9 
16 PEG 2000 MDI none 48.5 51.5 0.0 90000 45000 2.0 
ti PF61900  MDI none - 51.5 0.0 151000 57000 2.7 
IS ITO 400  MDI none - 51.5 0.0 61000 26000 2.4 
I') PPO 2000 MDI none - 51.5 0.0 53000 27000 1.9 
20 PTMO 2000 MD] none 	1 5 -  51.5 0.0 87000 48000 1.8 
21 PEG 2600 P1)1 none - 51. 0.01 73000 37000 2.0 
22 PEG 900  P1)1 none - 51 00 2420000 81000 3,0 
23 PEG 400  'P1)1 none - 51.5 0.0 162000 43000 3.8 
24 PP6 2000 P1)1 none - 51.5 0-0 73000 44000 1.8 
25 PTM 0 PD! none - 51.5 0.0 103000 44000 2.2 
26 PP 0 UMDI none - 51. 0.0 41000 21000 1 	I.') 
27 PF6 900  1I.1Dl none 48.5 51.5 0.0 32000 18000 1.8 
28 PEG 400  UMI)l none 485 515 0.0 101000 55000 1.8 
29 PPG 2000 HMDI none 	1 48,5 51 0.01 44000 10000 1.5 
30 P*I \16 2000 HMDI none 48.5 51.5 0.0 81000 48000 1.7 
31 P11  HI)! BD 25.0 52.0 23.0 71000 25000 2.8 
33 PC G 900  HDl BD - 52.0 23.0 45000 22000 2.0 
35 PEG 400  111)1 BD - 52.0 23.0 196000 69000 2.8 
37 pp G, 2000 411)1 131) - 52.0 23.0 75000 36000 2.1 
38 PPG 2000 111)1 ED - 510 23.0 156000 75000 2.1 
39 PTM 00 HDI BD - 52.0 23.0 99000 58000 1.7 
40 PTM(; 2003 HDI ED 1 -  52.0 23.01 20000 11000 1.9 
41 PEG 2000 BICH BD 25.0 52.0 23.0 45000 25000 1.8 
43 PEG 900  BICH RD 25.0 52.0 23.0 46000 254)00 1.8 
44 PEG 900  RICH ED 25.0 52.0 23.0 450000 123000 3.6 
45 PEG 400  BICH BD - 52.0 23.0 70000 39000 1.8 
46 PEG 400  BICH ED - 520 23.0 130000 15000 8.5 
47 PPG 2000 RICH BD - 52.0 23.0 70000 31000 2.2 
48 PPG 2000 BICH ED 25.01 52.0 23.0 583000 90000 6.5 
49 PTMO 2000 RICH RD - 52.0 23.0 95000 4500)) 2.1 
50 PTMG 2000  BICH ED - 52.0 23.0 163000 20000 5.5 
SI PEG 2000 TDI RD 25.0 52.0 23.0 74000 36000 2.1 
53 PFC, 900  TDI RD 25.0 52,0 23,0 120000 37000 12 
55 Pf 0 400  TI)! BD 25.0 52.0 23.0 71000 26000 2.8 
57 PPO 2000 TDI BD 25.0 52.0 23.0 95000 37000 2.6 
59 PI MG JO TDI BD 25.0 52.0 23.0 77000 45000 1.7 
61 PEG 2000 MD] RD 25.0 52.0 23.0 156000 56000 2.8 
63 PEG 900  MDI BD 25.0  52.0 23.0 47000 23000 2.0 
65 PEG 400  MDI BD 25.0  23.0 76000 38000 2.0 
67 PPG 2000 MIN BD 25.0  21 99000 44000 2.3 
69 PTM( 2000 MDI RD 25.0  23.0 113000 53000 2.1 
- 71 P C 2000 P1)1 RD 25.0  23.0 93000 35000 2.7 
73 PEG 900 PDI BD 1 	25.0  23.0 50000 26000 1.9 
77 PPG 2000 PDI BD 25.0  23.0 70000 32000 2.2 
79 P41MG 2000 PD! RD 25.0  23.0 81000 3000)) 2.7 
81 PFG 2000 HMDI BD 25.0  23.0 81000 39000 2.1 
83 PEG 900 I-IMDI BD 250  23.01 145000 4000 1 	3.1 
85 I' 400 HMDI RD 25.0  23.01 123000 57000 2.1 
87 PPG 2000 HMDI RD 25.0  23 48000 25000 1.9 
89 PTMG 2000 HMDI BD 25.0  23.0 54000 32000 1.7 
39DE PTMG 214(4(4 HDI DEAPD 1 	25.0  23.0 68000 36000 1.8 
39DM PTMG 2000 HDI 1)MAPD 25.0  23.0 72000 29000 2.5 
49DM PTMG12000 BICH DMA PD 250  23 70000 39000 IS 
49DE PTM61 7 000 BICH DEAPD 25.0  23.0 51000 26000 2.0 
91 PTM (,50 HI)! BD 48. 51.5 0. 179000 95000 1.9 








Ratio (% mol.) Molecular weight 
Nature MW (Da) M (Polyol) M (Dlisocyanate) 
M 
(Ender) 
Mw Mn D 
93 PTMG 650 BICH BD 48.5 SI 0.0 109000 49000 2.2 
94 PTMG 1000 BICH BD 48.5 51.5 0.0 170000 90000 1.9 
95 PTMG 650 MDI BD 48.5 51.5 0.0 52000 26000 2.0 
96 PTMG 1000 MDI BD 48.51 51.5 0.066000 34000 1.9 
97 PI-INGAD 1800 RICH DMAPD 25.0 52.0 23.0 121000 55000 	1 2.2 
98 PHNGAI) 1 800 RICH DEAPD 25.0 52.0 23.0 150000 60000 2.6 
99 P1MG 650 HDI DMAPD 25.0 52.0 23.0 125000 62000 2.0 
100 P1MG 1000 1101 DMAPD 25.0 52.0 23.0 81000 41000 2.0 
101 P1MG 650 RICH DMAPD 25.0 52.0 23.0 63000 34000 1.9 
102 P1MG 1000 BICH DMAPD 25.0 52.0 23.0. 121000 58000 2.0 
103 PHNGAD 1800 MDI DMAPD 25.0 52.0 23.0 55000 25000 2.2 
104 PHNGADJ 1900 MDI DEAI'D 25.0 52.0 23.0 38000 17000 2.1 
105 PHNGAD 1900 HO! DMAPD 25.0 52.0 23.0 78000 27000 2.9 
106 PHNGAI) I 800 HDI DEAN) 25,0 52.0 _23.0 52000 24000 2.2 
107 PTMG 650 HDI DEAPD 25.0 52.0 23.0 - 233000 95000 2,5 
109 PTMC 650 RICH DEAN) 25.0 52.0 23.0 80000 41000 2.0 
10 - P1MG 1000 BICH DEAPD 25.0 52.0 - 23.0 147000 52000 1.7 
II - PTM( 650 MDI DEAPD 25.0 52.0 - 84000 36000 2.2 
12 - El W, MDI DEAPD 25.0 52.0 23.0 - 52000 27000 1.9 
13 - P1MG 2000 MDI DEAPD 25.0 52.0 23.0 76000 36000 2.1 
14 - PEG 425 HDI RD 48.5 51.5 0.0 64000 30000 2.1 
15 PP( 1000 HDI RD 48.5 51.5 0 91000 37000 21 
16 - EEC 425 BICH RD 48.5 51.5 0 63000 40000 1.6 
17 PPCI 1000 RICH RI) 48.5 51.5 0 138000 68000 2.0 
18 - PPG 425  MDI DMAPD 25.0 52.0 23.0 72000 25000 2.9 
19 - PPCI 1000 MDI I DIVIAPD 25.01 52.0 23.0 - 63000 	1 30000 2.2 
120 PPG 425 RICH DEAPD 25.0 520 3 - 46000 26000 1.8 
121 PPG1I00O RICH DEAPD 25.0 52.0 23.0 172000 63000 2.7 
122 EEC 2000 RICH DEAPD 25,0 52.0 23.0 106000 5100)) 2.1 
123 PPG 2000 MDI DMAPD 25.0 52.0 - 58000 30000 1.9 
124 PPC 2000 101 OMAN) 25.0 52.01 23.0 - 60000 34000 1.8 
125 PPG 1000 101 DMAPD 25.0 52.0 23.0 110000 32000 3.5 
126 PPG 425 101 DMAPD 25.0 52.0 23.01 64000 21000 1 	3.1 
127 PPG 1000 BICH DMAPD 1 	25.0 52. 23.0 - 165000 79000 2.2 
128 PEG 2000 BICH DMAPD 25.0 52.0 23.0 N.D. N.D. N.D. 
129 EEC 425 RICH DMAPD 25.0 52.0 23.0 104000 45000 2.3 
130 PTMC 650 11)1 DMAED 25.0 52.0 23.0 66000 34.000 1.9 
131 P'MG 1000 IDI DMAPD 25.01 52.0 23.0 82000 32000 2.5 
132 PH­NGAD 1800 RICH RD 25.0 52.0 23.0 76000 32000 2.1 
133 PHNGAD 1800 fbI BD 25.0 52.0 23.0 70000 30000 2.3 
134 PH7NGAD 1800 MDI RD 25.0 52.0 23.01 64000 25000 1 	2.5 
135 PTMCj 250 RICH DMAPD 25.0 52.0 23.0 36000 9500 1 1.9 
36 PTMG 250 RICH DEAED _25.0 52.0 23.0 121000 47000 2.6 
137 PTM 250 RICH BD - 52. 23.0 34000 20000 1.7 
138 PIM 250 RICH EG 52. 23.0 47000 28000 1.7 
139 ElM 650 BICH EG - 52. 23.0 75000 44000 1.7 
140 ElM 1 000 BICH EG 52 23.0 76000 44000 1.7 
141 PIM 00 RICH EG 52. 23.0 54000 32000 1.7 
142 PTM  RICH PG - 52. 23.0 75000 36000 2.1 
143 PTMG 650  BICH PG 25.0 52.0 23.0 73000 36000 1 	2.0 
144 PTMG 1000 RICH PG 
- 
25.0 - 52.0 230 51000 31000 1.7 
145 PTMGj2000 BICH PG 25.0 52.0 23.0 98000 56000 .7 
146 PTMG 250  HDI DMAPD 
- 
25.0 - 52.0 23.0 69000 36000 1.8 
147 PTMG 250  UDI DEAPD 25.0 - 52.0 23.0 58000 27000 2.1 
148 PTMG 250 HDI RD 25.0  52.0 23.0 80000 4200)) 1.9 
149 PTMG 250 HDI EG 
- 
25.0  23.0 43000 24000 1.8 
ISO PTMG 650 HDI EG 
- 
25.0  23.0 155000 71000 2.2 
151 PTM6 1000 HDI EG 25.0  23.0 58000 35000 1.7 
152 PI - MG 2000 HDI EG 25.0  23.0 90000 54000 1.7 
53 P -FMG 250 HDI PG - 25.0  23.0 310000 102000 3.0 
154 PTh 650 HDI PG 25.0  2 23 208000 105000 2.0 
155 PTMG 1000 HDI PG 
- 
25.01  23.0 85000 51000 1.7 
156 PTMG 2000 1 	HDI PG 25.01  23.0 101000 50000 2.0 
157 PTMG 250 MDI DMAPD 2  23. 41000 21000 1.9 
158 ElM 250 MDI OFHD 2  23.0 49000 22000 2.2 








Ratio (%mol.) Molecular weight 
Nature MW (Da) M (Polyol) M (Diisocyanate) 
(Extender) 
Mw Mn D 
60 P1MG 250 MDI El) 25.0  230 91000 36000 2.5 
161 P1MG 650 MDI El) 25.0  23.0 188000 86000 2.2 
162 PTMG 000 MDI El) 25.0  23.0 160000 74000 2.2 
163 P1MG 2000 MDI El) 25.0 1  21 203000 79000 2.6 
164 P1MG 250 MDI PG 25.0  23.0 55000 28000 1.9 
165 PTMC 650 MDI PG 25.0  23.0 78000 41000 2.0 
166 PTMG 1000 MDI PG 25.0  23.0 90000 50000 1.8 
167 PTM(, 2000 MDI PG 25.0  23.0 78000 39000 2.0 
168 PTMC 2SO  BICH none 48.5 51.5 0.0 80000 41000 2.0 
169 PIM( 650  131(11 none 48-5 51.5 0.0 90000 30000 	1 3.0 
170 PIM( 1000 RICH none 48.5 51.5 0.0 190000 101000 1.9 
171 PTMC 250  131)1 none 48.51 51.5 0-0 128000 69000 1.8 
172 PTMG1650  HDI none 48.5 51.5 0.01 128000 69000 1.8 
173 PIN 3) [I DI none 4&5 51.5 0.01 190000 114000 1.7 
174 PI NIG 250  MDI none 48.5 51.5 0.0 196000 88000 2.2 
175 PTIMG 650  MIA none 48.5 51.5 0.0 107000 55000 2.0 
176 PTMG 1000 MIA none 48.5 51.5 0.0 152000 75000 2.0 
Ill PTMC 250  1301 NMPD 25.0 52.0 23.0 50000 29000 	1 1.7 
178 Pi M 1000 HDI NMPD 25-0 52.0 23.0 61000 31000 2.0 
179 PTMG 20W HDI NMPD 25.0 52.0 23.0 58000 33000 1.7 
ISO PTMGj IOW  RICH NMPI) 25. 52.0 23 46000 26000 1.8 
181 PTMG12000  RICH NMPD 25.0 52.0 23.01 48000 28000 1.7 
182 PTMG 650  MDI NMPD 25.0 52.0 23.01 203000 59000 3.4 
183 PI- MG (10 MDI NMPD 25.0 52.0 23.0 84000 33000 2.5 
184 PT.MG 2000 MDI NMPD 25.0 52.0 23.0 104000 45000 2.3 
185 PHNAD 900  MI)I OFHD 17.0 52.0 33.0 65000 34000 1.9 
186 PTNIG 650  RICH OFHD 25.01 51 23 0 59000 34000 1.8 
187 PTMG 1000 RICH OFHD 25.O 52.0 23,0 46000 27000 1.7 
188 PFMG 2000 131(13 OFHD 25-0 52 21.0 63000 38000 1.7 
189 PPG I I OW BIC'H OFHD 17.0 52.0 33.O 40000 26000 1.5 
190 PTMG 650  IIDI OFHD 25.O 52.0 23.01 63000 38000 1.8 
191 PTM G 1000 1101 OFHD 25.0 52.0 23 55000 36000 1.5 
192 PTMG 2000 HDI OFHD 25.0 52.0 23 50000 28000 1.8 
193 PP( 1000 MDI DMAPD 17.0 51 33.01 37000 19000 V9 
194 P ,rMG 650  MDI OFI-tD 1 	25.0 52.0 23.01 52000 27000 1.9 
195 PTMG 1000 MDI OFHD 25.0 52.0 23.0 81000 38000 2.1 
196 PTMO 2000 MDI OFHD 25.0 52.0 23.01 51000 29000 1.8 
197 PTMG1650  BICH DHM 25.0 52.0 23.01 44000 25000 1.8 
198 PTMG 1000 BICII DHM - 52 23.01 41000 25000 1 	1.6 
199 PTMG 2000 BKIt DI-IM - 52.0 23.01 76000 36000 2.1 
200 PTM 650 111)1 DHM - 52. 230 57000 27000 2,1 
201 PTM 000 1IDI OHM 52. 23.0 60000 33000 1.8 
202 PTM 20(X) HDI OHM  52. 23.0 65000 38000 1.7 
203 PTM 650 MDI OHM -  23.0 81000 34000 2.4 
204 PTM 0)10 MDI DI-IM -  23.0 69000 30000 2.2 
205 PTM 2000 MI)l DHM  23.0 104000 42000 2.5 
206 PP 000 1101 OFI-ID  23 60000 28000 2.1 
207 PP 000 BICH OFHD  2 23. 45000 28000 1.6 
208 PPG 1000 MIN OFHD 25.0  23.0 27000 15000 1.8 
209 PP( I 000 111)1 PG  23.0 68000 35000 1.9 
210 PPC, 10(3) RICH PG 25.0  23.0 54000 31000 1.8 
211 PPG 1000 MDI PG 25.0  23,0 35000 18000 2.0 
212 PHNAD 900  1-11)1 PG 25.0  23.0 66000 30000 2.2 
213 PHNAD 900  RICH PG 25.0  23,0 46000 30000 1.7 
214 PHNA I _______ MDI PG 25.0  23.0 92000 53000 1.7 
215 PHNAD 900  1101 ISO 25.0  23-0 69000 34000 1 	2.0 
216 PHNAD 900  BICH BD 25.0  23-01 54000 32000 1.7 
217 PFIN..\ _______ MDI BD 250  0 23.01 49000 23000 1.7 
218 PHNAD WO  11131 DMAPD 25.0  52.0 23.0 83000 38000 2.2 
219 PHNAD 900  RICH DMAPI) 25.0 52.0 23.0 164000 71000 2.3 
220 PHNAD 900  MDI DMAPD 25.0 5' 23 50000 25000 2.0 
221 PHNAD 900 HDI OFHI) 25.0 52.0 23.0 77000 40000 1.9 
222 PIINA 900 RICH OFHD 25.0 52.0 23.0 44000 22000 1.6 
223 PHNAD 90)) MDI I 	OFHD 25. 52.0 23.0 73000 34000 2.1 
224 PHNAD '100 1101 none 48. 51. 0. 119000 61000 2.0 
225 PHNA 900 BICII none 48. SI. 0. 135000 69000 1.9 
226 PHNA 900 NMI none 48 51. 0. 178000 77000 2,3 









Rano(%mol.)  Molecularwei 1 
Nature MW (Da) M (Polyol) M (Diisocyanate) 
(Extender) 
Mw Mn D 
229 PPG-PEG 1900 MDI none 48.5 51. 5 0 62000 38000 1.6 
230 PPG-PEG 1900 HDI BD 25.0 520 23-0 99000 59000 1.7 
232 PPG-PE6 1900 MDI BD 25.0 52.0 23.0 47000 24000 1.9 
233 PPG-PE(, 1900 MDI OFHD 25.0 52.0 23.0 91000 59000 1.6 
234 PPG-PEG 1900 BIC1I I 	OFHI) 25.0  52.0 23.0 56000 38000 1.5 
235 PPG-PEG 1900 MDI On-lI) 1 	25.0  23.0 55000 28000 1 	1.9 
238 PPG-PEG 1900 MDI PG 25.0  23.0 62000 30000 1 2.1 
241 PPG-PEG 1900 MDI DMAPD 25.0  23.0 93000 40000 1 	2.3 
244 PPG-PEG 1900 MDI EG 25.0  23.0 58000 26000 2.2 
245 PHNGAD 1800 MDI OFHD 25.0  0 23-0 146000 4600)) 3.2 
246 PHNC,AD 1800 RICH OFHD 250  23.0 91000 38000 2.4 
247 P}{NGAD 1800 MDI OFHD 25.0  23.0 46000 22000 2.1 
248 PI-INGAD 1800 RICH DMAPD 25.0  23.01 94000 42000 2.2 
249 PHNGAI) 1800 MDI none 1 	48.5  0.0 79000 36000 2.2 
250 PHNGAD 1800 BICH none 48.5  0.0 75000 38000 2.0 
251 PI-INGAD 1800 MDI none 48.5  0.0 65000 26000 1 	2.5 
252 PI-INGAD 1900 MDI DHM -  33.0 32000 19000 1.7 
253 PPG-PEG 1900 MDI DMAPD -  33.0 108000 51000 2.1 
254 PHNGAD 1800 BICH MD -  33.0 41000 21000 1.9 
255 PPG-PEG 11900 MDI RD -  33.0 53000 29000 2.2 
256 PPG 425 MDI I 	none 48.5 51.5 0.01 123000 39000 3.2 
257 PTMG I 000) RICH DMAPD 1 17.0 52.0 33.01 39000 21000 18 
258 P MG 1000 BICH On-ID 1 -  52.0 33.0 40000 23000 1.7 
259 PI MG 2000 BICH DMAPD 17.0 52.0 33.0 35000 1 	20000 1.8 
260 PTMG 2000 RICH OFHD 52.0 33.0 39000 24000 1.6 
262 PTMG 2000 RICH RD 52.0 33.0 40000 23000 1.8 
263 P1MG I 000 IIDI OFUD 17.01 52.0 33.0 61000 37000 1.7 
264 PTMC 1000 MDI DMAPD - 52.0 33.0 42000 23000 1.8 
266 PPG-PEG 1900 RICH DMAPD - 52.0 33.0 75000 47000 1.6 
267 PPG-PEG 1900 RICH RD 17.0 52.0 33.0 35000 23000 1.5 
268 PTMG 1000 MDI DMAPI) - 52.0 23.01 63000 33000 1.9 
269 PPG 2000 MDI DEAPD 25 . 0 52.0 23.0 47000 24000 1.9 
270 P1MG 2000 MDI DMAPD 25.0 52.0 23.0 95000 45000 2.1 
271 PEG 400 MDI DMAPD - 52 23.0 21000 10000 2.1 
272 PEG 400 MDI none 58.01 42.0 0.0 9000 6500 1.4 
273 PPG 425 MDI DMAPD - 52.0 23.0 23000 12000 1.9 
274 PPG 425 MDI none _48.5 51.5 0.0 15000 9000 1.6 
275 PEG 400 MDI none 48.5 51.5 0.0 18000 10500 1.7 
276 P1MG 1000 MDI OFHD 17 52 33.0 58000 30000 1.9 
277 PTMG 2000 MDI OFHD 17. 52. 33.0 60000 31000 2.0 
278 PPG-PEG 900 MDI OFHD 17. 52.0 27000 2.0 
List of (polyurethanes) used in the thesis with their corresponding monomers, polyol 
molecular weights and monomers molecular ratio used in the synthesis. 
Appendix II: poly(acrylate) libraries) 230 
=\ + =\ No 
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[AJ/[B] = 90/10, 70/30, 50/50 
-185- 
+ 	\ 	+ 	' x y z 
Monomer A 	Monomer B 	Monomer C 
Synthesis of the poly(acrylates). 
* 
x Y Z 
Random terpolymer 
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List of monomer A used. 
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List of monomer C used 
- 187 - 
DMAAm 	DEAAm 	NIPAAm 	 A-H 	 MA-H 	 VAA 
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List of monomer B used. 
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p(MEMA-co-GMA): R = -C2H4-0-CH3 
p(MMA-co-GMA): R = -CH3 
Functionalisation scheme for the copolymer of GMA. 
	
TMEDA 	DEMEDA 	TMPDA 	MnHA 
HN 	HN 	HN 	 HN 
DnBA 	 DnHA 	 TEDETA 
HN 	 HN 
HN N 
r Nj 
MAn 	Pyrrole 	 DBnA 	 BnMA 
No  KD- N P H\-P 









MMA: methyl methacrylate 
EMA: ethyl methacrylate 










DAAAm: diacetone acrylamide(N-( 1,1 -dimethyl-3-oxobutyl)-acrylamide) 
DMA PMAAm: N-[3-(dimethylamino)propyl]acrylamide 
DEAEMA: 2-(diethylamino)ethyl methacrylate 
DMAEMA: 2-(diethylamino)ethyl methacrylate 
DEAEA: 2-(diethylamino)ethyl acrylate 
DMAEA: 2-(diethylamino)ethyl aciylate 
MTEMA: 2-(methylthio)ethyl methacrylate 
BAEMA: 2-(tert-butylamino)ethyl methacrylate 
BACOEA: 2-[[(butylamino)carbonyl]oxy]ethyl acrylate 
MNPMA: 2-methyl-2-nitropropyl methacrylate 
DMVBA: 	NN-dimethylvinylbenzylamine 
VAA: 	N-vinylacetamide 





A-H: acrylic acid 
AES-H: mono-2-(acryloyoxy)ethyl succinate 
MA-H: methacrylic acid 
AAG-H: 2-acrylamidoglycolic acid 
EGMP-H: ethylene glycol methacrylate phosphate 
Monomers C: 
DEAEMA: 2-(diethylamino)ethyl methacrylate 
DEAEA: 2-(diethylamino)ethyl acrylate 
Amines used to functionalise GMA based co-polymers: 











TMEDA N, N,N-trimethylethylenediamine 
DEMEDA NN-diethyl-}V'-methylethylenediamine 
TMPDA N,N,N-trimethyl- 1 ,3-propanediamine 
Mpi 1 -methylpiperazine 
TEDETA N,N,N,N-tetraethyldiethylenetriamine 
- 191 - 
Polymer 
reference 
Monomer (1) Monomer (2) Monomer (3) 
Ratio (% mol.) Molecluler_weight 
MW Mn PDI 
1a9 St DEAAm - 90 10 - 137000 63600 2.2 
I a7 St DEAAni - 70 30 - 138000 76700 18 
laS St DEAAm - 50 50 - 114000 56000 2.0 
1b7 St DMAAm - 70 30 - 124000 62500 2.0 
1c9 St NIPAAm - 90 10 - 143000 81700 1.8 
10 St NIPAAm - 70 30 - 137000 67500 2.0 
2a9 MMA DEAAm - 90 10 - 269000 98900 2.7 
2a7 MMA DEAAm - 70 30 - 291000 135000 2.2 
2a5 MMA DEAAm - 50 50 - 278000 116000 2.4 
2b9 MMA DMAAm - 90 10 - 273000 114000 2.4 
2b7 M M A DMAAm - 70 30 - 308000 117000 2.6 
2c9 MMA NIPAAm - 90 10 - 247000 106000 23 
20 MMA NIPAAm - 70 30 - 1926400 172000 11.2 
2c5 MMA NIPAAm - 50 50 - 1004400 108000 9.3 
3a9 MEMA DEAAm - 90 10 - 218500 73200 3.0 
3a7 MEMA DEAAni - 70 30 - 215200 62200 3.5 
385 MEMA DEAAm - 50 50 - 194000 62400 3.1 
3b9 MEMA DMAAm - 90 10 - 198000 67100 3.0 
3b7 MEMA DMAAm - 70 30 - 213000 70300 3.0 
3c9 MEMA NIPAAm - 90 10 - 218000 70500 3.1 
30 MEMA NIPAAm - 70 30 - 634000 82500 7.7 
3c5 MEMA NIPAArn  50 50 - 417000 70600 5.9 
4a9 MEA DEAAm - 90 10 - 173000 39700 4.4 
4a7 MEA DEAAm - 70 30 - 161000 47400 14 
4b9 MEA DEAAm - 90 10 - 213000 56800 3.8 
4c9 MEA NIPAAm - 90 10 - 547560 46800 11.7 
40 MEA NIPAAm - 70 30 - 1736610 54100 32.1 
4c5 MEA DEAAm - 50 50 - 3403080 82800 41.1 
5a9 HEMA DEAAm - 90 10 - 426000 59300 7.2 
5a7 I-IEMA DEAAm - 70 30 - 192000 29000 6.6 
5b9 IIEMA DMAAm - 90 10 - 515000 68300 7.5 
5b7 HEMA DMAAm - 70 30 - 258000 41500 6.2 
5c9 IiEMA NIPAAm - 90 10 - 266000 39500 6.7 
50 IIEMA DEAAni - 70 30 - 150000 20600 7.3 
5c5 HEMA DEAArn - 50 50 - 101000 12700 8.0 
6a9 IIPMA DEAAm - 90 10 - 157000 32500 4.8 
6a5 IIPMA DMAAm - 50 50 - 101000 15300 6.6 
6b9 IIPMA DMAAm - 90 10 - 331000 50500 6.6 
6b7 IIPMA DMAA - 70 30 - 204000 40500 50 
6c9 HPMA NIPAAm - 90 10 - 81300 26800 3.0 
60 HPMA NIPAAm - 70 30 - 67100 16200 4.1 
6c5 HPMA DEAAm - 50 50 - 106600 13700 7.8 
7a9 HBMA DEAAm - 90 10 - 175000 30500 5.7 
7a7 LII3MA DEAAm - 70 30 - 128000 19900 6.4 
7a5 HI3MA DMAAm - 50 50 - 61500 11600 5.3 
7b9 HBMA DMAAm - 90 10 - 431000 52500 8.2 
7b7 IIBMA DMAA - 70 30 - 309000 46200 6.7 
7b5 IIBMA DMAAm - 50 50 - 136000 27000 5.0 
7c9 HBMA NIPAAm - 90 10 - 111000 26200 4.2 
70 HBMA NIPAAm - 70 30 - 72100 17000 4.2 
7c5 HBMA NIPAAm - 50 50 - 52100 12300 4,2 
3e9 MEMA DEAEMA - 90 10 - 418000 102000 4.1 
3e7 MEMA DEAEMA - 70 30 - 315000 71500 4.4 
3e5 MEMA DEAEMA - 50 50 - 301000 99200 3.0 
31`9 MEMA DMAEMA - 90 10 - 455000 79100 5.8 
3f7 MEMA DMAEMA - 70 30 - 372000 87600 4.2 
3f5 MEMA DMAEMA - 50 50 - 239000 50800 4.T  
3g9 MEMA DEAEA - 90 10 - 242000 54300 45 
3g7 MEMA DEAEA - 70 30 - 277000 61100 4.5 
30 MEMA DEAEA - 50 50 - 222000 58600 38 
3h9 MEMA DMAEA - 90 10 - 282000 69500 4.1 
3h7 MIMA DMAEA - 70 30 - 392000 67100 5.8 
3i9 MEMA MTEMA - 90 10 - 177000 49100 3.6 




Monomer (l) ) Monomer (2) Monomer  3 
Mot cu1er weight 
i
Ratio(%mol.) 
 ti MW 
36 MEMA MTEMA  50 50 - 146000 46800 3.1 
3j9 MF.MA I3AIMA - 90 10 - 273000 61800 44 
3j7 MEMA I3AEMA - 70 30 - 315000 64100 49 
3j5 MF.MA BAEMA - 50 50 - 295000 75200 3.9 
319 MEMA DMAPMAA - 90 10 - 270000 68300 4.0 
3m9 MEMA BA('OEA - 90 10 - 241000 58700 4.1 
3m7 MEMA BACOEA - 70 30 - 302000 66800 4.5 
3m5 MEMA BACOEA - 50 50 - 337000 49000 6.9 
3n9 MEMA 1)MVI3A - 90 10 - 235000 67800 3.5 
3n7 MEMA E)MVI3A - 70 30 - 128000 40700 3.1 
3n5 MEMA 1)MVBA - 50 50 - 104000 35900 29 
3v9 MIMA VAA - 90 10 - 377000 79900 4.7 
30 MEMA VAA - 70 30 - 355000 94700 3.7 
3v5 MEMA VAA - 50 50 - 215000 68600 3.1 
3x9 MEMA VI - 90 10 - 382000 92200 4,0 
3x7 MEMA VI - 70 30 - 264000 72200 3.7 
3x5 MEMA VI - 50 50 - 301700 73500 4] 
3z9 MEMA VPNO - 90 10 - 218000 58900 17 
3z7 MEMA VPNO - 70 30 - 253000 56300 4.5 
3z5 MINA VPNO - 50 50 - 254000 37900 6.7 
3AA9 MINA VP4 - 90 to - 225000 75600 30 
3AA7 MEMA VP4 - 70 30 - 304000 103000 3.0 
3AA5 MEMA VP4 - 50 50 - 207000 70800 2.9 
3AB9 MIMA VP-2 - 90 10 - 235000 82400 29 
3A137 MINA VP-2 - 70 30 - 169000 65800 16 
3A135 ME-MA VP-2 - 50 50 - 383000 164000 2.3 
3AC9 MEMA DAAA - 90 10 - 54000 56900 2.7 
3AC7 MEMA DAAA - 70 30 - 228000 74200 3.1 
3AC5 MEMA DAAA - 50 50 - 211000 51400 4.1 
3AE9 MEMA MNPMA - 90 10 - 12900() 50600 2.5 
3AE7 MEMA MNPMA - 70 30 - 289000 98800 19 
3AE5 MEMA MNI'MA - 50 50 - 177000 58500 3.0 
5e9 HEMA DEAEMA - 90 10 - 175000 35500 4.9 
5e7 HEMA DEAEMA - 70 30 - 158000 32000 4.9 
5e5 IIEMA DLAEMA - 50 50 - 199000 48800 4.1 
519 HEMA DMAEMA - 90 10 - 180000 40500 4.4 
517 IIEMA DMAEMA - 70 30 - 201000 47600 4.2 
51`5 I'IEMA DMAEMA - 50 50 - 167000 46100 3.6 
5g9 HEMA DEAEA - 90 10 - I5000 43300 45 
5g7 HEMA DEAEA - 70 30 - 84000 37000 5.0 
595 IIFMA DEAEA - 50 50 - 101000 21900 4.6 
5h9 IIFMA 1)MAEA - 90 10 - 208000 46700 4.5 
5h7 HIMA DMAF.A - 70 30 - 198000 44600 4.4 
5115 IIEMA DMAEA - 50 50 - 160000 31500 5.1 
519 HEMA MTEMA - 90 10 - 218000 58400 37 
50 FIEMA MTEMA - 70 30 - 160000 42000 3.8 
5i5 HI MA MTEMA - 50 50 - 165000 47900 3.4 
5j9 lIEMA BALMA - 90 10 - 239000 55300 4.3 
5j7 IIEMA BAEMA - 70 30 - 255000 51900 4.9 
50 IIEMA BAEMA - 50 50 - 21600() 54900 3.9 
519 HIMA DMAPMAA - 90 10 - 299000 74800 4.0 
517 HEMA DMAPMAA - 70 30 - 257000 69000 3.7 
515 HEMA DMAPMAA - 50 50 - 238000 57300 4 
5m9 HEMA BACOEA - 90 10 - 296000 60600 4.9 
5m7 IIEMA BACOEA - 70 30 - 302000 52000 5 
5in5 IIEMA I3ACOEA - 50 50 - 1960{)0 20700 9 
5n9 IHMA DMV13A - 90 10 - 243000 63600 18 
5n7 HEMA l)MVIIA - 70 30 - 163000 50600 3.2 
5n5 IlIMA DMVI3A - 50 50 - 110000 43800 2.5 
5v9 III MA VAA - 90 10 - 266000 62600 4.2 
50 FIEMA VAA - 70 30 - 211000 40900 52 
5v5 IJEMA VAA - 50 50 - 203000 42900 t7 
5x9 HEMA VI - 90 10 - 421000 83100 5.1 




Monomer (I) Monomer (2) Monomer (3) 
Ratio (% rnol.) Molecluler_weight 
 !!W! Jyfl Mw Mn PDI 
5x5 HEMA VI - 50 50 - 284000 52500 54 
5z9 HEMA VPNO - 90 10 - 372000 87000 4.3 
50 lIEMA VPNO - 70 30 - 322000 73800 4.4 
5z5 HEMA VPNO - 50 50 - 243000 63000 3.9 
5AA9 HEMA VP4 - 90 10 - 312000 72300 43 
5AA7 HEMA VP4 - 70 30 - 163000 42300 3.9 
5AA5 H EMA VP4 - 50 50 - 141000 48000 2.9 
5AB9 1-IEMA VP-2 - 90 10 - 290000 59800 48 
5AB7 HEMA VP-2 - 70 30 - 154000 44800 3.4 
5AB5 HEMA VP-2 - 50 50 - 153000 58000 26 
5AC9 IIEMA DAAA - 90 10 - 543000 88300 6.1 
5AC7 1-IEMA DAAA - 70 30 - 403000 77000 5.2 
SACS HEMA DAAA - 50 50 - 240000 47600 5.0 
5AE9 HEMA MNI'MA - 90 10 - 636000 110000 58 
5AE7 HEMA MNPMA - 70 30 - 560000 99500 5.6 
SAES IIEMA MNPMA - 50 50 - 477000 89800 53 
2BA9 MMA A-LI - 90 10 - 27800 12400 2.2 
213A7 MMA A-H - 70 30 - 38700 12500 3.1 
213139 MMA AES-H - 90 10 - 39400 16900 2.3 
20037 MMA A[S-H - 70 30 - N. D. N . D. N.D. 
2BC9 MMA MA-H - 90 tO - 24400 11000 2.2 
2BE9 MMA AAG-H - 90 tO - 2560() 11600 22 
2BE7 MMA AAG-H - 70 30 - 28500 13500 21 
2l3G9 MMA EGMP-1I - 90 10 - 31400 16800 1.9 
21367 MMA EGMP-}l - 70 30 - N. D N. D, ND 
2BG5 MMA EGMP-H - 50 50 - ND N.D. N . D. 
313A9 MEMA A-H - 90 10 - 28500 12700 12 
3BA7 MEMA A-ll - 70 30 - 42800 15300 2.9 
3BA5 MEMA A-Il - 50 50 - 27700 11900 2.3 
313B9 MEMA AES-I-I - 90 10 - 58200 20300 19 
313137 MEMA AES-H - 70 30 - N.D. N.D. N.D. 
313135 MEMA AES-H - 50 50 - N. D. N.D. ND 
3BC9 MEMA MA-H - 90 tO - 30900 12700 14 
3BC7 MEMA MA-Fl - 70 30 - 39800 15200 16 
313(5 MEMA MA-H - 50 50 - 37100 17500 21 
313E9 MEMA AAG-H - 90 tO - 50400 18500 17 
3BE7 MEMA AAG-H - 70 30 - 41400 15700 lb 
313E5 MEMA AAG-I-1 - 50 50 - 31100 13100 2.4 
313G9 MEMA EGMP-H - 90 - 53600 17700 30 
3BG7 MEMA EGMP-H - 70  - N. D. ND. ND 
313G5 MIMA EGMP-H - 50  - N. D. N. D. ND 
3e8.5 MEMA DEAEMA - 85  
V30 
- 216000 55600 3.9 
3e8 MIMA DEAEMA - 80  - 201000 51500 3.9 
3e7.5 MEMA DEAEMA - 75  - 172000 47100 3.7 
3e7 MEMA DEAEMA - 70 - 15500() 42200 3.7 
3e6.5 MEMA DEAEMA - 65 35 - 122000 37600 3.2 
3e6 MIMA DEAEMA - 60 40 - 158000 44600 3.5 
3e5.5 MEMA DEAEMA - 55 45 - 141000 40800 3.5 
2e9 MMA DEAEMA - 90 10 - 207000 66800 3.1 
2e7 MMA DEAEMA - 70 30 - 183000 53400 3.4 
219 MMA DMAIIMA - 90 10 - 200000 75300 2.7 
217 MMA DMAEMA - 70 30 - 199000 64100 3.1 
2f5 MMA DMAEMA - 50 50 - 200000 65100 3.1 
2g9 MMA DEAL A - 90 10 - 149000 46800 32 
2g7 MMA DEAEA - 70 30 - 120000 33600 16 
2g5 MMA DEAF.A - 50 50 - 43300 20000 22 
2h9 MMA DMAEA - 90 10 - 186000 58500 3.2 
2h7 MMA DMAEA - 70 30 - 163000 35600 4.6 
AS MMA DMAEA - 50 50 - 143000 26100 5.5 
6e9 HPMA DEAEMA - 90 10 - I4900() 75800 2.0 
619 HPMA DMAEMA - 90 10 - 166000 83200 2.0 
6g9 HPMA DEAEA - 90 10 - 145000 70700 2] 
6h9 HPMA DMAEA - 90 10 - 120000 60400 20 
7e9 HISMA DIjAIMA - 90 10 - 161000 78000 2.1 
7e7 HI3MA DEAEMA - 70 30 - 121000 58900 2.1 




Monomer (1) Monomer (2) Monomer (3) 
Ratio (% mot.) MoIecluIe,'eh1 
M(2) MW Mn P1)1 
719 HBMA DMAEMA - 90 10 - 192000 89000 2.2 
717 FIRMA DMAEMA - 70 30 - 149000 70700 2.1 
7g9 FIRMA DEAEA - 90 10 - 103000 51400 213 
7g7 IIRMA DEAEA - 70 30 - 48200 21200 2.3 
7h9 HBMA DMAEA - 90 10 - 133000 66000 2.0 
7h7 FIRMA DMAEA - 70 30 - 80900 28900 2.8 
8e9 EMA DEAEMA - 90 10 - 114000 25500 4.5 
8.e5 EMA DEAEMA - 50 50 - 126000 35700 3.5 
819 EMA DMAEMA - 90 10 - 2000 43200 2.6 
817 EMA DMAEMA - 70 30 - 120000 41900 19 
81`5 EMA DMAEMA - 50 50 - 124000 38200 12 
8g9 EMA DEAEA - 90 10 - 123000 45000 17 
8g7 EMA DEAEA - 70 30 - 900000 35800 2.5 
8g5 EMA DEAEA - 50 50 - 44000 17800 2.5 
8h9 EMA DMAEA - 90 10 - 240000 56100 4.3 
8h7 EMA I)MAEA - 70 30 - 369000 42500 87 
8h5 EMA DMAEA  50 50 - 291000 30700 9.5 
9e9 BMA DEAEMA - 90 10 - 208000 78400 17 
919 DMA DMAEMA - 90 10 - 278000 105000 16 
9f5 BMA DMAEMA - 50 50 - 256000 78300 3.3 
9g9 BMA DEAEA - 90 10 - 203000 74100 27 
9g5 DMA DEAEA - 50 50 - 49300 22300 2.2 
9h9 DMA DMAEA - 90 10 - 188000 76700 2.5 
9h7 DMA DMAEA - 70 30 - 214000 51100 4.2 
9h5 BMA DMAEA - 50 50 - 206000 30600 6.7 
2BAe7-2.0 MMA A-H DEAEMA 70 20 10 73200 36900 2.0 
2BAe7-I.5 MMA A-H DEAEMA 70 15 IS 89000 42200 2.1 
2BAe7-I.0 MMA A-H DEAEMA 70 10 20 106000 44700 2.4 
2BAg7-2.0 MMA A-H DEAEA 70 20 10 54200 27500 2.0 
2BAg74.5 MMA A-H DEAEA 70 IS IS 63600 31600 2.0 
2BAg7-1.0 MMA A-Il DEAFA 70 10 20 62600 28300 2.2 
2HCe7-1.5 MMA MA-H DEAEMA 70 15 15 60900 31700 1.9 
213Ce7-1.0 MMA MA-H DEAEMA 70 10 20 83500 42300 10 
2BCg7-1.0 MMA MA-H DEAEA 70 10 20 56800 26100 2.2 
3BAe7-1.0 MEMA A-H DEAEMA 70 10 20 168000 58100 2.9 
3BCe7-I.0 MEMA MA-H DEAEMA 70 10 20 141000 54200 2.6 
3BCg7-1.0 MEMA MA-H DEAEA 70 10 20 105000 38900 2.7 
2GAI-9 MMA GMA DnBA 90 10 - >2.000.000 NA. N.A. 
2GAI-7 MMA GMA DnBA 70 30 - >2,000000 N.A. N . A. 
2GA2-9 MMA GMA DnHA 90 10 - 1900000 529000 3.6 
2GA2-7 MMA GMA DnHA 70 30 - >2,000.000 N.A. N . A. 
2GA3-9 MMA GMA DcHA 90 10 - 1280000 276000 4.6 
2GA3-7 MMA GMA DcHA 70 30 .- 2.000.000 N.A. N.A. 
2GA4-9 MMA GMA DBnA 90 to - 633000 170000 3.7 
2GA4-7 MMA OMA DBnA 70 30 - >2,000,000 N.A. NA 
2GA4-5 MMA GMA DBnA 50 50 - >2.000.000 N.A. N .A. 
2GA5-9 MMA GMA MnHA 90 10 - >2.000.000 N.A. N . A. 
2GA5-7 MMA GMA MnFIA 70 30 - ..' 2.000.000 N.A. N . A. 
2GA5-5 MMA GMA MnIIA 50 50 - >2.000.000 N.A. N.A. 
2GA6-9 MMA GMA cHMA 90 10 - >2.000.000 N.A. N.A. 
2GA6-7 MMA GMA cI-IMA 70 30 - >2,000,000 N.A. N . A. 
2GA6-5 MMA GMA cIIMA 50 50 - >2.000.000 N.A. N.A. 
2GA7-9 MMA CJMA RnMA 90 10 - 1030000 224000 4.6 
2GA7-7 MMA GMA BnMA 70 30 - >2.000.000 N . A. N.A. 
2GA7-5 MMA GMA RnMA 50 50 - > 2.000.000 N.A. N .A. 
2GA8-9 MMA GMA MAEPy 90 10 - >2.000.000 N.A. N.A. 
2GA8-5 MMA GMA MAEPy 50 50 - >2,000,000 NA NA 
2GA9-9 MMA GMA Pyrrole 90 10 - 471000 124000 3.8 
2GA9-7 MMA GMA Pyrrole 70 30 - 718000 160000 45 
2GA9-5 MMA GMA Pyrrole 50 50 - 518000 132000 39 
2GAII-9 MMA GMA MAn 90 10 - >2.000.000 N.A.. NA. 
2GAII-7 MMA GMA MAn 70 30 - >2,000,000 N.A. N.A. 
2GAI I-S MMA GMA MAn 50 50 - >2,000,000 N.A. N A 
2GA12-9 MMA GMA TMEDA 90 10 - N . D. N . D. N . D. 
2GA12-7 MMA GMA TMLI)A 70 30 - N. D, N.D. N.D. 




Monomer (I) Monomer (2) Monomer (3) 
Ratio (°a moli MolecIu1el- A'eht 
:ii Mn PDI 
2GA13-9 MMA GMA DEMEDA 90 10 - N. D. N.D. ND. 
2GA14-9 MMA GMA TMPDA 90 10 - ND N, D N.D. 
2GA14-7 MMA GMA TMPDA 70 30 - N.D. N.D. N.D. 
2GA 15-9 MMA GMA Mpi 90 10 - N.D. N.D. N.D. 
2GA 15-7 MMA (]MA Mpi 70 30 - N . D. N.D. N.D. 
3GAI-9 MEMA GMA DnBA 90 10 - 762000 149000 5.1 
3GA2-9 MEMA GMA DnHA 90 10 - 942000 134000 7.0 
3GA4-9 MIMA G M A DBriA 90 10 - 676000 131000 52 
3GA5-9 MEMA GMA MnIIA 90 10 - 358000 75600 4.7 
3GA7-9 MFMA GMA BnMA 90 10 - 1800000 235000 7.7 
3GA9-9 MEMA GMA Pyrrole 90 10 - 791000 282000 2.8 
3GA9-7 MEMA GMA Pyrrole 70 30 - 922000 413000 2.2 
3GA9-5 MEMA GMA Pvrrole 50 50 - >2.000.000 N.A. N . A. 
3GAI 1-9 MEMA GMA MAn 90 10 - 723000 2920001 25 
3GA13-9 MEMA GMA DEMEDA 90 10 - N.D. N . D. N.D. 
3GA14-5 MEMA GMA TMPDA 50 50 - N.D. N . D. N . D. 
List of poly(acrvlates) used in the thesis with their corresponding monomers and 
monomer molecular ratio used in the synthesis. 
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Appendix III: grafted poly(allylamine) library)" 
A 
HCI 
LNH 	H20 	 LNHHCI 	




+ xcl + 
'~ NH 2 . HCI Ycl  
Carbonyl A 	Carbonyl B 	 X 0 	Y 
[A]/[B] = 67/33, 50/50, 33/67 
Synthesis of the poly(allylamine) derivatives. (A) Synthesis of poly(allylamine 
hydrochloride), (B) grafting with carbonyl chlorides. 
Cl 
Decanoyl chloride 
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Carbonyl (I) Carbonyl (2) 
Ratio (% mot.) Molecular weight _________ 
 C(l) C(2) Mw Mn P01 
1/4a hexanovl myristoyl 33.3 667 ND. N . D. N.D. 
1/4b hexanoyl myristoyl 50.0 50.0 N.D. N.D. N.D. 
1/4c hexanoyl myristoyl 66.7 33.3 ND. N.D. N.D. 
l/Sa hexanoyl toluoyl 33.3 66.7 7210 12300 1.7 
1/5b hexanoyl toluoyl 50.0 50.0 8720 13900 1.6 
1/5c hexanoyl toluoyl 66.7 33.3 6860 1 	13800 2.0 
I/6a hexanoyl p-hexyl benzoyl 33.3 66.7 8970 13500 1.5 
I/6b hexanoyl p-hexyl benzoyl 50.0 50.0 6780 11400 1.7 
1/6c hexanoyl p-hexyl benzoyl 66.7 33.3 6770 11700 1.7 
1/7a hexanoyl 2,6-dimethoxybenzoyl 33.3 66.7 8140 12800 1.6 
1/7b hexanoyl 2.6-dimethoxybenzoyl 50.0 50.0 7580 12800 1.7 
inc hexanovi 2,6-dimethoxyhenzoyl 66.71 33.3 7800 13700 1.8 
I/8a hexanoyl p-anisoyl 33.3 66.7 8530 1 	14000 1.6 
I/815 hexanoyl p-anisoyl 50.0 50.0 8520 14100 1.7 
I/8c hexanoyl p-anisoyl 66.7 33.3 8320 14100 1.7 
2J3a benzoyl decanoyl 33.3 66.7 18900 28800 1.5 
23b benzoyl decanoyl 50.0 50.0 9150 14000 1.5 
2/4b benzoyl mvristoyl 50.0 50.0 15500 24200 1.6 
2/4c benzoyl myristoyl 66.71 33.3 7400 13000 1.8 
215a benzoyl toluoyl 33.3 66.7 7590 12800 1.7 
2/5b benzoyl toluoyl 50.0 50.0 7470 12300 1.7 
2/5c benzoyl toluoyl 66.7 33.3 7700 12100 1.6 
2/7a benzoyl 2.6-dimelhoxybenzoyl 33.3 66.7 8740 1 	12300 1.4 
2/7b benzoyl 2,6-dimethoxybenzoyl 50.0 50.0 8010 13000 1.6 
2/7c benzoyl 2.6-dimethoxybenzoyl 66.7 33.3 8010 12200 1.5 
2/8a benzoyl p-anisoyl 33.31 66.7 8350 12800 1.5 
2/8b benzoyl p-anisoyl 50.01 50.0 9080 14400 1.6 
2/8c benzoyl p-anisoyl 66.7 33.3 9090 13900 1.5 
2/9a bcnzoyl nicotonoyl 33.3 66.7 8530 12900 1 	1.5 
2/9b benzoyl nicotonoyl 50.0 50.0 28300 82900 2.9 
2/9c benzoyl nicotonoyl 66.7 33.3 28300 78900 2.7 
3/4c decanoyl myristoyl 66.7 33.3 N.D. N.D. N.D. 
3/5a decanoyl toluoyl 33.3 66.7 30400 67300 2.2 
3/5b decanoyl toluoyl 500 50.0 26800 76500 2.8 
3/8a decanoyl p-anisoyl 33.3 66.7 82600 77000 2.7 
3/8b decanoyl p-anisoyl 50.0 50.0 26800 75700 1 	2.8 
3/8c decanoyl p-anisoyl 66.7 33.3 24700 71900 2.9 
4/7a myristoyl 2,6-dimethoxybenzoyl 33.3 66.7 14900 39900 2.6 
5/6a toluoyl p-hexyl benzoyl 33.3 66.7 23100 55300 2.4 
5/6b toluoyl p-hexyl benzoyl 50,0 50.0 28600 79700 2.7 
5/6c toluoyl p-hexyl benzoyl 66.7 33.3 29500 88800 3.0 
5/7a toluoyl 2.6-dimethoxybenzoyl 33.3 66.7 24700 42400 1.7 
5/7b toiuoyl 2.6-dimethoxybenzoyl 50.0 50.0 27500 77300 2.8 
5/7c toluoyl 2,6-dimethoxybenzoyl 66.7 33.3 24300 73400 3.0 
5/8a toluoyl p-anisoyl 33.3 66.7 26200 46800 1.8 
5/8h toluoyl p-anisoyl 50.01 50.0 25400 44200 1.7 
5/8c toluoyl p-anisoyl 66.7 33.3 25000 43600 1.7 
6/7a p-hexyl benzoyl 2,6-dimethoxybenzoyl 33.3 66.7 N.D. 	I N.D. N.D. 
6/7b p-hexyl benzoyl 2,6-dimethoxybenzoyl 50.0 50.0 28600 84400 2.9 
6/8a p-hexyl benzoyl p-anisoyl 33.3 66.7 34000 89900 2.6 
6/8b p-hexyl benzoyl p-anisoyl 50.0 50.0 29500 82100 2.8 
6/9a p-hexyl beuzoyl nicotonoyl 33.3 66.7 24300 70700 2.9 
7/8a 2,6-dimethoxybenzoyl p-anisoyl 33.31 66.7 28100 74800 2.6 
7/8b 2,6-dimethoxybenzoyl p-anisoyl 50.0 50.0 28500 85700 2.9 
7/8c 2,6-dimethoxybenzoyl panisoyI 66.71 33.31 25000 	1 55300 	1 2.2 
8/9b p-anisoyl nicotonoyl 50.0 50 . 01 27700 	1 50500 	1 1.8 
List of grafted poly(allylamine) used in the thesis with their corresponding carbonyl 
chloride used tofunctionalise them. 
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Polymer microarrays for cellular adhesiont 
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Mlcroarray screening of polymer libraries for cellular adhesion 
was developed utilising a thin film of agarose to allow 
unsurpassed loeslisatlon of cell binding notes the array substrate 
and the discover)  of cell spcethc polymers. 
'l'he profound impact of array's in the biological arena cannot be 
overlooked, taking into consideration the t temendous multiplexing 
ability an array can oIler to a specific application. The most 
common examples are DNA "amsve' or chips, which are widely  
used for tnRNA profiling. touted for diagnostic applications, used 
for SNP analysis and potentially have a role to play in [)NA 
sequencing.' but the multiplexing power of arrays has been 
exploited in an increasing number of arenas such as the high- 
throughput (1-IT; characterisation of gene function with, for 
example, cell-based screens developed in a microarray type 
fomsat! 
Polymers are essential in the area of bionmatenials and have been 
used in a myriad of applications.' The mechanism of cirl 
attachment onto polsiner surlaixa in cell culture has been 
extensively studied and it is broadly axepted that the First steps 
in this process are the adsorption of extraxllular matrix proteins 
onto the surface of the polymer. Cells then indirectly interact with 
the polymer through the adsorbed pn4eins which control a variety 
of cellular proixases such as adhesion. gtowtln and differentiation' 
As a result of such complex and innperfecils understood 
interactions, it is still impossible to predict.  froin the chemical 
structures of a polsmer, how such materials will perform when in 
contact with cells, blood or body fluids. As a consequence, the use 
of an HT approach to allow the rapid synthesis of chemically 
diverse polymers offers an important tool to find correlations 
between the design and performance of such tnaterials. 
Traditional methods of synthesis, identification and testing of 
new polymers are slow and thus over recent years. the field of 
automated and parallel synthesis of pohmers has grown 
enonnouslv 1 but, as is usually the case in any UT process, the 
Schoo/o/'(Tl:emLriry. VniwrsirvofF4lnhur5h, EJnthwr5k UK £119 3)) 
E-mail. mark braJkded teak. Fm, ',44 131 650 642M:  
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'The Ream) (irm/1. F,,iaer,ciry of Smaha,nptan ,tkdi'd Sd,00l. 
Southampton General HospitaL Southasnpraz. UK SOlo 6)D, 
E-mail. i.E. L llsns'4satm ',s..uA; Tel +44 238f 75 5447 
'.iaah: 1.:amei Cmqmoronm. 1•3-1. }'ahoh, kaaasaki.ku, Kawasaki-cifs, 
Kanagaea 2104413. Japan E-,,,ai!: n;i:omoto khdm enmthi-ka.wi Co. 1P 
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mmbbr,viaiions and m,,k'eular weights, espernneimlml details st substrsle 
preparation and cell cul(ure. See DO!: tO. 31J39/bbtlliXl9g 
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development of high-throughput chamcsensation and screening 
methods are often the rate limiting steps. The use of polynser 
arrays for cellular screening was recently reported 5 where human 
embryonic stem cells were successfully differentiated following 
attachment and growth onto a poly(acrv late) array. However, in 
this case the undnaractcnsed polymers were prepared using a 
nanoliter-scale synthetic approach altuch was complicated by the 
sen-v rapid esguoraticn of the "spotted" monoim/ra meaning the 
exact composition of the final polvuser was hard tx define. 
The polyturethanei9 library used in our studies (see Fig. I for the 
monomers used; was prepared by parallel synthesis and all 
individual members wear fully purified and characterised by girl 
permeation chromatograph, differential scanning calorinnetty and 
contact angle measurements prior to use . 5 Before printing in a 
nuicroarray type format each kbnmy mentber (for details see ESIi; 
was dissolved in a common solvent and transferred into a 384 well 
plate prior to contact printing. A number of parameters, such as 
the nature of solvent and substrate, inking and printing time had 
to be optimised in this process to ensuie unifomuty f the polymer 
spots within the array 
To obtain untfonn printing. the polymer library needed to be 
printed front a common. non-volatile solvent. 1-Methyl-2-
pvrrslidmnonr NMP) was selected on the basis that the majority 
4>90 of the poImer library was soluble in this solvent and that 
it allowed uniform spots to be printed, The formation of so called 
"rings""' during solvent evaporation was minimised by a 
p..,, 	 Thn..y. a.... E.R.d.. 
±1 
Fig. I Stnmxiurems of the different nmoessrwrs used in the polymer library 
synthesis. One esampk of polysurethanel structure is given The 
monomers, nsolecular weights, abbrcviauota and proportions used during 
the synthesis on be fund in the ESl. 
-- ihe Ro lva, ''.'- 	,'':.h'rnO, ,:5(, 
-199- 
combination of the high boding point solvent and su,xesrve 
layering of polymer solutions 5 stamps per spot). 
In order to deselop a cell compatible aaca. in a microarray 
format, the substrate had to cornpFv with the following require-
ments. Firk the substrate had to be unaltered b the contact 
printing of polymer solution in NMP. which tided out the use of 
polymer coatings such as poh(h)dro%elhyl methacrylate;, 
p4IIEMA)" whidi would be dissolved locally and give rise to 
polymer mixtures. Secondly, a substrate with low levels of 
background cell binding had to be developed to facilitate data 
analysis (the majority of work published to date with cells is the 
result of dramatic data manipulauon to remove datalcells that 
surround the spots) and third.h. the substrate had to be stable 
under UV-irradiation to allow sterilisation prior to the plating of 
the cells. 
A number of substrates were prepared C18 functiojialised 
Silane-Prep" slides. prrfluoroalk'vlthiol monolavers on gold coated 
slides and Silane-Prryc slides dip-coated with a lawr of agarose 
gel and the antifouling properties of the different substrates were 
tested with seieral mammalian cell lines (HEK293, FieLa, N[)7 
and J316Fl(i). The C18 functionalised slides, as expected, were 
highly hydrophobic and were able to reduce non-specific binding, 
but not all cell hues could be blocked in this manner. The use of 
perl1ustroalkl(hiol-modiiietl slides inhibited cellular adhesion. 
howexer it was impossible to use UV-irradiation for sterilisation 
as this degraded the surface. The best results were obtained by slip-
coaling anrinoalkvlsilane slides iSilane-Prep: Sigma) with a thin 
film of agarose (Fig. 2).' Although agarose has been used to 
amplify loading on DNA arrays" and is known to inhibit cellulat 
adhesion in a number of different formats.' - agarose has not been 
used as coating material for cell based rnicroarra\ assays. 
The polymer arrays were fabricated by contact printing using 
polymer solutions in NMP with each polymer printed in 
quadruplicate. Once piiiated, the slides were dried overnight untie, 
vacuum at 45 'C and sterilised by exposure to I-TV irradiation for 
15 minutes prior to cell plating. 
l'o illustrate Ike potential of the arra'. screening was carded out 
with pnnrars cells using antibody staining as a means of detection. 
This was undertaken wing human renal tubular epithelial x& 
Me cells were plated at l0 cells per slide and incubated for 5 days. 
Following fixation anti penneabilisation. the cells were incubated 
with ('AM5-2 anti-cytokeratin monoclonal antibody and sisust-
used using Alexa fluor 488 labelled I8G antibody. Finally 
Hoechst 33242 was used to stain the nuclei. Analysis was carried 
out using the I I('S platform and the Pathfinder' software 
(IMS1'AR S.A., France). This platform. bstsed on a fluoreseent 
microscope with an X-Y-Z stage, allows the automated capture of 
single images (0.46 mm 2) for each polymer spot with a resolution 
of 1138 Irn (Fig. 3). 
Cell compatibility was evaluated in terms of the total number of 
cells immobilised onto each pohmirr spot which wits identified 
using the DAN channel and the Pathtinder software. Several 
poly(urethanes) were shown to provide significant attachment with 
an average over the 4 identical pssh'nier spots of up to 153 human 
renal tubular epithelial cells tfor details see ESIt). The 6 
poivtunahancs) showing the highest number of bound cells (more 
than 140 cells per spot) all contained 4,4'-methlenchi4pheii lists-
cvanate) (MDI) (l't.'-Ig: 161: 65; 182; 195: 217). while the diol 
VFMG 1650 Da or l(IJO Da) was present in four of these top six 
polymers, thus allowing the rapid and direct correlation of 
polymer structure with cell binding. 
Overall, the microarray platform allows the identification of 
new pobniers for the attachment of various cell types, including 
primary cells which are of significant interest within the medical 
community. Using this approach, a whole library of bio- 
compatible polytneta presenting a wide range of properties can 
be screened in a single experiment, in a self-consistent manner 
allowing the rnicroarmy platform to provide a rapid correlation of 
polymer structure with cell binding ability. l'urthermore, since 
each library member was svnthesised on a scale that allowed 
characterisation prior to array t'ahricnnioii lhre is full confidence 
lig 	3 	l'iiiri;it I 	 It 	U'uIai .j'1r541.II .:M 	'ii 	 ,i 
'n an SrruI5 coniwiting 51) pohurers such printed as : ieplioits' spots; one 
'ol'iiner spot with rio tsickground ,sssturjcri,un (h) Nuclei slanied with 
I l'ochst 33'42. (e) Cain6-2 antibod) staining with Alexa F1uor' 48* 
ccondary antibody. (d) (:ompoiste image of (b) and (C) the bar represents 
10(1 pmt. Note: the bc,undarini of the curtIs are a function or the polymer 
spot and are not software processed. 
Chem. Common, 2006, 2118-2120 I 2119 
11g. 2 Non-specific all bindmg reduction using an ag'arese.coatcd 
tilistrute. Nos.procesessl intages ol,taine,J with Sun-I + estla slained with 
CeltTracker Gnats on two at with dilferent aibslraie (at unmodified 
gla'c, slide, (bi a8sitswe-co,,icd slide 
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in any St111cfluni-a1vitV relauoruthq, generated while allowing 
immediate scak-up lollowing pohiner identification. The agarose 
substrate proved to be NCM reliable in pnvenIing unwanted 
cellular adheo. with the potential to be developed for use with a 
large variety of cell-specific applications. such as global RNAi cell 
based phenotypic screens. 
We would like to acknowledge the EPSR( fLSfJ, Dr Rahul 
Tare and the Wessex Renal and Transplant Rcaeareh Fund. 
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Abstract 
A polymer mseroazra of 120 pot urethanes was used to identify potsmers that promoted the adheaion or bone marrow dentiritic cells 
BMI)Ci. Identified ilmers were coated onto glass cover slips and shown to be efficient siihstr.mtet, for the immobilisation of these 
primary cells. uhich underwciit efficient phagocytouis while still presumably maintaining their immature state. 
& 2006 Elsesmer I.W. All rights reserved. 
esis,,k t)endrits cells; Microsurovi: lk4surethane; Cell adhesion-  
1. Introduction 
Cellular adhesion has been investigated on it large 
number of substrates including glass, polystyrene. stainless 
steel. pol)prop)lene and gold 11 31. These materials are 
also often coated with arkmus materials to promote cell 
binding. which include synthetic polymers (e.g. moditied-
polveih.lenirnine PEI)) 12] and a variety of natural 
polymers ranging from poly L-lysine [3.41.  libronectin 
[15 71 and collagen 12.61 to more exotic materials such as 
spiders' silk ]7]. Other approaches have included the use 
of monolavers of organic molecules coated onto gold 
substrates [SI, but there are numerous (see for example 
19 II]). 
Cellular adhesion can be mediated by a variety of 
interactions, perhaps the most common being based on 
electrostatic interactions, with a highl posititel) charged 
surface leading to cellular immobilisation 12.41. Such a 
surface is proided. at physiological p11, by coatings based 
on poly i_-lysine and this has led to a myriad of applications 
and virtually unicrsal use of poly t-l)sine as it substrate 
for the immobilisation of cell lineages, but other poly- 
Corre'poni1ing autho;. Pair 4440 131ScOStS3. 
E.rnailajthv.mu . marL.hrud1ey'ted.ae.uk (M. Bradley t. 
0142.%l2/S.see front matter 4 2006 Elsevier Ltd. All rights reserved. 
dor 10.I01bfj.biounatcrumti.200b.04.0'I0 
calionic snthetic pol)mers such as FF1 [12] have also been 
used to immobilise cells. Other materials commonly used. 
such as polystyrene, are bclised to excrt,mediate their 
affects by physiosorption of extracellular matrix proteins. 
which in turn promote interactions with membrane 
proteins and hence cell adhesion [2]. 
Dendntic cells (DC) play a central role in the initiation 
of immune responses and in the maintenance of tolerance 
to self 113]. As professional antigen presenting cells, they 
can engulf particulate matter, such as pathogens, necrotic 
and apoptotic cells by phagocytosis, process it and present 
it at the cell sttrface, bound to MUC class I or Mll(' class 
II molecules 1141. This ability means that DC are 
intensively studied as targets for vaixtne design. particu-
larly for vaccines against tumours. DC are a rare 
constituent of any organ: and one of the most common 
experimental sources is to purify the immature, highly 
phagocytic cells from mouse bone marrow dendritic cell 
I3MDC). However. immature murinit BMDC are extre-
mely sensitive to stimuli that cause maturation (15], 
which affects their ability to capture antigens by phagocy-
tosis. while immobilisation is quite generally complicated 
by the fact that cellular behaviour may be modified by 
interactions with the materials used to coat the substrates 
[16.17]. 
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However, the immobilisation ot' DC would be important 
for several applications. ranging from simple phenotpic 
studies by mlcroscop. to the development of inno%ative 
cell-based a&ays. This paper shows how a polymer 
microarray 18] allowed the rapid and straightforward 
identification of specific polyurethanes able to act as 
substrates for cellular attachment of BMIX' isolated from 
mouse. In addition we show that the identified polytir-
ethane polymers compared more than faourabl y with the 
traditional adhesion compound. poly L-lysine in terms of 
cell adhesion and ceihuLir behaviour. 
2. Mater" and methods 
2.1 Srnthesis oJ'the po!t w'cs/sant' littrrarr' fIQJ 
Twelve parallel im.uous were carried our in a Stern bloA on a mu 
a tpiast two stage pnlv addition rnrclion. In t,net a pro-polymer 
was, prepared bN tile imtniu ot 1.0 equis akivi of a polyot witti 2,0 
equivalents of a diisocanate in .lrs 1141', followed tiler titration) h lire 
Addition of tO equivalent ot a ,'hait, extender. the library was tailored by 
varying the uattitC of the pvitok 1250-2(510 Or. And different coniposi. 
trorish the diuso.'sauate and the drain extender and the ratio of chain 
exrcrtder!potyol) The monounen. structures used in the ssuithesis of lire 
potvmet library are shown in Fig I together with tin example of' a 
rcprereuLrnt1e potyurethaire. The nionorner used were. Puisletirykue 
glycol) (PE(i20(6), PE6900, PEG400), lioiIpiopyIcue giyx'I; (PPG2000, 
P15iI000. 	PP4525), 	potstlelraniethylene 	gJ.-oI) 	t?1Mü2000, 
PThIGItUO, PTtvlG60, }qMG:IOf PEG-Plk.PIG 161906). 
potvll,6hexarreubo1ueopeulsl ghcol'dietbvlcrue g 	'aIt'Iadipi a.idtJ 
diol t PHN.\G Dl ItOOt, It ,ti-tueu.urabol neopentyt ghcol-alt.trrdipic aid)) 
diol (PI1NAI)900) were psedrased from Aldrich (Fig 1) and dried in a 
vacuum osen at W(: for 24 It pour to rise. 
The lilt potsmers of the library were all diaractenserl rising high-
throughput methods such as (iP( 4olurnn Pt.gel 11Th-I) Nix 75mru 
II) Polymer Laboratories, l.metlnl.2.pyrrolilunone INStIl I nil ruiu, 
Ityper I)S( (t)tarnonl. Per -kin (dine,- ) and FT-Ill Mattson irusrnirnenl). 
Po4snuerr. were named n ed followg a l't.lnumber torrurat jsoa Supplenren 
(sty Data for detaulsi. 
2 2. Preparation i ,I pronarv ,,,Wrne 8M1)C 
('S7BL6 truce were (wed tcscalty and housed in standard fcrtit,es in 
Soutltanrpton Fetnak or male mix we're use.! for bone marrow 
extraciton. KMI)(.' were purified front the temnurs of 11-12 weeks old 
C57IIL 4, nuce, according to lire method of Lutz et al 1201 and were used 
on dim 10 of in vitro culture, 
2.3. Po/ti,tpr microarrar preparation 
(oatur,g glare slides with agarose was achwved by dip-coating the 
a,nuno;rIkisutin,,e slide iStgusa-Aldnctr) in a t' n wfv solution 01 agarose 
Type I-B iSiginaf at 55 C 1oilwed he removal of the coirnug on the 
bottom tide. After di 'rug overnight at room temperature, the coated slider 
were stored at room tenupelature ot used inunediateIN for printing 1151 , 
Polyol Diisocyanate Chain Extender 
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Fig. I. Components used in the polyurethane library rynihesis. A representative structure is shown. See Supplementary Data for details. 
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lIce poI'incn arrays were thhti.ated bs coutad printing ((irnetis 
QAreav mini, Hampshire, (JK) with I6 aQu solid pins I K2765. Genesis, 
Hampshire. IJK3 using 1% w/c pOlsma solutions in NM.P placed In 
p(iIvprpslctic 38-t-well5 niicroplates. The following pouting conditions 
were used, 5 stamping per spot. 200m inking time and lOuis stamping 
time. The typical spot sue was 00-32fljim in diameter with spot-b-spot 
distances of II10(un allowing up to 180 polymets to he ptinteal on a 
stattdard 25, 75tnitt slide. Polymers were punted in quadruplicate within 
2 tidds of It, / It, spots, while within mcli OeId a potters if c 'I spots was 
left empty. Once pnntesl. the sli,les were dried overnight uttilet vacuum at 
-15'C and were stenitsed by eaposure to UV irradiation for 20 nun prior 
to use 
Prior to spin coatitug on -c Pt.705 spin ceatet iSpeedlunes Technologies. 
IN, USA), 21mm diattietci glass cover slips were cleaned with 
tetralodcofur'.iri (THFi hIt' tuicrolitres of the pohiner solutions 
wjs in TIM were placed oct10 the cosersltj,s and spun for lOs at 
00Orpnt Coset-utips wete ,JtieuJ under vacuum for llb and irrad.ted 
with LTV tight for 10min before use. 
24 Cell-based mitrr'arrar assays 
I3MDC were stained with 5pM carbosyfluorescein suoitumiciyt ester 
1('F1iE. Molecular Probes. Invitrogen Detection lectinrikigies. Renfrew. 
shirr, Uki to ttconutot cell adhesion as foilcitse: an aliquot of-? / 10' culLs 
was cesttrtfugrst fat S nut. at 300.5 at 20'(' and scastceul once with 
phoSplsite-buffered saline 4PBSj before retuspeneciori in I ml PBS contain-
ing 511st Ct-SI- and incubating for 1Omm at room temperature in the dark. 
After staining. the cells were centrifuged lot 5 nun at 300.5 at 20 `C and 
gently re.succpnnlnl in I tnt cell culture medium, RIO: RPMI-ttio 
llumvtirogm,tu, Rctmfcewslmire, UK) sutpl.letticnted with jwmcilliu. stceptoltmy. 
n and i .gicttamuine tlnvmtrcsgen, I)))) l.nil, lBlugtnI, 2mM, rt'speciivelvl. 
2.tnercurp(cceiltanol )SOJiM. Sigma) anti 10% heat.iriactis'atu,d anti filtered 
lots ettdotoeitc (octal calf serum iAutcgcai lliockar. Wiltshire. UK). the 
e'lIs were getmmIptperremi onto the surl'aae of a polsmer m,croarray 
contained in sterile Pein dish A further lflmtul kIt) was .'neel'ully added to 
the dish. whkh was suhsequenrh incccbnre,i il 37 C with Su CO2  for 2h. 
Aftet gentle uashcuig with RIO and threti PBS. the cells were them] with 4% 
wis fonnaldelcccle in PBS for IS nun at ricotmi tencperciture, threti timed and 
stored in PBS at I C.  Adhesion was chocked using a Zriss Asiovnt 200 
fluorescence nacroscope For precise quancihicatiors of cell adhesion, the 
lined cells were further stained with a 0.Spg'mmul solution of l)&Pi for 
IS nun at t oonc temperature Slides were netted and stored in Mat •t 1 
Image capture and atialyse's were cat dad Out using ciii ISISTAR high 
content screemtmg iI -hCSt desice equipped with the Pathcth,dertsi  soliware 
UMSF.AR SA, Paris. France). Cell compatibility with the diltereut 
polymers was determined by automated counting of the nunitier of cells 
pre-sent on each spot using both the DAPI and I'ETC channels 
2.5. .-lrtaly.scs ol BAltiC 
BMt)C were tesuspenuled in PBS containing 2% v:v Hl-FCS and 5p&, 
nil pit cerv(hruu.conjugared hamster ani-Cl) I Ic monoclonal antibody 
(B) Phartungeu 
 
Oxfoidsluime. UK) or a phcoerythtin.coujugateul ecotype 
cutmttol antiliody on ice for Sflncin before washing three runes with PBS 
l -ll-FCS (.eIlc weme rmuceu,Ijate)y attcrly-seml l't flow cvtome(rs FACS(,a-
Iibur, Ill). (hfotclshire, UK). Pot ncicrccsccopy. RNIDC ucilcete,l to 
o'sersltps ivete (iced in 4% v .tc luirrnaklehyule in PBS list 7 min at room 
temperature, pernse.cubiltsecl with 0,1', intrsu X-lOO for 7ncmn at room 
temperature. smshe,I 3 (tines with PBS and hint incubated with anti. 
CDT Ic mi'mnc,ehouial iscuitbody (icr I  at room ie,npematccre The criverslips 
were than washed 3 nines usitli PBS before staining statIc a Quantum Dot 
SoS rum-conjugated anti-nuouse ,ecottdarv atttitxaiv iQuccntuaut Dol. Cain' 
btidge, UK) and the nuclear mine, TO-PRO-S )Mculecu(.at Ptobes. 
hnvttrogerm t)ete,iion Technologies, Renfrewshire, UK). Ccivershps were 
mounted and acuculyseul usiuug ci Leica SF2 liner scanning conficival 
mnietcrsceope and a 100, objective. Cells stained with secondary antibody  
alone showed no detectable fluorescence using the swine instrument 
settings. 
Plcagiacybosis assays were crured Out with ins'erships coated with 
polymer Pt5I4, PU16tr or P1, 7 17 4 tal described above), or 001% sc/v 
Poly L-IySine solution Sigma histology grade or Sigma tissue cuhtttia 
grade). or uncu'rccted titicuisateml with Pith atone), were sti't-ili.sed by ISV 
light for 15 tutu in the bottom of a cm-well po1y resie culture plate 
(Ceretner Bio-Orte, Glousestereluire, t,'Ki A drOp ofO.Smh RIO containing 
Se 10' BTsII)C was pipetted into the centre ofeach coserslup, and the plate 
incubated at 5 7 'C, 5% CO- for the mills to adhere. taking care not to 
disturb the meniscus. ,l1ee Stinctti, a further I ml of RIO was added to 
each coeerslrp. colitaltung 5 I of 1  0 lun diiuuuetei sulphate Icier micro-
splcet es ([DC Leue, OR. USA). pie-coated ivuthi pusiirels adsot tutu] foetal 
uIfserucn proteins. The tnmcrcuspheres dime brought into cr.'ritart with the 
adhered cells by centrifuging the plate for Jnuui at 200.5 and 20'C. The 
plate was 11mm transferred to 37'C, 5%  CO: for a l'uttluer to  nit,. 
Afteu the itucuh,attc,tt, the RIO was meniciserl flotn the cocenslips, which 
wete ,itised briefly and gently with PBS, before being third with 1'4 
fornoildehyde in PBS lot 7nuiti at room temperature '[he HMDU were 
lmertneatnti , em,l t,s inculmuuting with)) I". S'JC Triton X-100 in PBS for 7nnuri 
at room tetnpeeuuture, then washed 3 times with PBS before being stained 
with turtihit anti-calnexmn antibody (SOtesgen, CA, USA) and goat anti-
iabl,mt Alesahlaor'lS$ secondary antibody iMolecuiar Probes, Itisitrugen 
E)csteclucn 1'echriologies, Rerifrewahire, 1.5K). Nuclei were stained willt 
TO-PRO-S. 
Ncccgocy'mosis quanritamiour scm curried out by examination of the 
c.iverships rising a I erca SP1 laser sccumtmng oorct'ocal utirctoscxipe with a 
'Ii), objective Three independent espemirtme'nis were caim'nmed ouc, in which 
each .covermcicp was tepresented in duplicate, h'licmgi.icytosms was quantified 
lr .xmtmmmtttug the tciumtmhmer of tnccumispherei iuterncsli,ucd and the number of 
cells in a randomly selected held of view. tnternahmsecl microsplieres were 
those tietittect as surrounded by cauhiuwin siammtig in all three dimensions 
(Fig, 5) Figures fur 1rhagiscytosis elhcietccy were derived from the counts 
of two to foccm held, of siew pet' tu ecitnieumt, etixsmnpcuasing a mnmnimurmi of 73 
and a ina,eicriwit of 556 cells. The degree of adicisiciti ccciv classified by 
comparing time trucciher of cells liresemmr in ioum randomls' selected fields of 
stew for each tieaiimreut and che:kirmg clicit dicer were typical over the three 
independent evpeuimenls. 
3. Results and discussion 
The aim of this project was 10 USC a polymer microarray 
platform its order to discover new substrates for immobilis-
ing BMIX'. The substrates so identified were used as per 
traditional coating systems on coserslips both to improve 
cellular adhesion and to allow dtl'fereril bioassays requiring 
cellular attachment to a 21) surface (such as phagt'mes'tosis 
and microscopy) to be carried out. The process is 
sunmianised in Fig. 2. 
In this study 120 well-characterised politreIhane.s were 
used. The advantages of IhS microarray platform are that 
it allows a common set of screening conditions for all 
polymers, reqtimres only very limited amount: of each 
compound, and limited numbers of cells for each screen. 
3.! ldi'n:i/icinion of memft'ria/ifvr B1IDC intnto1miliszi ion 
usinq pr)/h'nwr flticrorirriivs 
After extraction of HMDC from mice, cells were labelled 
with CFSF before incubating with the PU polymer 
onicroarray. Following fixation, slides were scanned and 
The number of cells per spot counted to determine which 
substrates showed good cellular compatibility with BMDC 
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(Fig. 3). The LICS platform from IMSTAR was used to 
scan the slides, allowing automated capture of single 
images kr each single polymer spot with 0.58 mi resolu-
tion. This analsis also allowed polymers to be discarded 
which showed autolluorescence. avoiding the identification 
of false posilt%es. 
Three different polyurethanes 1PEJI59. PUI66 and 
PU 174) immobilised more than RI cells per spot (average  
across 4 identicalspots) and were selected and subse-
quently coated onto coverslips. 
Prior to plating on ctiverslips, the purit of the BMD(' 
preparation was assessed h staining cells with a fluor-
escent antibody against Cl)llc, a cell surface marker 
expressed by BMDC 1201. Stained cells were analysed by 
flow esIornetry. which showed that greater than 90% of the 
cells were positive for CD  Ic (Fig. 4A). Cells also stained 
—205— 
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CDflc-posttNEI calls 
CDI1c Nu'ti 
-t i,'.) fiNtilt 	i.iia,I oilS-, 11,­ . i­ , ,, I , .&.TljuCol&sl 
against a detulnue ..rll taifa,e 	irk, 	I. 1)1 I, tst., -k l,, it otiS in 
isolvpe ,ic,utrol ant ihists ,.hadtxt area, troll, and analysed by itoss 
torn5tr). Calls staining pcwtive Im CDI te are indicated b a ltonjonutj 
bar (itt [he tiitj'(Dt lzaniihod, Omit was used to stain BMDC that had 
adhered to the pohiners (hem, PUt 9), as desouibrd in Se,.-tion 2. Nuclei 
(blue) were euwttctstaiited with TO-PRO-3 The image was obtained using 
a corifocal laser scanning nm.mosoope and is aonIposite of It, O.5un 
thick optical sceuioris. 
positive for the characteristic cost imulatorx markers CD80 
and CD86 and were brightly stained by antibodies against 
major histocornpatibiLity complex 11 (data not shown). all 
of which taken together indicate that the vast majority of 
cells in the preparation were BMDC. The CD] lc antibody 
was then used to identify BMDC that had adhered to the 
polymer-coated coxerslips. BMDC adhered rapidly and 
well to all three polymers, and the vast majority of adhered 
cells stained positive for CI)l Ic (Fig. 411). We cannot 
exclude that a xery small number of the cells adhering to 
the polymers were contaminants, as I3MIX.' preparations 
are never 1(X) 0,0 pure. 
3 2. P/tajoetioiz 
Although 131M1)C could adhere well to the three 
polymers, it was possible that the cells were not able to 
phagocylose while immobilised. A comparison cd phago-
ciic capacity was made between the three polmers and 
the traditional cell adhesion compound, poly t.-lysine. 
BMI)C were plated and allowed to adhere to covershps 
coated with either PUI59, PUI66. PU174. two grades of 
commercially available poly L-lysine or coverslips incu-
bated in PBS alone. Cells were then supplied with 3 im 
diameter latex microspheres and incubated for 30n,in at 
37T. Post- incttbalion, the cells were fixed and stained for 
the endoplasmic rehicuhun protein. calnexin. which pro-
vides a convenient cotunterstain revealing the presence of 
internalised niicrospheres (Fig. 5). Phagocytic capacity was 
determined by confocal microscopy and counting of the 
number of microspheres that had been completely inter-
nalised (rable I). 
Interesting], the greatest phagoc'v tie capacity, an 
.i'.erage of 4.4 microspheres per cell, was observed for cells 
list had adhered to coverslips treated with PBS alone 
Hg. 5. Control panels). However, the degree of adhesion 
it cells was very poor, and the cells were liable to be 
.ushed away from the coverslip both during the assay and 
ilterwards during staining. Poly i.-lysine of both grades 
i -eatly improved adhesion, but there was it concomitant 
.k'crease in the phagocvtic capacity to an axerage of 1.3 
rnierospheres per cell iFig,S. Poly L-lysiuie panels). 
•\llhough many microspheres were bound to the cell 
urtsce. closer examination of optical sections revealed 
that most had not been internalised. One possible 
explanation is that the physical restriction of cell move-
ment caused by adhesion to a substrate inhibits the 
cx toskeletal rearrangements necessary during phagecyto-
Sw. In support of this idea, phagocytosis decreased to zero 
when the concentration of poly u.-lysine was increased ten-
fold (data not shown). Similar signalling pathways are 
involved for both cell adhesion to a substrate and adhesion 
to a particle to be phagocylosed 1211. Whereas cell adhesion 
can stimulate membrane extension, as for the filopoctia and 
ruffles that engulf a particle, there are also eases where 
adhesion can inhibit membrane protrusion, such as the 
inhibition of cell migration in culture caused by cell cell 
contacts 122], which may provide an alternative explana-
tion for the observed decrease in phagoctosis b y cells 
adhered to poly i.-lysine. In addition to reducing the 
phagoevtic capacity, polv t.-ivsinc caused greater back-
ground binding of microspheres to the coverslip than was 
observed for the polymers and PBS control. This is most 
likely due to charge interactions, since the microspheres 
carry a net negative charge, and lysine is a positively 
charged amino acid at physiological p11. 
By contrast. phagocytic capacity was much greater for 
the three polymers. with average values 01' 33 and 3.6 
microspheres per cell for P1159 and PU 174. respectively. 
although still less than that observed in the PBS control 
sample. Adhesion, measured as the number of cells in a 
field of' view, was greater for 1 11166 than PU159 and 
1111174. but this was accompanied by a decrease in 
phagoex. tic capacity to 2.2 microspheres per cell. Taken 
together with the results for poly i-lysinc. it appears that 
there is a trade-off between degree of adhesion and 
phagoeytic capacity. Importantly however, adhesion to 
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Fig. 5 (onI,.I 	 p. 	 o B11)(. adhered to covet slips and stained with anti-,liu 
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rpediveh Ptu.seoinliasi images indicate the number ti ukiospheces bound ll,uI not nconssuril internaltsedt to cells and also reveal the degree on 
spesalk binding of nuruspheres to the .oset.lip. 
	non- 
Fluorescence images shots oplalal se,iions It) ran thick llon,ontal scale bars represent 75in BI 
tmages aken with a 100, objeeluse. The fluoresenee image shows in more detail the internalised nurosplueius ilypical examples marked ba axrowsj. The 
asterisk denotes tire position of a nuezosplucre that has bound to the cell surface (shown in the cortesponding phase contrast image), but has not been 
inteinaliaesl Horizontal scale bars represent  I I pin. 
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.( 5Inp11 .1 	BknInitTndiS L" (214,6 52" 5O) 
	 mm 
Table I 
Pbapctoa renika on differs,it aubstrales 
Treatment 	 .Adbion 	 MioaWhejes,icell 	 Cells .xsuulrd 	 M,pheees nx'unled 
Control Poor 1.4 73 323 
Pots i'lsEtc, histology grade Good 1.3 312 421 
Poly i.lssaie, tissue culture grade Excellent 13 529 684 
Pt'-159 Good Ii 297 
P15-161, Fxn,'ellent 2.2 556 1249 
Pt'-174 Good 3.6 301 1073 
PU 166 was as good as to tissue-culture grade poly L-l)Sifle. 
but PU 166 enabled almost double the phagocs tic capacity. 
Our  observations suggest that the Pt polsmers are 
superior to pok i-1vsine, because they mediate good 
adhesion, while allowing much greater phagoctic aCtivtt't. 
4. Conclusions 
The high multiplexing power of the pohrner microarray 
approach allows the screening of large numbers of different 
hiomaterials under identical conditions in a single experi-
ment, thus enabling the rapid determination of structure 
activity relationships. Three polvut'ethaties were identified 
using the microarra approach which bound immature DC 
from murine bone marrow's, all of which contained 
pol).ktetramethykne glcol) tPTMG 250 or 1000 l).t as 
the diol and 44nteth'.lene biMphcnvlisocyanate) (MI)l) as 
the djisocyanate, with variation found in the chain extender 
(propleaeglvcol. butane-I .4-diol or no chain extendert. 
This family of polmers will facilitate experimental 
handling of these cells and aid efforts in elucidating 
processes underlying antigen uptake, processing, presenta-
tion and immune stimulation or tolerisation and for 
studying intracellular processes such as cell migration and 
even interactions between cell tpes. 
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